,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,GO_Biological_Process_2021,negative regulation of relaxation of muscle (GO:1901078),2/6,0.001299607122307,0.2886174440439021,0,0,52.95989304812834,351.955205011133,PDE4D;PDE4B
1,GO_Biological_Process_2021,regulation of relaxation of cardiac muscle (GO:1901897),2/6,0.001299607122307,0.2886174440439021,0,0,52.95989304812834,351.955205011133,PDE4D;PDE4B
2,GO_Biological_Process_2021,cilium organization (GO:0044782),8/228,0.001501984387151,0.2886174440439021,0,0,3.935911602209945,25.587235850681488,ARMC2;CEP126;FAM161A;CEP83;NEK1;FAM161B;DZIP1;KIF27
3,GO_Biological_Process_2021,positive regulation of interleukin-2 production (GO:0032743),3/26,0.001839965414496,0.2886174440439021,0,0,13.8765778401122,87.39480524354776,PDE4D;PDE4B;MAP3K7
4,GO_Biological_Process_2021,regulation of cardiac muscle cell contraction (GO:0086004),3/27,0.0020556675397121,0.2886174440439021,0,0,13.29771505376344,82.27501948856492,PDE4D;PDE4B;CACNA1C
5,GO_Biological_Process_2021,establishment of endothelial barrier (GO:0061028),3/29,0.0025326839204598,0.2886174440439021,0,0,12.273573200992557,73.37725913930568,PDE4D;RDX;RAPGEF6
6,GO_Biological_Process_2021,regulation of transmembrane transporter activity (GO:0022898),2/9,0.003061318462855,0.2886174440439021,0,0,30.25821237585944,175.16205566578424,CHRM3;BCL2
7,GO_Biological_Process_2021,negative regulation of JNK cascade (GO:0046329),3/33,0.0036785274595423,0.2886174440439021,0,0,10.63494623655914,59.61145532893969,TAOK3;ZMYND11;HIPK3
8,GO_Biological_Process_2021,regulation of actin filament-based movement (GO:1903115),2/10,0.0038029224368117,0.2886174440439021,0,0,26.47459893048128,147.51607991629834,PDE4D;PDE4B
9,GO_Biological_Process_2021,cellular response to oxygen levels (GO:0071453),2/10,0.0038029224368117,0.2886174440439021,0,0,26.47459893048128,147.51607991629834,ATP6V1A;CPEB4
10,GO_Biological_Process_2021,positive regulation of keratinocyte migration (GO:0051549),2/10,0.0038029224368117,0.2886174440439021,0,0,26.47459893048128,147.51607991629834,ADAM9;MAPRE2
11,GO_Biological_Process_2021,lipoprotein transport (GO:0042953),2/10,0.0038029224368117,0.2886174440439021,0,0,26.47459893048128,147.51607991629834,MIA3;ZDHHC17
12,GO_Biological_Process_2021,response to tumor necrosis factor (GO:0034612),5/110,0.0039303267027592,0.2886174440439021,0,0,5.099896480331263,28.24849350419042,ASAH1;ERBIN;ADAM9;CXCL16;NFE2L2
13,GO_Biological_Process_2021,regulation of JUN kinase activity (GO:0043506),3/35,0.0043522225478852,0.2886174440439021,0,0,9.969254032258064,54.2035184013119,TAOK3;MAP3K7;HIPK3
14,GO_Biological_Process_2021,lipoprotein localization (GO:0044872),2/11,0.0046192192413566,0.2886174440439021,0,0,23.531788472964944,126.54288866714312,MIA3;ZDHHC17
15,GO_Biological_Process_2021,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",3/36,0.004715227161258,0.2886174440439021,0,0,9.666666666666666,51.78392912781091,PPP3CA;MAP3K7;TNRC6B
16,GO_Biological_Process_2021,endoplasmic reticulum organization (GO:0007029),4/73,0.005061730048437,0.2886174440439021,0,0,6.186290638464551,32.701022744651674,REEP5;CAV2;MIA3;TMCC1
17,GO_Biological_Process_2021,positive regulation of cell projection organization (GO:0031346),5/117,0.0051041766970617,0.2886174440439021,0,0,4.779454580745342,25.224508868836235,PTPRD;NTRK2;MAGI2;CAPRIN2;TWF1
18,GO_Biological_Process_2021,cellular response to thyroid hormone stimulus (GO:0097067),2/12,0.0055087461361039,0.2886174440439021,0,0,21.17754010695187,110.15324345880153,THRB;RDX
19,GO_Biological_Process_2021,regulation of keratinocyte migration (GO:0051547),2/12,0.0055087461361039,0.2886174440439021,0,0,21.17754010695187,110.15324345880153,ADAM9;MAPRE2
20,GO_Biological_Process_2021,integrin-mediated signaling pathway (GO:0007229),4/75,0.005570741107465,0.2886174440439021,0,0,6.0114198705748,31.200634805588464,DST;ERBIN;ITGB8;ADAM9
21,GO_Biological_Process_2021,response to thyroid hormone (GO:0097066),2/13,0.0064700610948986,0.3199739305113489,0,0,19.25133689839572,97.03770598812706,THRB;RDX
22,GO_Biological_Process_2021,integrated stress response signaling (GO:0140467),2/15,0.0086023891435701,0.4069304081827969,0,0,16.287947346770878,77.46084051521699,IMPACT;NFE2L2
23,GO_Biological_Process_2021,positive regulation of neuron projection development (GO:0010976),4/88,0.0097249036949203,0.4177697011463238,0,0,5.077734877734878,23.5254772258526,NTRK2;MAGI2;CAPRIN2;TWF1
24,GO_Biological_Process_2021,regulation of interleukin-2 production (GO:0032663),3/48,0.0105170541821969,0.4177697011463238,0,0,7.084587813620072,32.26857686845743,PDE4D;PDE4B;MAP3K7
25,GO_Biological_Process_2021,response to hydrogen peroxide (GO:0042542),3/49,0.0111263696842571,0.4177697011463238,0,0,6.930224403927069,31.17518023890249,IMPACT;ADAM9;NFE2L2
26,GO_Biological_Process_2021,positive regulation of dendrite morphogenesis (GO:0050775),2/20,0.0150924344910985,0.4177697011463238,0,0,11.760546642899584,49.31857782921134,PTPRD;CAPRIN2
27,GO_Biological_Process_2021,regulation of cell migration (GO:0030334),9/408,0.015808490259334,0.4177697011463238,0,0,2.4325814536340853,10.088421569451423,PPP3CA;PARD6B;SEMA6D;RDX;MAGI2;ADAM9;MIA3;SCAI;CXCL16
28,GO_Biological_Process_2021,neurotrophin signaling pathway (GO:0038179),2/21,0.0165785435434317,0.4177697011463238,0,0,11.141007599211934,45.67418698737144,NTRK2;MAGI2
29,GO_Biological_Process_2021,plasma membrane bounded cell projection assembly (GO:0120031),7/278,0.0167660916727604,0.4177697011463238,0,0,2.7732046551234744,11.337960996164234,CEP126;FAM161A;CEP83;NEK1;DZIP1;RAPGEF6;KIF27
30,GO_Biological_Process_2021,cellular response to nerve growth factor stimulus (GO:1990090),2/22,0.0181243532212572,0.4177697011463238,0,0,10.583422459893049,42.44480268606261,NTRK2;MAGI2
31,GO_Biological_Process_2021,membrane lipid metabolic process (GO:0006643),2/22,0.0181243532212572,0.4177697011463238,0,0,10.583422459893049,42.44480268606261,SERINC1;TEX2
32,GO_Biological_Process_2021,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),2/23,0.0197286150021996,0.4177697011463238,0,0,10.078940667175962,39.56674779525792,PDE4D;CACNA1C
33,GO_Biological_Process_2021,positive regulation of JUN kinase activity (GO:0043507),2/23,0.0197286150021996,0.4177697011463238,0,0,10.078940667175962,39.56674779525792,TAOK3;MAP3K7
34,GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),5/166,0.0208705106443578,0.4177697011463238,0,0,3.316567647853092,12.83318685439478,NTRK2;TAOK3;CAV2;STYX;ZDHHC17
35,GO_Biological_Process_2021,cAMP-mediated signaling (GO:0019933),2/25,0.0231075907946105,0.4177697011463238,0,0,9.201581027667984,34.66782247890572,PDE4D;ADGRG6
36,GO_Biological_Process_2021,negative regulation of sequestering of calcium ion (GO:0051283),2/25,0.0231075907946105,0.4177697011463238,0,0,9.201581027667984,34.66782247890572,IBTK;ITPR2
37,GO_Biological_Process_2021,protein transport (GO:0015031),8/369,0.0243948284513396,0.4177697011463238,0,0,2.3813532085520577,8.842879183659006,ATP6V1A;TBCK;RABGAP1L;STXBP3;SNX27;MIA2;MIA3;ZDHHC17
38,GO_Biological_Process_2021,endothelial cell development (GO:0001885),2/26,0.0248798970854269,0.4177697011463238,0,0,8.817736185383245,32.57002936039262,PDE4D;RDX
39,GO_Biological_Process_2021,peptidyl-threonine modification (GO:0018210),3/67,0.0255844142914928,0.4177697011463238,0,0,4.9765625,18.242943118595804,GALNT13;CDC42BPA;HIPK3
40,GO_Biological_Process_2021,regulation of translational initiation (GO:0006446),3/68,0.0265839510168534,0.4177697011463238,0,0,4.899751861042184,17.77359308244188,DNAJC3;IMPACT;EIF4G3
41,GO_Biological_Process_2021,release of sequestered calcium ion into cytosol (GO:0051209),2/27,0.0267058396026312,0.4177697011463238,0,0,8.464598930481284,30.666167139293783,IBTK;ITPR2
42,GO_Biological_Process_2021,regulation of plasma membrane bounded cell projection assembly (GO:0120032),3/70,0.0286450317745308,0.4177697011463238,0,0,4.75300914780934,16.88637331977862,DYNC2LI1;RDX;TWF1
43,GO_Biological_Process_2021,wound healing (GO:0042060),3/70,0.0286450317745308,0.4177697011463238,0,0,4.75300914780934,16.88637331977862,PPP3CA;DST;MIA3
44,GO_Biological_Process_2021,negative regulation of neuron apoptotic process (GO:0043524),3/71,0.0297065107886141,0.4177697011463238,0,0,4.682874762808349,16.466809485668165,NTRK2;BCL2;CPEB4
45,GO_Biological_Process_2021,response to metal ion (GO:0010038),3/71,0.0297065107886141,0.4177697011463238,0,0,4.682874762808349,16.466809485668165,PPP3CA;BCL2;ADAM9
46,GO_Biological_Process_2021,protein polyubiquitination (GO:0000209),7/314,0.0300367048556104,0.4177697011463238,0,0,2.443497870207968,8.565278973373662,KBTBD6;RNF19A;AKTIP;BCL2;WWP1;DZIP3;TRIM22
47,GO_Biological_Process_2021,cilium assembly (GO:0060271),7/314,0.0300367048556104,0.4177697011463238,0,0,2.443497870207968,8.565278973373662,DYNC2LI1;CEP126;FAM161A;CEP83;NEK1;DZIP1;KIF27
48,GO_Biological_Process_2021,positive regulation of neurogenesis (GO:0050769),3/72,0.030788563321566,0.4177697011463238,0,0,4.614773258532025,16.062235082573757,PTPRD;NTRK2;CAPRIN2
49,GO_Biological_Process_2021,regulation of hydrolase activity (GO:0051336),3/73,0.0318911437297608,0.4177697011463238,0,0,4.548617511520737,15.671929285579049,NTRK2;RDX;RAPGEF6
50,GO_Biological_Process_2021,insulin receptor signaling pathway (GO:0008286),3/73,0.0318911437297608,0.4177697011463238,0,0,4.548617511520737,15.671929285579049,ATP6V1A;CAV2;NAMPT
51,GO_Biological_Process_2021,ncRNA catabolic process (GO:0034661),2/30,0.0324939636407943,0.4177697011463238,0,0,7.556531703590527,25.893974299590774,DIS3L;RBM7
52,GO_Biological_Process_2021,regulation of GTPase activity (GO:0043087),5/189,0.0339223469766118,0.4177697011463238,0,0,2.8985999527410207,9.80793839518148,NTRK2;CAV2;RDX;RAPGEF6;MAPRE2
53,GO_Biological_Process_2021,cellular protein modification process (GO:0006464),16/1025,0.0339538440912289,0.4177697011463238,0,0,1.7234026707608403,5.829845905210428,CHRM3;USP25;MIA3;CDC42BPA;HIPK3;KTN1;DNAJC3;PTPRD;TBCK;PPP3CA;SNRK;KBTBD6;GRK5;TAOK3;MGAT4A;NEK1
54,GO_Biological_Process_2021,regulation of dendrite morphogenesis (GO:0048814),2/32,0.0366000652779162,0.4177697011463238,0,0,7.05204991087344,23.32610254890724,PTPRD;CAPRIN2
55,GO_Biological_Process_2021,phosphorylation (GO:0016310),8/400,0.036739217495625,0.4177697011463238,0,0,2.189536588115909,7.234032918910525,TBCK;SNRK;GRK5;TAOK3;POMK;NEK1;CDC42BPA;HIPK3
56,GO_Biological_Process_2021,axon development (GO:0061564),3/79,0.0389345417076376,0.4177697011463238,0,0,4.188242784380305,13.594506100899364,PARD6B;MTR;ZDHHC17
57,GO_Biological_Process_2021,negative regulation of NF-kappaB transcription factor activity (GO:0032088),3/79,0.0389345417076376,0.4177697011463238,0,0,4.188242784380305,13.594506100899364,NWD1;TAX1BP1;ERBIN
58,GO_Biological_Process_2021,negative regulation of intracellular signal transduction (GO:1902532),5/198,0.0401522119354284,0.4177697011463238,0,0,2.762164902004956,8.880574913613842,PDE4D;WWC2;MAGI2;BCL2;ZMYND11
59,GO_Biological_Process_2021,endomembrane system organization (GO:0010256),5/199,0.0408845448400235,0.4177697011463238,0,0,2.7477868668758405,8.784683307726258,REEP5;CAV2;AKTIP;MIA3;TMCC1
60,GO_Biological_Process_2021,regulation of protein phosphorylation (GO:0001932),6/266,0.0410283164682355,0.4177697011463238,0,0,2.465447667087011,7.873389386185562,MOB1B;NTRK2;IBTK;IMPACT;AKTIP;TWF1
61,GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),6/269,0.0429297700553985,0.4177697011463238,0,0,2.436950695007168,7.671983206656982,PPP3CA;SEMA6D;RDX;ADAM9;MIA3;CXCL16
62,GO_Biological_Process_2021,cellular response to hydrogen peroxide (GO:0070301),2/35,0.0431085237261873,0.4177697011463238,0,0,6.409982174688057,20.153205326958467,IMPACT;NFE2L2
63,GO_Biological_Process_2021,neuron projection morphogenesis (GO:0048812),4/140,0.0440041052106832,0.4177697011463238,0,0,3.127980922098569,9.7701619189164,IMPACT;PARD6B;TAOK3;ZDHHC17
64,GO_Biological_Process_2021,regulation of cardiac muscle contraction (GO:0055117),2/36,0.0453669567251516,0.4177697011463238,0,0,6.221138722868827,19.24180330146504,PDE4D;PDE4B
65,GO_Biological_Process_2021,cyclic-nucleotide-mediated signaling (GO:0019935),2/36,0.0453669567251516,0.4177697011463238,0,0,6.221138722868827,19.24180330146504,PDE4D;ADGRG6
66,GO_Biological_Process_2021,negative regulation of calcium ion-dependent exocytosis (GO:0045955),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,STXBP3
67,GO_Biological_Process_2021,anion homeostasis (GO:0055081),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,GLS
68,GO_Biological_Process_2021,regulation of adherens junction organization (GO:1903391),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,RDX
69,GO_Biological_Process_2021,caveola assembly (GO:0070836),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,CAV2
70,GO_Biological_Process_2021,negative regulation of organ growth (GO:0046621),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,WWC2
71,GO_Biological_Process_2021,cell-cell adhesion mediated by integrin (GO:0033631),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,ADAM9
72,GO_Biological_Process_2021,cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,NTRK2
73,GO_Biological_Process_2021,regulation of guanyl-nucleotide exchange factor activity (GO:1905097),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,CCPG1
74,GO_Biological_Process_2021,dorsal/ventral axis specification (GO:0009950),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,CXXC4
75,GO_Biological_Process_2021,positive regulation of dopamine receptor signaling pathway (GO:0060161),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,CAV2
76,GO_Biological_Process_2021,regulation of vascular associated smooth muscle contraction (GO:0003056),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,CHRM3
77,GO_Biological_Process_2021,Schwann cell differentiation (GO:0014037),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,ADGRG6
78,GO_Biological_Process_2021,positive regulation of protein localization to cilium (GO:1903566),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,EFCAB7
79,GO_Biological_Process_2021,membrane depolarization during AV node cell action potential (GO:0086045),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,CACNA1C
80,GO_Biological_Process_2021,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,NFE2L2
81,GO_Biological_Process_2021,positive regulation of translation in response to stress (GO:0032056),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,IMPACT
82,GO_Biological_Process_2021,mitochondrial RNA 3'-end processing (GO:0000965),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,TRNT1
83,GO_Biological_Process_2021,mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,CPSF2
84,GO_Biological_Process_2021,protein localization to microtubule end (GO:1905725),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,MAPRE2
85,GO_Biological_Process_2021,protein localization to microtubule plus-end (GO:1904825),1/5,0.0463696956816514,0.4177697011463238,0,0,26.33909574468085,80.89023777113094,MAPRE2
86,GO_Biological_Process_2021,protein phosphorylation (GO:0006468),9/496,0.0465481427964541,0.4177697011463238,0,0,1.9839835728952773,6.085409668928667,TBCK;NTRK2;SNRK;GRK5;TAOK3;NEK1;CDC42BPA;MAP3K7;HIPK3
87,GO_Biological_Process_2021,organelle organization (GO:0006996),8/420,0.0466228168068323,0.4177697011463238,0,0,2.081102826798262,6.379964569162653,ARMC2;FAM161A;REEP5;DST;CAV2;MIA3;FAM161B;TMCC1
88,GO_Biological_Process_2021,positive regulation of protein catabolic process (GO:0045732),3/85,0.046700229415973,0.4177697011463238,0,0,3.880605822187254,11.890200305813304,RDX;ADAM9;WWP1
89,GO_Biological_Process_2021,negative regulation of stress-activated MAPK cascade (GO:0032873),2/37,0.0476681577540553,0.4177697011463238,0,0,6.043086325439266,18.392082809932084,TAOK3;ZMYND11
90,GO_Biological_Process_2021,regulation of protein autophosphorylation (GO:0031952),2/37,0.0476681577540553,0.4177697011463238,0,0,6.043086325439266,18.392082809932084,MOB1B;IMPACT
91,GO_Biological_Process_2021,regulation of Ras protein signal transduction (GO:0046578),3/86,0.0480634180595958,0.4177697011463238,0,0,3.8336572094830936,11.636046440239054,KBTBD6;RDX;ERBIN
92,GO_Biological_Process_2021,connective tissue development (GO:0061448),2/38,0.0500111263466359,0.4177697011463238,0,0,5.874925727866905,17.59839742393779,NAMPT;ITGB8
93,GO_Biological_Process_2021,regulation of intracellular transport (GO:0032386),2/39,0.0523948769550082,0.4177697011463238,0,0,5.71585489232548,16.855750053277294,REEP5;ATP9A
94,GO_Biological_Process_2021,positive regulation of GTPase activity (GO:0043547),5/214,0.0528441530613147,0.4177697011463238,0,0,2.5486270022883297,7.49400375027579,TBCK;RABGAP1L;CAV2;RAPGEF6;MAPRE2
95,GO_Biological_Process_2021,protein localization to perinuclear region of cytoplasm (GO:1905719),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,AKTIP
96,GO_Biological_Process_2021,proton-transporting V-type ATPase complex assembly (GO:0070070),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,VMA21
97,GO_Biological_Process_2021,negative regulation of cell size (GO:0045792),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,RDX
98,GO_Biological_Process_2021,negative regulation of ERAD pathway (GO:1904293),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,USP25
99,GO_Biological_Process_2021,cellular response to cold (GO:0070417),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,DNAJC3
100,GO_Biological_Process_2021,regulation of focal adhesion disassembly (GO:0120182),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,MAPRE2
101,GO_Biological_Process_2021,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,ERBIN
102,GO_Biological_Process_2021,plasma membrane raft assembly (GO:0044854),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,CAV2
103,GO_Biological_Process_2021,establishment of lymphocyte polarity (GO:0001767),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,SNX27
104,GO_Biological_Process_2021,"regulation of retrograde transport, endosome to Golgi (GO:1905279)",1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,ATP9A
105,GO_Biological_Process_2021,positive regulation of focal adhesion disassembly (GO:0120183),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,MAPRE2
106,GO_Biological_Process_2021,positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,PDE4D
107,GO_Biological_Process_2021,response to manganese ion (GO:0010042),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,ADAM9
108,GO_Biological_Process_2021,intracellular pH elevation (GO:0051454),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,BCL2
109,GO_Biological_Process_2021,positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,NTRK2
110,GO_Biological_Process_2021,taurine metabolic process (GO:0019530),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,CSAD
111,GO_Biological_Process_2021,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,PTPRD
112,GO_Biological_Process_2021,tRNA 3'-end processing (GO:0042780),1/6,0.0553837340579632,0.4177697011463238,0,0,21.070212765957447,60.96601457084486,TRNT1
113,GO_Biological_Process_2021,negative regulation of protein phosphorylation (GO:0001933),4/152,0.0563428282096979,0.4177697011463238,0,0,2.872607742878013,8.262482566709712,DNAJC3;IBTK;IMPACT;PDE4D
114,GO_Biological_Process_2021,negative regulation of cell-cell adhesion (GO:0022408),2/41,0.0572808554084418,0.4177697011463238,0,0,5.422185657479775,15.50630593751062,RDX;MIA3
115,GO_Biological_Process_2021,endosome organization (GO:0007032),2/41,0.0572808554084418,0.4177697011463238,0,0,5.422185657479775,15.50630593751062,AKTIP;TMCC1
116,GO_Biological_Process_2021,keratinocyte differentiation (GO:0030216),2/41,0.0572808554084418,0.4177697011463238,0,0,5.422185657479775,15.50630593751062,ASAH1;ADAM9
117,GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),5/221,0.0590539553725135,0.4177697011463238,0,0,2.4651519726247986,6.974663733127261,PPP3CA;SEMA6D;RDX;ADAM9;CXCL16
118,GO_Biological_Process_2021,calcium ion transmembrane import into cytosol (GO:0097553),2/42,0.0597811850121942,0.4177697011463238,0,0,5.286363636363636,14.89202627383487,IBTK;ITPR2
119,GO_Biological_Process_2021,cellular response to glucose starvation (GO:0042149),2/43,0.062318499756473,0.4177697011463238,0,0,5.157167079692187,14.313701505156972,IMPACT;CPEB4
120,GO_Biological_Process_2021,positive regulation of neuron differentiation (GO:0045666),2/43,0.062318499756473,0.4177697011463238,0,0,5.157167079692187,14.313701505156972,IMPACT;BEND6
121,GO_Biological_Process_2021,receptor-mediated endocytosis of virus by host cell (GO:0019065),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,CAV2
122,GO_Biological_Process_2021,negative regulation of cytoplasmic translation (GO:2000766),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,CPEB4
123,GO_Biological_Process_2021,AV node cell action potential (GO:0086016),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,CACNA1C
124,GO_Biological_Process_2021,cellular response to laminar fluid shear stress (GO:0071499),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,NFE2L2
125,GO_Biological_Process_2021,regulation of glycogen (starch) synthase activity (GO:2000465),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,EPM2AIP1
126,GO_Biological_Process_2021,regulation of miRNA mediated inhibition of translation (GO:1905616),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,TNRC6B
127,GO_Biological_Process_2021,regulation of necrotic cell death (GO:0010939),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,ASAH1
128,GO_Biological_Process_2021,regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,ZDHHC17
129,GO_Biological_Process_2021,regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,NTRK2
130,GO_Biological_Process_2021,positive regulation of adenylate cyclase activity (GO:0045762),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,CACNA1C
131,GO_Biological_Process_2021,regulation of transforming growth factor beta activation (GO:1901388),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,ITGB8
132,GO_Biological_Process_2021,glomerular epithelial cell development (GO:0072310),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,MAGI2
133,GO_Biological_Process_2021,glomerular visceral epithelial cell development (GO:0072015),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,MAGI2
134,GO_Biological_Process_2021,positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,NFE2L2
135,GO_Biological_Process_2021,heart trabecula formation (GO:0060347),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,ADGRG6
136,GO_Biological_Process_2021,response to increased oxygen levels (GO:0036296),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,ATP6V1A
137,GO_Biological_Process_2021,positive regulation of interleukin-5 production (GO:0032754),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,PDE4D
138,GO_Biological_Process_2021,positive regulation of miRNA mediated inhibition of translation (GO:1905618),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,TNRC6B
139,GO_Biological_Process_2021,tachykinin receptor signaling pathway (GO:0007217),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,GRK5
140,GO_Biological_Process_2021,membrane biogenesis (GO:0044091),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,SERINC1
141,GO_Biological_Process_2021,membrane fission (GO:0090148),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,TMCC1
142,GO_Biological_Process_2021,protein localization to endoplasmic reticulum exit site (GO:0070973),1/7,0.0643130171482511,0.4177697011463238,0,0,17.55762411347518,48.17800160116977,MIA3
143,GO_Biological_Process_2021,response to lipopolysaccharide (GO:0032496),4/159,0.06431413886175,0.4177697011463238,0,0,2.7419006102877077,7.523708873817779,PDE4B;ERBIN;ADAM9;IFNAR1
144,GO_Biological_Process_2021,mRNA processing (GO:0006397),6/300,0.0658200279084398,0.4177697011463238,0,0,2.17653618824579,5.921987376187886,NOVA1;PRPF3;CPSF2;PPWD1;RPRD2;RBM6
145,GO_Biological_Process_2021,negative regulation of neuron death (GO:1901215),3/98,0.0659035895319266,0.4177697011463238,0,0,3.347368421052632,9.103377195016318,NTRK2;BCL2;CPEB4
146,GO_Biological_Process_2021,regulation of neuron apoptotic process (GO:0043523),3/98,0.0659035895319266,0.4177697011463238,0,0,3.347368421052632,9.103377195016318,NTRK2;BCL2;CPEB4
147,GO_Biological_Process_2021,establishment of protein localization to extracellular region (GO:0035592),2/46,0.0701432856658954,0.4177697011463238,0,0,4.804812834224599,12.767421652878062,MIA2;MIA3
148,GO_Biological_Process_2021,vesicle organization (GO:0016050),2/46,0.0701432856658954,0.4177697011463238,0,0,4.804812834224599,12.767421652878062,CAV2;AKTIP
149,GO_Biological_Process_2021,protein O-linked glycosylation (GO:0006493),3/102,0.0724354889901942,0.4177697011463238,0,0,3.2114695340501798,8.430296747522787,GALNT13;TMTC3;POMK
150,GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),3/102,0.0724354889901942,0.4177697011463238,0,0,3.2114695340501798,8.430296747522787,CHRM3;PPP3CA;CACNA1C
151,GO_Biological_Process_2021,positive regulation of cell growth (GO:0030307),3/102,0.0724354889901942,0.4177697011463238,0,0,3.2114695340501798,8.430296747522787,ITSN2;BCL2;CXCL16
152,GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),7/384,0.072794410926999,0.4177697011463238,0,0,1.982656600693736,5.194790479668953,NTRK2;NWD1;RDX;MAGI2;ITGB8;NFE2L2;TNRC6B
153,GO_Biological_Process_2021,adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,CHRM3
154,GO_Biological_Process_2021,aspartate family amino acid biosynthetic process (GO:0009067),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,MTR
155,GO_Biological_Process_2021,carbohydrate phosphorylation (GO:0046835),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,POMK
156,GO_Biological_Process_2021,regulation of dopamine receptor signaling pathway (GO:0060159),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,CAV2
157,GO_Biological_Process_2021,negative regulation of regulated secretory pathway (GO:1903306),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,STXBP3
158,GO_Biological_Process_2021,cellular response to epinephrine stimulus (GO:0071872),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,PDE4B
159,GO_Biological_Process_2021,negative regulation of response to reactive oxygen species (GO:1901032),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,NFE2L2
160,GO_Biological_Process_2021,cellular response to interferon-alpha (GO:0035457),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,IFNAR1
161,GO_Biological_Process_2021,regulation of protein localization to early endosome (GO:1902965),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,RDX
162,GO_Biological_Process_2021,positive regulation of early endosome to late endosome transport (GO:2000643),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,RDX
163,GO_Biological_Process_2021,response to epinephrine (GO:0071871),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,PDE4B
164,GO_Biological_Process_2021,skeletal muscle tissue regeneration (GO:0043403),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,PPP3CA
165,GO_Biological_Process_2021,sulfur amino acid biosynthetic process (GO:0000097),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,MTR
166,GO_Biological_Process_2021,positive regulation of protein localization to early endosome (GO:1902966),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,RDX
167,GO_Biological_Process_2021,positive regulation of protein localization to endosome (GO:1905668),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,RDX
168,GO_Biological_Process_2021,methionine metabolic process (GO:0006555),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,MTR
169,GO_Biological_Process_2021,mitochondrial tRNA processing (GO:0090646),1/8,0.0731583372077776,0.4177697011463238,0,0,15.048632218844984,39.35411729295222,TRNT1
170,GO_Biological_Process_2021,regulation of cellular localization (GO:0060341),2/49,0.0782688596985083,0.4177697011463238,0,0,4.497439981795426,11.457702654053058,PARD6B;REEP5
171,GO_Biological_Process_2021,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),2/50,0.0810402447075638,0.4177697011463238,0,0,4.403520499108734,11.065207700859313,PTPRD;CAPRIN2
172,GO_Biological_Process_2021,protein O-linked glycosylation via threonine (GO:0018243),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,GALNT13
173,GO_Biological_Process_2021,anoikis (GO:0043276),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,MAP3K7
174,GO_Biological_Process_2021,regulation of actin filament organization (GO:0110053),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,RDX
175,GO_Biological_Process_2021,negative regulation of exocytosis (GO:0045920),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,ATP9A
176,GO_Biological_Process_2021,axon regeneration (GO:0031103),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,MTR
177,GO_Biological_Process_2021,regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,NFE2L2
178,GO_Biological_Process_2021,cellular response to nitric oxide (GO:0071732),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,MTR
179,GO_Biological_Process_2021,cellular response to reactive nitrogen species (GO:1902170),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,MTR
180,GO_Biological_Process_2021,regulation of mitotic centrosome separation (GO:0046602),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,MAP9
181,GO_Biological_Process_2021,peripheral nervous system axon ensheathment (GO:0032292),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,ADGRG6
182,GO_Biological_Process_2021,embryonic forelimb morphogenesis (GO:0035115),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,CACNA1C
183,GO_Biological_Process_2021,fatty acid alpha-oxidation (GO:0001561),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,PECR
184,GO_Biological_Process_2021,response to UV-C (GO:0010225),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,IMPACT
185,GO_Biological_Process_2021,Schwann cell development (GO:0014044),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,ADGRG6
186,GO_Biological_Process_2021,skeletal muscle fiber development (GO:0048741),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,CAV2
187,GO_Biological_Process_2021,tetrahydrofolate interconversion (GO:0035999),1/9,0.0819204792179246,0.4177697011463238,0,0,13.16688829787234,32.943637049750684,MTHFD2L
188,GO_Biological_Process_2021,epidermal cell differentiation (GO:0009913),2/53,0.0895314881378626,0.4177697011463238,0,0,4.143860752857293,9.999819289476129,ASAH1;ADAM9
189,GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),8/485,0.0900513050882865,0.4177697011463238,0,0,1.791491481056789,4.312793084293991,DNAJC3;NTRK2;GRK5;BCL2;TAX1BP1;HIPK3;IFIT3;CPEB4
190,GO_Biological_Process_2021,RNA processing (GO:0006396),4/179,0.0901240815811989,0.4177697011463238,0,0,2.426069498069498,5.8385009139726725,ATXN1;NOVA1;PRPF3;RBM6
191,GO_Biological_Process_2021,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",5/251,0.0901600392156898,0.4177697011463238,0,0,2.1612097914457404,5.20023594711732,NOVA1;PRPF3;CPSF2;PPWD1;RBM6
192,GO_Biological_Process_2021,protein O-linked glycosylation via serine (GO:0018242),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,GALNT13
193,GO_Biological_Process_2021,negative regulation of cAMP-mediated signaling (GO:0043951),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,PDE4D
194,GO_Biological_Process_2021,negative regulation of protein autophosphorylation (GO:0031953),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,IMPACT
195,GO_Biological_Process_2021,cellular response to acetylcholine (GO:1905145),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,CHRM3
196,GO_Biological_Process_2021,cellular response to acidic pH (GO:0071468),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,IMPACT
197,GO_Biological_Process_2021,cellular response to leucine starvation (GO:1990253),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,IMPACT
198,GO_Biological_Process_2021,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,MIA3
199,GO_Biological_Process_2021,regulation of high voltage-gated calcium channel activity (GO:1901841),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,PDE4B
200,GO_Biological_Process_2021,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,IMPACT
201,GO_Biological_Process_2021,regulation of hydrogen peroxide-induced cell death (GO:1903205),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,NFE2L2
202,GO_Biological_Process_2021,nerve growth factor signaling pathway (GO:0038180),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,MAGI2
203,GO_Biological_Process_2021,neuron projection regeneration (GO:0031102),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,MTR
204,GO_Biological_Process_2021,regulation of macrophage migration (GO:1905521),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,MTUS1
205,GO_Biological_Process_2021,dicarboxylic acid biosynthetic process (GO:0043650),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,GLS
206,GO_Biological_Process_2021,regulation of organ growth (GO:0046620),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,WWC2
207,GO_Biological_Process_2021,regulation of store-operated calcium entry (GO:2001256),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,SARAF
208,GO_Biological_Process_2021,forelimb morphogenesis (GO:0035136),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,CACNA1C
209,GO_Biological_Process_2021,positive regulation of dendritic spine morphogenesis (GO:0061003),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,CAPRIN2
210,GO_Biological_Process_2021,response to laminar fluid shear stress (GO:0034616),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,NFE2L2
211,GO_Biological_Process_2021,I-kappaB phosphorylation (GO:0007252),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,MAP3K7
212,GO_Biological_Process_2021,sequestering of actin monomers (GO:0042989),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,TWF1
213,GO_Biological_Process_2021,ionotropic glutamate receptor signaling pathway (GO:0035235),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,CPEB4
214,GO_Biological_Process_2021,presynaptic membrane assembly (GO:0097105),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,PTPRD
215,GO_Biological_Process_2021,monocyte activation (GO:0042117),1/10,0.0906002210285699,0.4177697011463238,0,0,11.703309692671397,28.103141488494085,ADAM9
216,GO_Biological_Process_2021,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",2/54,0.0924182793586917,0.4177697011463238,0,0,4.063965446318387,9.678051229625822,NOVA1;RBM7
217,GO_Biological_Process_2021,cytoplasmic microtubule organization (GO:0031122),2/54,0.0924182793586917,0.4177697011463238,0,0,4.063965446318387,9.678051229625822,CEP126;DST
218,GO_Biological_Process_2021,negative regulation of cell motility (GO:2000146),3/114,0.0936591719339945,0.4177697011463238,0,0,2.862539959314153,6.778760600728176,MAGI2;MIA3;SCAI
219,GO_Biological_Process_2021,cytosolic transport (GO:0016482),3/116,0.097420772897327,0.4177697011463238,0,0,2.8115900656580077,6.547394256743275,MON2;HEATR5A;AKTIP
220,GO_Biological_Process_2021,sphingolipid metabolic process (GO:0006665),3/116,0.097420772897327,0.4177697011463238,0,0,2.8115900656580077,6.547394256743275,ASAH1;SERINC1;TEX2
221,GO_Biological_Process_2021,antigen receptor-mediated signaling pathway (GO:0050851),4/185,0.0987060616967294,0.4177697011463238,0,0,2.344930565925041,5.429942133035911,PDE4D;BCL2;PDE4B;MAP3K7
222,GO_Biological_Process_2021,actin filament depolymerization (GO:0030042),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,TWF1
223,GO_Biological_Process_2021,negative regulation of homotypic cell-cell adhesion (GO:0034111),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,RDX
224,GO_Biological_Process_2021,calcineurin-NFAT signaling cascade (GO:0033173),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,PPP3CA
225,GO_Biological_Process_2021,negative regulation of lymphocyte migration (GO:2000402),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,MIA3
226,GO_Biological_Process_2021,regulation of cytoplasmic transport (GO:1903649),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,ATP9A
227,GO_Biological_Process_2021,regulation of endocytic recycling (GO:2001135),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,ATP9A
228,GO_Biological_Process_2021,regulation of ERAD pathway (GO:1904292),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,USP25
229,GO_Biological_Process_2021,cellular response to increased oxygen levels (GO:0036295),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,ATP6V1A
230,GO_Biological_Process_2021,regulation of lymphocyte migration (GO:2000401),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,MIA3
231,GO_Biological_Process_2021,regulation of mitochondrial depolarization (GO:0051900),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,BCL2
232,GO_Biological_Process_2021,PERK-mediated unfolded protein response (GO:0036499),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,NFE2L2
233,GO_Biological_Process_2021,positive regulation by host of viral process (GO:0044794),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,CAV2
234,GO_Biological_Process_2021,ER-associated misfolded protein catabolic process (GO:0071712),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,UGGT2
235,GO_Biological_Process_2021,establishment of endothelial intestinal barrier (GO:0090557),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,RAPGEF6
236,GO_Biological_Process_2021,positive regulation of cellular respiration (GO:1901857),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,IFNAR1
237,GO_Biological_Process_2021,positive regulation of cytoplasmic transport (GO:1903651),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,RDX
238,GO_Biological_Process_2021,glutamine family amino acid biosynthetic process (GO:0009084),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,GLS
239,GO_Biological_Process_2021,response to corticosteroid (GO:0031960),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,ADAM9
240,GO_Biological_Process_2021,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,NAMPT
241,GO_Biological_Process_2021,T cell chemotaxis (GO:0010818),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,CXCL16
242,GO_Biological_Process_2021,tetrahydrofolate metabolic process (GO:0046653),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,MTHFD2L
243,GO_Biological_Process_2021,positive regulation of viral release from host cell (GO:1902188),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,CAV2
244,GO_Biological_Process_2021,presynaptic membrane organization (GO:0097090),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,PTPRD
245,GO_Biological_Process_2021,myotube cell development (GO:0014904),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,CAV2
246,GO_Biological_Process_2021,negative regulation of activin receptor signaling pathway (GO:0032926),1/11,0.0991983332467463,0.4177697011463238,0,0,10.532446808510638,24.33663040229913,MAGI2
247,GO_Biological_Process_2021,positive regulation of interferon-gamma production (GO:0032729),2/57,0.1012369831995028,0.4177697011463238,0,0,3.841711229946524,8.798637201039348,PDE4D;PDE4B
248,GO_Biological_Process_2021,regulation of protein binding (GO:0043393),3/118,0.1012429964623553,0.4177697011463238,0,0,2.7624123422159887,6.326564442044565,AKTIP;STYX;CAPRIN2
249,GO_Biological_Process_2021,cellular protein metabolic process (GO:0044267),7/417,0.1013889070477136,0.4177697011463238,0,0,1.819981238273921,4.165557755324103,DNAJC3;CHRM3;USP25;MGAT4A;MIA3;MRPS6;KTN1
250,GO_Biological_Process_2021,regulation of calcium ion transport (GO:0051924),2/58,0.1042268357813296,0.4177697011463238,0,0,3.772918258212376,8.531268592903112,BCL2;SARAF
251,GO_Biological_Process_2021,positive regulation of protein binding (GO:0032092),2/58,0.1042268357813296,0.4177697011463238,0,0,3.772918258212376,8.531268592903112,AKTIP;CAPRIN2
252,GO_Biological_Process_2021,negative regulation of autophagy (GO:0010507),2/59,0.107240613730395,0.4177697011463238,0,0,3.706539074960128,8.27551656134492,BCL2;EIF4G3
253,GO_Biological_Process_2021,adipose tissue development (GO:0060612),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,NAMPT
254,GO_Biological_Process_2021,autophagy of peroxisome (GO:0030242),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,ACBD5
255,GO_Biological_Process_2021,negative regulation of heart contraction (GO:0045822),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,PDE4D
256,GO_Biological_Process_2021,negative regulation of JUN kinase activity (GO:0043508),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,HIPK3
257,GO_Biological_Process_2021,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,PDE4D
258,GO_Biological_Process_2021,calcineurin-mediated signaling (GO:0097720),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,PPP3CA
259,GO_Biological_Process_2021,cellular response to fluid shear stress (GO:0071498),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,NFE2L2
260,GO_Biological_Process_2021,regulation of leukocyte cell-cell adhesion (GO:1903037),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,MIA3
261,GO_Biological_Process_2021,regulation of nucleobase-containing compound metabolic process (GO:0019219),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,NOVA1
262,GO_Biological_Process_2021,glomerular visceral epithelial cell differentiation (GO:0072112),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,MAGI2
263,GO_Biological_Process_2021,glutamine metabolic process (GO:0006541),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,GLS
264,GO_Biological_Process_2021,regulation of ventricular cardiac muscle cell action potential (GO:0098911),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,CACNA1C
265,GO_Biological_Process_2021,hemidesmosome assembly (GO:0031581),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,DST
266,GO_Biological_Process_2021,microtubule anchoring (GO:0034453),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,SAXO2
267,GO_Biological_Process_2021,modulation by host of viral process (GO:0044788),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,CAV2
268,GO_Biological_Process_2021,mRNA transcription (GO:0009299),1/12,0.107715579413401,0.4177697011463238,0,0,9.574468085106384,21.33441430499087,HIPK3
269,GO_Biological_Process_2021,organelle assembly (GO:0070925),7/425,0.109131460269089,0.4177697011463238,0,0,1.784412955465587,3.952835265440219,CEP126;FAM161A;CEP83;NEK1;DZIP1;MAPRE2;KIF27
270,GO_Biological_Process_2021,peptidyl-threonine phosphorylation (GO:0018107),2/60,0.1102776039877517,0.4177697011463238,0,0,3.642448829061405,8.030705154360367,CDC42BPA;HIPK3
271,GO_Biological_Process_2021,non-canonical Wnt signaling pathway (GO:0035567),3/124,0.1130599463959972,0.4177697011463238,0,0,2.624633431085044,5.721273331848338,PPP3CA;MAP3K7;TNRC6B
272,GO_Biological_Process_2021,defense response to symbiont (GO:0140546),3/124,0.1130599463959972,0.4177697011463238,0,0,2.624633431085044,5.721273331848338,BCL2;ZMYND11;IFIT3
273,GO_Biological_Process_2021,regulation of protein secretion (GO:0050708),3/125,0.115078732478271,0.4177697011463238,0,0,2.602987837123216,5.628020880462722,ADAM9;ITPR2;CACNA1C
274,GO_Biological_Process_2021,atrial cardiac muscle cell action potential (GO:0086014),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,CACNA1C
275,GO_Biological_Process_2021,negative regulation of hippo signaling (GO:0035331),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,WWC2
276,GO_Biological_Process_2021,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,NFE2L2
277,GO_Biological_Process_2021,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,BCL2
278,GO_Biological_Process_2021,regulation of cell communication by electrical coupling (GO:0010649),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,PDE4D
279,GO_Biological_Process_2021,negative regulation of mononuclear cell migration (GO:0071676),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,MIA3
280,GO_Biological_Process_2021,regulation of homotypic cell-cell adhesion (GO:0034110),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,RDX
281,GO_Biological_Process_2021,regulation of interleukin-5 production (GO:0032674),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,PDE4D
282,GO_Biological_Process_2021,regulation of protein acetylation (GO:1901983),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,FAM161A
283,GO_Biological_Process_2021,positive regulation of ERAD pathway (GO:1904294),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,NFE2L2
284,GO_Biological_Process_2021,response to iron ion (GO:0010039),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,BCL2
285,GO_Biological_Process_2021,response to muramyl dipeptide (GO:0032495),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,ERBIN
286,GO_Biological_Process_2021,response to nitric oxide (GO:0071731),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,MTR
287,GO_Biological_Process_2021,intraciliary retrograde transport (GO:0035721),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,DYNC2LI1
288,GO_Biological_Process_2021,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,TNRC6B
289,GO_Biological_Process_2021,sphingoid biosynthetic process (GO:0046520),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,ASAH1
290,GO_Biological_Process_2021,sphingosine biosynthetic process (GO:0046512),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,ASAH1
291,GO_Biological_Process_2021,spliceosomal tri-snRNP complex assembly (GO:0000244),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,PRPF3
292,GO_Biological_Process_2021,positive regulation of protein acetylation (GO:1901985),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,FAM161A
293,GO_Biological_Process_2021,pre-mRNA cleavage required for polyadenylation (GO:0098789),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,CPSF2
294,GO_Biological_Process_2021,myelination in peripheral nervous system (GO:0022011),1/13,0.1161527159532597,0.4177697011463238,0,0,8.776152482269504,18.893734929477525,ADGRG6
295,GO_Biological_Process_2021,"mRNA splicing, via spliceosome (GO:0000398)",5/274,0.1187424943139545,0.4177697011463238,0,0,1.974098917084209,4.206406110874,NOVA1;PRPF3;CPSF2;PPWD1;RBM6
296,GO_Biological_Process_2021,cellular response to reactive oxygen species (GO:0034614),2/63,0.1195208853855036,0.4177697011463238,0,0,3.462786008591216,7.355872176414121,IMPACT;NFE2L2
297,GO_Biological_Process_2021,positive regulation of Ras protein signal transduction (GO:0046579),2/63,0.1195208853855036,0.4177697011463238,0,0,3.462786008591216,7.355872176414121,ERBIN;MAPRE2
298,GO_Biological_Process_2021,plasma membrane bounded cell projection organization (GO:0120036),3/128,0.1212161532958154,0.4177697011463238,0,0,2.5401290322580645,5.360129319253891,ARMC2;FAM161A;FAM161B
299,GO_Biological_Process_2021,gene expression (GO:0010467),6/356,0.1221643581320255,0.4177697011463238,0,0,1.8230444964871195,3.832746769153245,ATXN1;THRB;NOVA1;CPSF2;MRPS6;RBM6
300,GO_Biological_Process_2021,protein secretion (GO:0009306),2/64,0.1226438163832368,0.4177697011463238,0,0,3.406762118337071,7.148991258211783,MIA2;MIA3
301,GO_Biological_Process_2021,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),2/64,0.1226438163832368,0.4177697011463238,0,0,3.406762118337071,7.148991258211783,BCL2;NFE2L2
302,GO_Biological_Process_2021,cellular response to insulin stimulus (GO:0032869),3/129,0.123288402982508,0.4177697011463238,0,0,2.5198412698412698,5.274604641328511,ATP6V1A;CAV2;NAMPT
303,GO_Biological_Process_2021,cAMP metabolic process (GO:0046058),1/14,0.124510492276309,0.4177697011463238,0,0,8.100654664484452,16.87662276492899,PDE4D
304,GO_Biological_Process_2021,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/14,0.124510492276309,0.4177697011463238,0,0,8.100654664484452,16.87662276492899,BCL2
305,GO_Biological_Process_2021,regulation of lamellipodium organization (GO:1902743),1/14,0.124510492276309,0.4177697011463238,0,0,8.100654664484452,16.87662276492899,TWF1
306,GO_Biological_Process_2021,COPII-coated vesicle cargo loading (GO:0090110),1/14,0.124510492276309,0.4177697011463238,0,0,8.100654664484452,16.87662276492899,MIA3
307,GO_Biological_Process_2021,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),1/14,0.124510492276309,0.4177697011463238,0,0,8.100654664484452,16.87662276492899,NAMPT
308,GO_Biological_Process_2021,peptidyl-serine dephosphorylation (GO:0070262),1/14,0.124510492276309,0.4177697011463238,0,0,8.100654664484452,16.87662276492899,PPP3CA
309,GO_Biological_Process_2021,positive regulation of cyclase activity (GO:0031281),1/14,0.124510492276309,0.4177697011463238,0,0,8.100654664484452,16.87662276492899,CACNA1C
310,GO_Biological_Process_2021,positive regulation of glycogen biosynthetic process (GO:0045725),1/14,0.124510492276309,0.4177697011463238,0,0,8.100654664484452,16.87662276492899,EPM2AIP1
311,GO_Biological_Process_2021,synaptic membrane adhesion (GO:0099560),1/14,0.124510492276309,0.4177697011463238,0,0,8.100654664484452,16.87662276492899,PTPRD
312,GO_Biological_Process_2021,microvillus organization (GO:0032528),1/14,0.124510492276309,0.4177697011463238,0,0,8.100654664484452,16.87662276492899,RAPGEF6
313,GO_Biological_Process_2021,mRNA cleavage involved in mRNA processing (GO:0098787),1/14,0.124510492276309,0.4177697011463238,0,0,8.100654664484452,16.87662276492899,CPSF2
314,GO_Biological_Process_2021,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),1/14,0.124510492276309,0.4177697011463238,0,0,8.100654664484452,16.87662276492899,NAMPT
315,GO_Biological_Process_2021,cellular response to type I interferon (GO:0071357),2/65,0.1257865596889854,0.4177697011463238,0,0,3.35251676428147,6.950333087264424,IFIT3;IFNAR1
316,GO_Biological_Process_2021,regulation of RNA metabolic process (GO:0051252),2/65,0.1257865596889854,0.4177697011463238,0,0,3.35251676428147,6.950333087264424,NOVA1;PTBP3
317,GO_Biological_Process_2021,type I interferon signaling pathway (GO:0060337),2/65,0.1257865596889854,0.4177697011463238,0,0,3.35251676428147,6.950333087264424,IFIT3;IFNAR1
318,GO_Biological_Process_2021,cell-cell junction assembly (GO:0007043),2/66,0.1289484673318831,0.4177697011463238,0,0,3.299966577540107,6.759461566542831,PARD6B;CDH8
319,GO_Biological_Process_2021,regulation of protein localization (GO:0032880),2/66,0.1289484673318831,0.4177697011463238,0,0,3.299966577540107,6.759461566542831,RABGAP1L;TRIM22
320,GO_Biological_Process_2021,defense response to virus (GO:0051607),3/133,0.1317049700454103,0.4177697011463238,0,0,2.44181141439206,4.950017960129075,BCL2;ZMYND11;IFIT3
321,GO_Biological_Process_2021,RNA metabolic process (GO:0016070),3/133,0.1317049700454103,0.4177697011463238,0,0,2.44181141439206,4.950017960129075,ATXN1;NOVA1;RBM6
322,GO_Biological_Process_2021,protein N-linked glycosylation (GO:0006487),2/67,0.132128901743807,0.4177697011463238,0,0,3.249033319621555,6.575969700566797,MGAT4A;UGGT2
323,GO_Biological_Process_2021,negative regulation of androgen receptor signaling pathway (GO:0060766),1/15,0.1327896508776999,0.4177697011463238,0,0,7.521656534954407,15.1861416186695,PIAS2
324,GO_Biological_Process_2021,regulation of cytoplasmic translation (GO:2000765),1/15,0.1327896508776999,0.4177697011463238,0,0,7.521656534954407,15.1861416186695,CPEB4
325,GO_Biological_Process_2021,central nervous system neuron development (GO:0021954),1/15,0.1327896508776999,0.4177697011463238,0,0,7.521656534954407,15.1861416186695,NTRK2
326,GO_Biological_Process_2021,neurotrophin TRK receptor signaling pathway (GO:0048011),1/15,0.1327896508776999,0.4177697011463238,0,0,7.521656534954407,15.1861416186695,NTRK2
327,GO_Biological_Process_2021,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",1/15,0.1327896508776999,0.4177697011463238,0,0,7.521656534954407,15.1861416186695,TNRC6B
328,GO_Biological_Process_2021,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),1/15,0.1327896508776999,0.4177697011463238,0,0,7.521656534954407,15.1861416186695,TNRC6B
329,GO_Biological_Process_2021,engulfment of apoptotic cell (GO:0043652),1/15,0.1327896508776999,0.4177697011463238,0,0,7.521656534954407,15.1861416186695,XKR4
330,GO_Biological_Process_2021,response to acidic pH (GO:0010447),1/15,0.1327896508776999,0.4177697011463238,0,0,7.521656534954407,15.1861416186695,IMPACT
331,GO_Biological_Process_2021,positive regulation of glycogen metabolic process (GO:0070875),1/15,0.1327896508776999,0.4177697011463238,0,0,7.521656534954407,15.1861416186695,EPM2AIP1
332,GO_Biological_Process_2021,positive regulation of lyase activity (GO:0051349),1/15,0.1327896508776999,0.4177697011463238,0,0,7.521656534954407,15.1861416186695,CACNA1C
333,GO_Biological_Process_2021,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),1/15,0.1327896508776999,0.4177697011463238,0,0,7.521656534954407,15.1861416186695,ADAM9
334,GO_Biological_Process_2021,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",1/15,0.1327896508776999,0.4177697011463238,0,0,7.521656534954407,15.1861416186695,TNRC6B
335,GO_Biological_Process_2021,microvillus assembly (GO:0030033),1/15,0.1327896508776999,0.4177697011463238,0,0,7.521656534954407,15.1861416186695,RAPGEF6
336,GO_Biological_Process_2021,protein kinase A signaling (GO:0010737),1/15,0.1327896508776999,0.4177697011463238,0,0,7.521656534954407,15.1861416186695,RDX
337,GO_Biological_Process_2021,negative regulation of cellular catabolic process (GO:0031330),2/69,0.1385428514202368,0.4177697011463238,0,0,3.151727991060739,6.229628659692471,BCL2;EIF4G3
338,GO_Biological_Process_2021,RNA 3'-end processing (GO:0031123),2/69,0.1385428514202368,0.4177697011463238,0,0,3.151727991060739,6.229628659692471,CPSF2;RPRD2
339,GO_Biological_Process_2021,positive regulation of MAP kinase activity (GO:0043406),2/69,0.1385428514202368,0.4177697011463238,0,0,3.151727991060739,6.229628659692471,TAOK3;MAP3K7
340,GO_Biological_Process_2021,negative regulation of anoikis (GO:2000811),1/16,0.1409909273153888,0.4177697011463238,0,0,7.019858156028369,13.752321465591514,BCL2
341,GO_Biological_Process_2021,activation of NF-kappaB-inducing kinase activity (GO:0007250),1/16,0.1409909273153888,0.4177697011463238,0,0,7.019858156028369,13.752321465591514,MAP3K7
342,GO_Biological_Process_2021,regulation of activin receptor signaling pathway (GO:0032925),1/16,0.1409909273153888,0.4177697011463238,0,0,7.019858156028369,13.752321465591514,MAGI2
343,GO_Biological_Process_2021,ceramide catabolic process (GO:0046514),1/16,0.1409909273153888,0.4177697011463238,0,0,7.019858156028369,13.752321465591514,ASAH1
344,GO_Biological_Process_2021,regulation of Rac protein signal transduction (GO:0035020),1/16,0.1409909273153888,0.4177697011463238,0,0,7.019858156028369,13.752321465591514,KBTBD6
345,GO_Biological_Process_2021,glutamine family amino acid catabolic process (GO:0009065),1/16,0.1409909273153888,0.4177697011463238,0,0,7.019858156028369,13.752321465591514,GLS
346,GO_Biological_Process_2021,Golgi to endosome transport (GO:0006895),1/16,0.1409909273153888,0.4177697011463238,0,0,7.019858156028369,13.752321465591514,MON2
347,GO_Biological_Process_2021,retrograde axonal transport (GO:0008090),1/16,0.1409909273153888,0.4177697011463238,0,0,7.019858156028369,13.752321465591514,DST
348,GO_Biological_Process_2021,sphingolipid catabolic process (GO:0030149),1/16,0.1409909273153888,0.4177697011463238,0,0,7.019858156028369,13.752321465591514,ASAH1
349,GO_Biological_Process_2021,positive regulation of small molecule metabolic process (GO:0062013),1/16,0.1409909273153888,0.4177697011463238,0,0,7.019858156028369,13.752321465591514,PPM1K
350,GO_Biological_Process_2021,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),1/16,0.1409909273153888,0.4177697011463238,0,0,7.019858156028369,13.752321465591514,ADAM9
351,GO_Biological_Process_2021,protein localization to endoplasmic reticulum (GO:0070972),1/16,0.1409909273153888,0.4177697011463238,0,0,7.019858156028369,13.752321465591514,MIA3
352,GO_Biological_Process_2021,protein localization to microtubule organizing center (GO:1905508),1/16,0.1409909273153888,0.4177697011463238,0,0,7.019858156028369,13.752321465591514,CEP83
353,GO_Biological_Process_2021,fatty acid catabolic process (GO:0009062),2/70,0.1417751420882622,0.4177697011463238,0,0,3.1052217678515257,6.066091038197726,PECR;ACBD5
354,GO_Biological_Process_2021,positive regulation of cellular catabolic process (GO:0031331),3/141,0.1491140333473516,0.4177697011463238,0,0,2.29932211313698,4.375711016431739,RDX;ADAM9;TRIM22
355,GO_Biological_Process_2021,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),1/17,0.1491150502899167,0.4177697011463238,0,0,6.580784574468085,12.52347733311014,CACNA1C
356,GO_Biological_Process_2021,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/17,0.1491150502899167,0.4177697011463238,0,0,6.580784574468085,12.52347733311014,BCL2
357,GO_Biological_Process_2021,regulation of cellular respiration (GO:0043457),1/17,0.1491150502899167,0.4177697011463238,0,0,6.580784574468085,12.52347733311014,IFNAR1
358,GO_Biological_Process_2021,regulation of cellular response to growth factor stimulus (GO:0090287),1/17,0.1491150502899167,0.4177697011463238,0,0,6.580784574468085,12.52347733311014,ZDHHC17
359,GO_Biological_Process_2021,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),1/17,0.1491150502899167,0.4177697011463238,0,0,6.580784574468085,12.52347733311014,CACNA1C
360,GO_Biological_Process_2021,regulation of leukocyte migration (GO:0002685),1/17,0.1491150502899167,0.4177697011463238,0,0,6.580784574468085,12.52347733311014,MIA3
361,GO_Biological_Process_2021,regulation of metal ion transport (GO:0010959),1/17,0.1491150502899167,0.4177697011463238,0,0,6.580784574468085,12.52347733311014,BCL2
362,GO_Biological_Process_2021,diol biosynthetic process (GO:0034312),1/17,0.1491150502899167,0.4177697011463238,0,0,6.580784574468085,12.52347733311014,ASAH1
363,GO_Biological_Process_2021,regulation of steroid biosynthetic process (GO:0050810),1/17,0.1491150502899167,0.4177697011463238,0,0,6.580784574468085,12.52347733311014,ASAH1
364,GO_Biological_Process_2021,positive regulation of dendrite extension (GO:1903861),1/17,0.1491150502899167,0.4177697011463238,0,0,6.580784574468085,12.52347733311014,ITSN2
365,GO_Biological_Process_2021,positive regulation of heart rate (GO:0010460),1/17,0.1491150502899167,0.4177697011463238,0,0,6.580784574468085,12.52347733311014,PDE4D
366,GO_Biological_Process_2021,snRNA metabolic process (GO:0016073),1/17,0.1491150502899167,0.4177697011463238,0,0,6.580784574468085,12.52347733311014,RBM7
367,GO_Biological_Process_2021,membrane depolarization during cardiac muscle cell action potential (GO:0086012),1/17,0.1491150502899167,0.4177697011463238,0,0,6.580784574468085,12.52347733311014,CACNA1C
368,GO_Biological_Process_2021,negative regulation of amyloid-beta formation (GO:1902430),1/17,0.1491150502899167,0.4177697011463238,0,0,6.580784574468085,12.52347733311014,NTRK2
369,GO_Biological_Process_2021,regulation of cell growth (GO:0001558),4/217,0.1503206172391251,0.4177697011463238,0,0,1.989392209110519,3.769868032750272,CAPRIN2;BCL2;SMARCA2;CXCL16
370,GO_Biological_Process_2021,neurotransmitter transport (GO:0006836),2/73,0.1515661358846441,0.4177697011463238,0,0,2.973563304963471,5.610320635932044,STXBP3;GLS
371,GO_Biological_Process_2021,response to molecule of bacterial origin (GO:0002237),2/73,0.1515661358846441,0.4177697011463238,0,0,2.973563304963471,5.610320635932044,ERBIN;IFNAR1
372,GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),6/381,0.1531477107345973,0.4177697011463238,0,0,1.6993224043715849,3.1885276610754456,DNAJC3;GRK5;BCL2;TAX1BP1;HIPK3;IFIT3
373,GO_Biological_Process_2021,negative regulation of DNA-binding transcription factor activity (GO:0043433),3/143,0.1535781081807438,0.4177697011463238,0,0,2.2662442396313365,4.245912814980434,NWD1;TAX1BP1;ERBIN
374,GO_Biological_Process_2021,cellular response to amino acid starvation (GO:0034198),2/74,0.1548592468071058,0.4177697011463238,0,0,2.9321152703505646,5.469094757064261,ATP6V1A;IMPACT
375,GO_Biological_Process_2021,regulation of peptide hormone secretion (GO:0090276),2/74,0.1548592468071058,0.4177697011463238,0,0,2.9321152703505646,5.469094757064261,ITPR2;CACNA1C
376,GO_Biological_Process_2021,negative regulation of cell migration (GO:0030336),3/144,0.155825954567429,0.4177697011463238,0,0,2.250057195149852,4.182891360101145,MAGI2;MIA3;SCAI
377,GO_Biological_Process_2021,protein O-linked mannosylation (GO:0035269),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,TMTC3
378,GO_Biological_Process_2021,negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,MIA3
379,GO_Biological_Process_2021,regulation of cellular protein catabolic process (GO:1903362),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,RDX
380,GO_Biological_Process_2021,cell migration involved in sprouting angiogenesis (GO:0002042),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,MIA3
381,GO_Biological_Process_2021,regulation of dendrite extension (GO:1903859),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,ITSN2
382,GO_Biological_Process_2021,regulation of early endosome to late endosome transport (GO:2000641),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,RDX
383,GO_Biological_Process_2021,negative regulation of Rho protein signal transduction (GO:0035024),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,SCAI
384,GO_Biological_Process_2021,cellular response to pH (GO:0071467),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,IMPACT
385,GO_Biological_Process_2021,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,NFE2L2
386,GO_Biological_Process_2021,embryonic axis specification (GO:0000578),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,CXXC4
387,GO_Biological_Process_2021,regulation of presynapse assembly (GO:1905606),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,PTPRD
388,GO_Biological_Process_2021,regulation of presynapse organization (GO:0099174),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,PTPRD
389,GO_Biological_Process_2021,regulation of spindle organization (GO:0090224),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,MAP9
390,GO_Biological_Process_2021,positive regulation of cell adhesion mediated by integrin (GO:0033630),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,ADAM9
391,GO_Biological_Process_2021,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,CHRM3
392,GO_Biological_Process_2021,regulation of transforming growth factor beta production (GO:0071634),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,ITGB8
393,GO_Biological_Process_2021,release of cytochrome c from mitochondria (GO:0001836),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,BCL2
394,GO_Biological_Process_2021,response to axon injury (GO:0048678),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,MTR
395,GO_Biological_Process_2021,response to interferon-alpha (GO:0035455),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,IFNAR1
396,GO_Biological_Process_2021,rRNA catabolic process (GO:0016075),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,DIS3L
397,GO_Biological_Process_2021,positive regulation of phosphoprotein phosphatase activity (GO:0032516),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,MAGI2
398,GO_Biological_Process_2021,"synaptic transmission, glutamatergic (GO:0035249)",1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,CDH8
399,GO_Biological_Process_2021,T cell migration (GO:0072678),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,CXCL16
400,GO_Biological_Process_2021,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,TAOK3
401,GO_Biological_Process_2021,presynapse assembly (GO:0099054),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,PTPRD
402,GO_Biological_Process_2021,protein localization to centrosome (GO:0071539),1/18,0.157162741797235,0.4177697011463238,0,0,6.193366708385482,11.46066058904648,CEP83
403,GO_Biological_Process_2021,response to amino acid starvation (GO:1990928),2/75,0.1581661406146077,0.4177697011463238,0,0,2.8918027983297927,5.332800363434916,ATP6V1A;IMPACT
404,GO_Biological_Process_2021,cell morphogenesis involved in neuron differentiation (GO:0048667),2/76,0.1614862669771164,0.4177697011463238,0,0,2.8525798525798525,5.201209182230431,PARD6B;ZDHHC17
405,GO_Biological_Process_2021,cellular response to hormone stimulus (GO:0032870),2/76,0.1614862669771164,0.4177697011463238,0,0,2.8525798525798525,5.201209182230431,THRB;RDX
406,GO_Biological_Process_2021,positive regulation of growth (GO:0045927),2/76,0.1614862669771164,0.4177697011463238,0,0,2.8525798525798525,5.201209182230431,BCL2;CXCL16
407,GO_Biological_Process_2021,water-soluble vitamin metabolic process (GO:0006767),2/76,0.1614862669771164,0.4177697011463238,0,0,2.8525798525798525,5.201209182230431,MTHFD2L;MTR
408,GO_Biological_Process_2021,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),4/224,0.1627788521149849,0.4177697011463238,0,0,1.9254054054054053,3.49530922248094,ZMYND11;MAP3K7;ZDHHC17;TRIM22
409,GO_Biological_Process_2021,regulation of organelle assembly (GO:1902115),2/77,0.1648190846691282,0.4177697011463238,0,0,2.814402852049911,5.0741062177156495,DYNC2LI1;RDX
410,GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),3/148,0.1649186669642718,0.4177697011463238,0,0,2.1875417130144603,3.9426126728276953,EPM2AIP1;NTRK2;SERINC1
411,GO_Biological_Process_2021,actin filament capping (GO:0051693),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,TWF1
412,GO_Biological_Process_2021,barbed-end actin filament capping (GO:0051016),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,TWF1
413,GO_Biological_Process_2021,cardiac muscle cell contraction (GO:0086003),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,CACNA1C
414,GO_Biological_Process_2021,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,NFE2L2
415,GO_Biological_Process_2021,regulation of exosomal secretion (GO:1903541),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,ATP9A
416,GO_Biological_Process_2021,negative regulation of RNA metabolic process (GO:0051253),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,PTBP3
417,GO_Biological_Process_2021,negative regulation of RNA splicing (GO:0033119),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,PTBP3
418,GO_Biological_Process_2021,regulation of leukocyte chemotaxis (GO:0002688),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,MTUS1
419,GO_Biological_Process_2021,regulation of mitochondrial membrane permeability (GO:0046902),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,BCL2
420,GO_Biological_Process_2021,endoplasmic reticulum mannose trimming (GO:1904380),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,UGGT2
421,GO_Biological_Process_2021,establishment or maintenance of apical/basal cell polarity (GO:0035088),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,ERBIN
422,GO_Biological_Process_2021,regulation of T cell cytokine production (GO:0002724),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,MAP3K7
423,GO_Biological_Process_2021,folic acid metabolic process (GO:0046655),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,MTHFD2L
424,GO_Biological_Process_2021,positive regulation of cellular protein catabolic process (GO:1903364),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,RDX
425,GO_Biological_Process_2021,heart trabecula morphogenesis (GO:0061384),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,ADGRG6
426,GO_Biological_Process_2021,sphingosine metabolic process (GO:0006670),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,ASAH1
427,GO_Biological_Process_2021,N-glycan processing (GO:0006491),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,MGAT4A
428,GO_Biological_Process_2021,negative regulation of amyloid precursor protein catabolic process (GO:1902992),1/19,0.1651347170981347,0.4177697011463238,0,0,5.848995271867612,10.534003466039604,NTRK2
429,GO_Biological_Process_2021,positive regulation of hydrolase activity (GO:0051345),3/149,0.1672163083200179,0.4177697011463238,0,0,2.172448077772868,3.885351794697963,CAV2;RAPGEF6;MAPRE2
430,GO_Biological_Process_2021,negative regulation of apoptotic signaling pathway (GO:2001234),2/78,0.1681640613837833,0.4177697011463238,0,0,2.777230509428652,4.951288822333974,BCL2;ZMYND11
431,GO_Biological_Process_2021,protein modification process (GO:0036211),2/78,0.1681640613837833,0.4177697011463238,0,0,2.777230509428652,4.951288822333974,CHRM3;USP25
432,GO_Biological_Process_2021,response to cytokine (GO:0034097),3/150,0.1695233887567999,0.4177697011463238,0,0,2.1575597981127936,3.829160266439708,BCL2;ADAM9;CXCL16
433,GO_Biological_Process_2021,regulation of neuron differentiation (GO:0045664),2/79,0.1715206736498606,0.4177697011463238,0,0,2.7410236822001526,4.8325658420149225,IMPACT;BEND6
434,GO_Biological_Process_2021,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),2/79,0.1715206736498606,0.4177697011463238,0,0,2.7410236822001526,4.8325658420149225,RNF19A;NFE2L2
435,GO_Biological_Process_2021,mRNA 3'-end processing (GO:0031124),2/79,0.1715206736498606,0.4177697011463238,0,0,2.7410236822001526,4.8325658420149225,CPSF2;RPRD2
436,GO_Biological_Process_2021,negative regulation of axon extension involved in axon guidance (GO:0048843),1/20,0.1730316847300859,0.4177697011463238,0,0,5.5408734602463605,9.720246555313304,SEMA6D
437,GO_Biological_Process_2021,adrenergic receptor signaling pathway (GO:0071875),1/20,0.1730316847300859,0.4177697011463238,0,0,5.5408734602463605,9.720246555313304,PDE4D
438,GO_Biological_Process_2021,cellular response to misfolded protein (GO:0071218),1/20,0.1730316847300859,0.4177697011463238,0,0,5.5408734602463605,9.720246555313304,UGGT2
439,GO_Biological_Process_2021,regulation of hippo signaling (GO:0035330),1/20,0.1730316847300859,0.4177697011463238,0,0,5.5408734602463605,9.720246555313304,WWC2
440,GO_Biological_Process_2021,regulation of nuclear division (GO:0051783),1/20,0.1730316847300859,0.4177697011463238,0,0,5.5408734602463605,9.720246555313304,CAV2
441,GO_Biological_Process_2021,early endosome to late endosome transport (GO:0045022),1/20,0.1730316847300859,0.4177697011463238,0,0,5.5408734602463605,9.720246555313304,AKTIP
442,GO_Biological_Process_2021,regulation of programmed necrotic cell death (GO:0062098),1/20,0.1730316847300859,0.4177697011463238,0,0,5.5408734602463605,9.720246555313304,ASAH1
443,GO_Biological_Process_2021,endoplasmic reticulum calcium ion homeostasis (GO:0032469),1/20,0.1730316847300859,0.4177697011463238,0,0,5.5408734602463605,9.720246555313304,BCL2
444,GO_Biological_Process_2021,regulation of smooth muscle contraction (GO:0006940),1/20,0.1730316847300859,0.4177697011463238,0,0,5.5408734602463605,9.720246555313304,CHRM3
445,GO_Biological_Process_2021,folic acid-containing compound metabolic process (GO:0006760),1/20,0.1730316847300859,0.4177697011463238,0,0,5.5408734602463605,9.720246555313304,MTHFD2L
446,GO_Biological_Process_2021,inositol phosphate-mediated signaling (GO:0048016),1/20,0.1730316847300859,0.4177697011463238,0,0,5.5408734602463605,9.720246555313304,PPP3CA
447,GO_Biological_Process_2021,mitochondrial cytochrome c oxidase assembly (GO:0033617),1/20,0.1730316847300859,0.4177697011463238,0,0,5.5408734602463605,9.720246555313304,COX20
448,GO_Biological_Process_2021,post-transcriptional gene silencing by RNA (GO:0035194),1/20,0.1730316847300859,0.4177697011463238,0,0,5.5408734602463605,9.720246555313304,TNRC6B
449,GO_Biological_Process_2021,modulation by symbiont of entry into host (GO:0052372),1/20,0.1730316847300859,0.4177697011463238,0,0,5.5408734602463605,9.720246555313304,TRIM22
450,GO_Biological_Process_2021,negative regulation of cellular component organization (GO:0051129),2/80,0.1748884067390613,0.4177697011463238,0,0,2.705745235157,4.717756830735014,IMPACT;RDX
451,GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),2/80,0.1748884067390613,0.4177697011463238,0,0,2.705745235157,4.717756830735014,BCL2;ZMYND11
452,GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),2/80,0.1748884067390613,0.4177697011463238,0,0,2.705745235157,4.717756830735014,PPP3CA;ADAM9
453,GO_Biological_Process_2021,skin development (GO:0043588),2/80,0.1748884067390613,0.4177697011463238,0,0,2.705745235157,4.717756830735014,ASAH1;ADAM9
454,GO_Biological_Process_2021,regulation of autophagy (GO:0010506),4/231,0.1755985387948355,0.4177697011463238,0,0,1.8653649243957613,3.2449047300180416,ATP6V1A;BCL2;EIF4G3;TRIM22
455,GO_Biological_Process_2021,negative regulation of protein modification process (GO:0031400),2/81,0.1782667544402766,0.4177697011463238,0,0,2.6713599133554458,4.606691329770196,IMPACT;IBTK
456,GO_Biological_Process_2021,acetylcholine receptor signaling pathway (GO:0095500),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,CHRM3
457,GO_Biological_Process_2021,regulation of anoikis (GO:2000209),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,BCL2
458,GO_Biological_Process_2021,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,CACNA1C
459,GO_Biological_Process_2021,calcium ion transport into cytosol (GO:0060402),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,CACNA1C
460,GO_Biological_Process_2021,negative regulation of peptidyl-serine phosphorylation (GO:0033137),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,PDE4D
461,GO_Biological_Process_2021,cellular response to inorganic substance (GO:0071241),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,MTR
462,GO_Biological_Process_2021,neuron apoptotic process (GO:0051402),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,BCL2
463,GO_Biological_Process_2021,cobalamin metabolic process (GO:0009235),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,MTR
464,GO_Biological_Process_2021,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,BCL2
465,GO_Biological_Process_2021,positive regulation of immune system process (GO:0002684),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,MIA3
466,GO_Biological_Process_2021,positive regulation of phosphatase activity (GO:0010922),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,MAGI2
467,GO_Biological_Process_2021,positive regulation of T cell cytokine production (GO:0002726),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,MAP3K7
468,GO_Biological_Process_2021,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,NFE2L2
469,GO_Biological_Process_2021,NAD biosynthetic process (GO:0009435),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,NAMPT
470,GO_Biological_Process_2021,protein localization to chromatin (GO:0071168),1/21,0.1808543467278663,0.4177697011463238,0,0,5.263563829787234,9.001027258222347,MCM9
471,GO_Biological_Process_2021,cell-cell junction organization (GO:0045216),2/82,0.1816552190824171,0.4187306744950633,0,0,2.6378342245989304,4.499208199954545,PARD6B;CDH8
472,GO_Biological_Process_2021,cellular response to starvation (GO:0009267),3/158,0.1882992446425599,0.4222232461203818,0,0,2.045369406867846,3.415200045124337,ATP6V1A;IMPACT;CPEB4
473,GO_Biological_Process_2021,T cell receptor signaling pathway (GO:0050852),3/158,0.1882992446425599,0.4222232461203818,0,0,2.045369406867846,3.415200045124337,PDE4D;PDE4B;MAP3K7
474,GO_Biological_Process_2021,spindle assembly (GO:0051225),2/84,0.1884605501631794,0.4222232461203818,0,0,2.573235946263206,4.294387465326928,MAPRE2;MAP9
475,GO_Biological_Process_2021,protein mannosylation (GO:0035268),1/22,0.188603398542744,0.4222232461203818,0,0,5.012664640324215,8.361670444603366,TMTC3
476,GO_Biological_Process_2021,regulation of adenylate cyclase activity (GO:0045761),1/22,0.188603398542744,0.4222232461203818,0,0,5.012664640324215,8.361670444603366,CACNA1C
477,GO_Biological_Process_2021,regulation of macrophage chemotaxis (GO:0010758),1/22,0.188603398542744,0.4222232461203818,0,0,5.012664640324215,8.361670444603366,MTUS1
478,GO_Biological_Process_2021,regulation of membrane protein ectodomain proteolysis (GO:0051043),1/22,0.188603398542744,0.4222232461203818,0,0,5.012664640324215,8.361670444603366,ADAM9
479,GO_Biological_Process_2021,positive regulation of dendritic spine development (GO:0060999),1/22,0.188603398542744,0.4222232461203818,0,0,5.012664640324215,8.361670444603366,CAPRIN2
480,GO_Biological_Process_2021,glutamate metabolic process (GO:0006536),1/22,0.188603398542744,0.4222232461203818,0,0,5.012664640324215,8.361670444603366,GLS
481,GO_Biological_Process_2021,regulation of voltage-gated calcium channel activity (GO:1901385),1/22,0.188603398542744,0.4222232461203818,0,0,5.012664640324215,8.361670444603366,PDE4B
482,GO_Biological_Process_2021,tetrapyrrole metabolic process (GO:0033013),1/22,0.188603398542744,0.4222232461203818,0,0,5.012664640324215,8.361670444603366,MTR
483,GO_Biological_Process_2021,membrane protein intracellular domain proteolysis (GO:0031293),1/22,0.188603398542744,0.4222232461203818,0,0,5.012664640324215,8.361670444603366,ADAM9
484,GO_Biological_Process_2021,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),1/22,0.188603398542744,0.4222232461203818,0,0,5.012664640324215,8.361670444603366,NFE2L2
485,GO_Biological_Process_2021,protein import into peroxisome membrane (GO:0045046),1/22,0.188603398542744,0.4222232461203818,0,0,5.012664640324215,8.361670444603366,ACBD5
486,GO_Biological_Process_2021,protein autophosphorylation (GO:0046777),3/159,0.1906835741692055,0.4260035496839746,0,0,2.032154673283705,3.367564601192826,NTRK2;GRK5;TAOK3
487,GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),5/323,0.1914926921155654,0.4269345266838836,0,0,1.6657266885425213,2.753289025474328,IMPACT;PDE4B;ADAM9;MTR;CPEB4
488,GO_Biological_Process_2021,negative regulation of phosphorylation (GO:0042326),2/86,0.1953005837306723,0.4279601758627888,0,0,2.5117137764196587,4.102169751181436,IMPACT;IBTK
489,GO_Biological_Process_2021,regulation of interferon-gamma production (GO:0032649),2/86,0.1953005837306723,0.4279601758627888,0,0,2.5117137764196587,4.102169751181436,PDE4D;PDE4B
490,GO_Biological_Process_2021,positive regulation of proteasomal protein catabolic process (GO:1901800),2/86,0.1953005837306723,0.4279601758627888,0,0,2.5117137764196587,4.102169751181436,RNF19A;TMTC3
491,GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,0.1962795291870694,0.4279601758627888,0,0,4.784574468085107,7.790318149286441,BCL2
492,GO_Biological_Process_2021,negative regulation of GTPase activity (GO:0034260),1/23,0.1962795291870694,0.4279601758627888,0,0,4.784574468085107,7.790318149286441,RDX
493,GO_Biological_Process_2021,blood vessel endothelial cell migration (GO:0043534),1/23,0.1962795291870694,0.4279601758627888,0,0,4.784574468085107,7.790318149286441,MIA3
494,GO_Biological_Process_2021,negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,0.1962795291870694,0.4279601758627888,0,0,4.784574468085107,7.790318149286441,BCL2
495,GO_Biological_Process_2021,regulation of steroid metabolic process (GO:0019218),1/23,0.1962795291870694,0.4279601758627888,0,0,4.784574468085107,7.790318149286441,ASAH1
496,GO_Biological_Process_2021,respiratory chain complex IV assembly (GO:0008535),1/23,0.1962795291870694,0.4279601758627888,0,0,4.784574468085107,7.790318149286441,COX20
497,GO_Biological_Process_2021,positive regulation of receptor internalization (GO:0002092),1/23,0.1962795291870694,0.4279601758627888,0,0,4.784574468085107,7.790318149286441,MAGI2
498,GO_Biological_Process_2021,membrane protein ectodomain proteolysis (GO:0006509),1/23,0.1962795291870694,0.4279601758627888,0,0,4.784574468085107,7.790318149286441,ADAM9
499,GO_Biological_Process_2021,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),2/87,0.1987324566199866,0.4318764933338619,0,0,2.4820383768480654,4.01046717959294,IMPACT;NFE2L2
500,GO_Biological_Process_2021,purine ribonucleotide catabolic process (GO:0009154),1/24,0.203883421235608,0.4318764933338619,0,0,4.57631822386679,7.277292875760221,PDE4D
501,GO_Biological_Process_2021,regulation of axon extension involved in axon guidance (GO:0048841),1/24,0.203883421235608,0.4318764933338619,0,0,4.57631822386679,7.277292875760221,SEMA6D
502,GO_Biological_Process_2021,regulation of cell size (GO:0008361),1/24,0.203883421235608,0.4318764933338619,0,0,4.57631822386679,7.277292875760221,RDX
503,GO_Biological_Process_2021,cellular response to catecholamine stimulus (GO:0071870),1/24,0.203883421235608,0.4318764933338619,0,0,4.57631822386679,7.277292875760221,PDE4B
504,GO_Biological_Process_2021,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",1/24,0.203883421235608,0.4318764933338619,0,0,4.57631822386679,7.277292875760221,MAP3K7
505,GO_Biological_Process_2021,regulation of ruffle assembly (GO:1900027),1/24,0.203883421235608,0.4318764933338619,0,0,4.57631822386679,7.277292875760221,RDX
506,GO_Biological_Process_2021,positive regulation of cell-substrate junction organization (GO:0150117),1/24,0.203883421235608,0.4318764933338619,0,0,4.57631822386679,7.277292875760221,MAPRE2
507,GO_Biological_Process_2021,lipid translocation (GO:0034204),1/24,0.203883421235608,0.4318764933338619,0,0,4.57631822386679,7.277292875760221,ATP9A
508,GO_Biological_Process_2021,sulfur amino acid metabolic process (GO:0000096),1/24,0.203883421235608,0.4318764933338619,0,0,4.57631822386679,7.277292875760221,MTR
509,GO_Biological_Process_2021,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/24,0.203883421235608,0.4318764933338619,0,0,4.57631822386679,7.277292875760221,NFE2L2
510,GO_Biological_Process_2021,"protein alpha-1,2-demannosylation (GO:0036508)",1/24,0.203883421235608,0.4318764933338619,0,0,4.57631822386679,7.277292875760221,UGGT2
511,GO_Biological_Process_2021,protein K48-linked deubiquitination (GO:0071108),1/24,0.203883421235608,0.4318764933338619,0,0,4.57631822386679,7.277292875760221,USP25
512,GO_Biological_Process_2021,ncRNA 3'-end processing (GO:0043628),1/24,0.203883421235608,0.4318764933338619,0,0,4.57631822386679,7.277292875760221,TRNT1
513,GO_Biological_Process_2021,regulation of neuron projection development (GO:0010975),3/165,0.2051462022242703,0.4318764933338619,0,0,1.9562923138191957,3.098830355074613,NTRK2;MAGI2;TWF1
514,GO_Biological_Process_2021,transforming growth factor beta receptor signaling pathway (GO:0007179),2/89,0.205617668701232,0.4318764933338619,0,0,2.424734156985678,3.835291275007575,ADAM9;MAP3K7
515,GO_Biological_Process_2021,mitochondrial translational elongation (GO:0070125),2/89,0.205617668701232,0.4318764933338619,0,0,2.424734156985678,3.835291275007575,MRPS25;MRPS6
516,GO_Biological_Process_2021,mitochondrial translational termination (GO:0070126),2/89,0.205617668701232,0.4318764933338619,0,0,2.424734156985678,3.835291275007575,MRPS25;MRPS6
517,GO_Biological_Process_2021,post-Golgi vesicle-mediated transport (GO:0006892),2/89,0.205617668701232,0.4318764933338619,0,0,2.424734156985678,3.835291275007575,MON2;AP4B1
518,GO_Biological_Process_2021,"regulation of mRNA splicing, via spliceosome (GO:0048024)",2/90,0.2090701326333077,0.4340006358067261,0,0,2.397058823529412,3.751602056413905,NOVA1;RBM7
519,GO_Biological_Process_2021,positive regulation of autophagy (GO:0010508),2/90,0.2090701326333077,0.4340006358067261,0,0,2.397058823529412,3.751602056413905,MAP3K7;TRIM22
520,GO_Biological_Process_2021,positive regulation of binding (GO:0051099),2/90,0.2090701326333077,0.4340006358067261,0,0,2.397058823529412,3.751602056413905,AKTIP;CAPRIN2
521,GO_Biological_Process_2021,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),1/25,0.2114157508984971,0.4340006358067261,0,0,4.385416666666667,6.814624823124887,UGGT2
522,GO_Biological_Process_2021,receptor signaling pathway via STAT (GO:0097696),1/25,0.2114157508984971,0.4340006358067261,0,0,4.385416666666667,6.814624823124887,IFNAR1
523,GO_Biological_Process_2021,regulation of cAMP-mediated signaling (GO:0043949),1/25,0.2114157508984971,0.4340006358067261,0,0,4.385416666666667,6.814624823124887,PDE4D
524,GO_Biological_Process_2021,regulation of cardiac muscle cell action potential (GO:0098901),1/25,0.2114157508984971,0.4340006358067261,0,0,4.385416666666667,6.814624823124887,CACNA1C
525,GO_Biological_Process_2021,negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/25,0.2114157508984971,0.4340006358067261,0,0,4.385416666666667,6.814624823124887,USP25
526,GO_Biological_Process_2021,peripheral nervous system development (GO:0007422),1/25,0.2114157508984971,0.4340006358067261,0,0,4.385416666666667,6.814624823124887,ADGRG6
527,GO_Biological_Process_2021,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),1/25,0.2114157508984971,0.4340006358067261,0,0,4.385416666666667,6.814624823124887,PDE4D
528,GO_Biological_Process_2021,"RNA splicing, via transesterification reactions (GO:0000375)",1/25,0.2114157508984971,0.4340006358067261,0,0,4.385416666666667,6.814624823124887,PRPF3
529,GO_Biological_Process_2021,negative regulation of actin filament polymerization (GO:0030837),1/25,0.2114157508984971,0.4340006358067261,0,0,4.385416666666667,6.814624823124887,TWF1
530,GO_Biological_Process_2021,intracellular protein transport (GO:0006886),5/336,0.2130240873914594,0.4361508803501138,0,0,1.5992381452778142,2.4729819592395383,TBCK;RABGAP1L;STXBP3;SNX27;AP4B1
531,GO_Biological_Process_2021,regulation of actin filament bundle assembly (GO:0032231),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,RDX
532,GO_Biological_Process_2021,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,BCL2
533,GO_Biological_Process_2021,cellular response to drug (GO:0035690),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,PDE4B
534,GO_Biological_Process_2021,regulation of glycogen biosynthetic process (GO:0005979),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,EPM2AIP1
535,GO_Biological_Process_2021,clathrin-dependent endocytosis (GO:0072583),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,ITSN2
536,GO_Biological_Process_2021,organelle fission (GO:0048285),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,TMCC1
537,GO_Biological_Process_2021,DNA geometric change (GO:0032392),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,MCM9
538,GO_Biological_Process_2021,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,BCL2
539,GO_Biological_Process_2021,regulation of viral life cycle (GO:1903900),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,TRIM22
540,GO_Biological_Process_2021,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,RDX
541,GO_Biological_Process_2021,hippo signaling (GO:0035329),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,MOB1B
542,GO_Biological_Process_2021,RNA polyadenylation (GO:0043631),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,CPSF2
543,GO_Biological_Process_2021,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,BCL2
544,GO_Biological_Process_2021,membrane depolarization during action potential (GO:0086010),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,CACNA1C
545,GO_Biological_Process_2021,mRNA polyadenylation (GO:0006378),1/26,0.2188771881168769,0.4361508803501138,0,0,4.209787234042553,6.395696064943001,CPSF2
546,GO_Biological_Process_2021,regulation of heart contraction (GO:0008016),2/93,0.2194618617493781,0.4364939097548359,0,0,2.317682317682318,3.514943260893697,PDE4D;ITPR2
547,GO_Biological_Process_2021,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),3/171,0.2198517118985754,0.4364939097548359,0,0,1.8858486943164363,2.856687367661177,MAP3K7;ZDHHC17;TRIM22
548,GO_Biological_Process_2021,regulation of gene expression (GO:0010468),13/1079,0.2215477160189285,0.4367706494560374,0,0,1.29884977827051,1.9575189585801027,NTRK2;WWC2;RDX;SMARCA2;PTBP3;NWD1;ATXN1;ZNF827;NOVA1;ITGB8;TRIM22;NFE2L2;TNRC6B
549,GO_Biological_Process_2021,positive regulation of epithelial cell migration (GO:0010634),2/94,0.2229358450352153,0.4367706494560374,0,0,2.2923738665426643,3.4405580061036805,ADAM9;MAPRE2
550,GO_Biological_Process_2021,protein peptidyl-prolyl isomerization (GO:0000413),1/27,0.2262683966074298,0.4367706494560374,0,0,4.047667757774141,6.01496943456091,PPWD1
551,GO_Biological_Process_2021,negative regulation of endothelial cell apoptotic process (GO:2000352),1/27,0.2262683966074298,0.4367706494560374,0,0,4.047667757774141,6.01496943456091,NFE2L2
552,GO_Biological_Process_2021,camera-type eye development (GO:0043010),1/27,0.2262683966074298,0.4367706494560374,0,0,4.047667757774141,6.01496943456091,CACNA1C
553,GO_Biological_Process_2021,cellular lipid catabolic process (GO:0044242),1/27,0.2262683966074298,0.4367706494560374,0,0,4.047667757774141,6.01496943456091,ACBD5
554,GO_Biological_Process_2021,negative regulation of protein polymerization (GO:0032272),1/27,0.2262683966074298,0.4367706494560374,0,0,4.047667757774141,6.01496943456091,TWF1
555,GO_Biological_Process_2021,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),1/27,0.2262683966074298,0.4367706494560374,0,0,4.047667757774141,6.01496943456091,MAP3K7
556,GO_Biological_Process_2021,peroxisomal membrane transport (GO:0015919),1/27,0.2262683966074298,0.4367706494560374,0,0,4.047667757774141,6.01496943456091,ACBD5
557,GO_Biological_Process_2021,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),1/27,0.2262683966074298,0.4367706494560374,0,0,4.047667757774141,6.01496943456091,ZMYND11
558,GO_Biological_Process_2021,positive regulation of gene silencing by miRNA (GO:2000637),1/27,0.2262683966074298,0.4367706494560374,0,0,4.047667757774141,6.01496943456091,TNRC6B
559,GO_Biological_Process_2021,response to glucocorticoid (GO:0051384),1/27,0.2262683966074298,0.4367706494560374,0,0,4.047667757774141,6.01496943456091,ADAM9
560,GO_Biological_Process_2021,stress-activated protein kinase signaling cascade (GO:0031098),1/27,0.2262683966074298,0.4367706494560374,0,0,4.047667757774141,6.01496943456091,MAP3K7
561,GO_Biological_Process_2021,monocarboxylic acid catabolic process (GO:0072329),1/27,0.2262683966074298,0.4367706494560374,0,0,4.047667757774141,6.01496943456091,ACBD5
562,GO_Biological_Process_2021,protein export from nucleus (GO:0006611),1/27,0.2262683966074298,0.4367706494560374,0,0,4.047667757774141,6.01496943456091,STYX
563,GO_Biological_Process_2021,mRNA metabolic process (GO:0016071),2/95,0.2264141969606664,0.4367706494560374,0,0,2.2676096831694554,3.368282994864561,PRPF3;HIPK3
564,GO_Biological_Process_2021,post-translational protein modification (GO:0043687),5/345,0.2283667122267741,0.4374284971837043,0,0,1.556186061381074,2.298179551716498,DNAJC3;KBTBD6;MGAT4A;MIA3;KTN1
565,GO_Biological_Process_2021,protein ubiquitination (GO:0016567),7/525,0.2294040045345837,0.4374284971837043,0,0,1.4325066825066826,2.10903749857199,RNF19A;AKTIP;BCL2;WWP1;DZIP3;TRIM22;NFE2L2
566,GO_Biological_Process_2021,translational termination (GO:0006415),2/96,0.2298965272128094,0.4374284971837043,0,0,2.2433723973148254,3.29803998346794,MRPS25;MRPS6
567,GO_Biological_Process_2021,receptor clustering (GO:0043113),1/28,0.2335900338821068,0.4374284971837043,0,0,3.897557131599685,5.667779610083707,MAGI2
568,GO_Biological_Process_2021,calcium ion import (GO:0070509),1/28,0.2335900338821068,0.4374284971837043,0,0,3.897557131599685,5.667779610083707,CACNA1C
569,GO_Biological_Process_2021,negative regulation of oxidative stress-induced cell death (GO:1903202),1/28,0.2335900338821068,0.4374284971837043,0,0,3.897557131599685,5.667779610083707,NFE2L2
570,GO_Biological_Process_2021,"regulation of DNA-templated transcription, elongation (GO:0032784)",1/28,0.2335900338821068,0.4374284971837043,0,0,3.897557131599685,5.667779610083707,ZMYND11
571,GO_Biological_Process_2021,cellular response to acid chemical (GO:0071229),1/28,0.2335900338821068,0.4374284971837043,0,0,3.897557131599685,5.667779610083707,CPEB4
572,GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.2335900338821068,0.4374284971837043,0,0,3.897557131599685,5.667779610083707,BCL2
573,GO_Biological_Process_2021,cytosolic calcium ion transport (GO:0060401),1/28,0.2335900338821068,0.4374284971837043,0,0,3.897557131599685,5.667779610083707,CACNA1C
574,GO_Biological_Process_2021,regulation of microtubule polymerization or depolymerization (GO:0031110),1/28,0.2335900338821068,0.4374284971837043,0,0,3.897557131599685,5.667779610083707,MAPRE2
575,GO_Biological_Process_2021,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),1/28,0.2335900338821068,0.4374284971837043,0,0,3.897557131599685,5.667779610083707,MAP3K7
576,GO_Biological_Process_2021,phagosome acidification (GO:0090383),1/28,0.2335900338821068,0.4374284971837043,0,0,3.897557131599685,5.667779610083707,ATP6V1A
577,GO_Biological_Process_2021,histone mRNA metabolic process (GO:0008334),1/28,0.2335900338821068,0.4374284971837043,0,0,3.897557131599685,5.667779610083707,CPSF2
578,GO_Biological_Process_2021,positive regulation of protein import into nucleus (GO:0042307),1/28,0.2335900338821068,0.4374284971837043,0,0,3.897557131599685,5.667779610083707,EFCAB7
579,GO_Biological_Process_2021,positive regulation of synapse assembly (GO:0051965),1/28,0.2335900338821068,0.4374284971837043,0,0,3.897557131599685,5.667779610083707,PTPRD
580,GO_Biological_Process_2021,protein depolymerization (GO:0051261),1/28,0.2335900338821068,0.4374284971837043,0,0,3.897557131599685,5.667779610083707,TWF1
581,GO_Biological_Process_2021,regulation of peptidyl-serine phosphorylation (GO:0033135),2/98,0.236871595914967,0.4420519663044324,0,0,2.1964126559714794,3.163354937056446,PDE4D;CAPRIN2
582,GO_Biological_Process_2021,RNA splicing (GO:0008380),2/98,0.236871595914967,0.4420519663044324,0,0,2.1964126559714794,3.163354937056446,NOVA1;PRPF3
583,GO_Biological_Process_2021,protein targeting to peroxisome (GO:0006625),1/29,0.2408427513052744,0.4426299213178017,0,0,3.7581686930091194,5.350170451555993,ACBD5
584,GO_Biological_Process_2021,aggrephagy (GO:0035973),1/29,0.2408427513052744,0.4426299213178017,0,0,3.7581686930091194,5.350170451555993,ACBD5
585,GO_Biological_Process_2021,regulation of calcium ion transmembrane transporter activity (GO:1901019),1/29,0.2408427513052744,0.4426299213178017,0,0,3.7581686930091194,5.350170451555993,PDE4D
586,GO_Biological_Process_2021,beta-catenin-TCF complex assembly (GO:1904837),1/29,0.2408427513052744,0.4426299213178017,0,0,3.7581686930091194,5.350170451555993,PYGO1
587,GO_Biological_Process_2021,glial cell differentiation (GO:0010001),1/29,0.2408427513052744,0.4426299213178017,0,0,3.7581686930091194,5.350170451555993,ADGRG6
588,GO_Biological_Process_2021,positive regulation of leukocyte migration (GO:0002687),1/29,0.2408427513052744,0.4426299213178017,0,0,3.7581686930091194,5.350170451555993,MIA3
589,GO_Biological_Process_2021,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),1/29,0.2408427513052744,0.4426299213178017,0,0,3.7581686930091194,5.350170451555993,BCL2
590,GO_Biological_Process_2021,mismatch repair (GO:0006298),1/29,0.2408427513052744,0.4426299213178017,0,0,3.7581686930091194,5.350170451555993,MCM9
591,GO_Biological_Process_2021,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/29,0.2408427513052744,0.4426299213178017,0,0,3.7581686930091194,5.350170451555993,MAP3K7
592,GO_Biological_Process_2021,cell-matrix adhesion (GO:0007160),2/100,0.2438580650566493,0.4474158090752689,0,0,2.1513696387645966,3.035945977250269,ADAM9;ITGB8
593,GO_Biological_Process_2021,positive regulation of protein localization to membrane (GO:1905477),2/101,0.2473546707768842,0.4475183869212635,0,0,2.1295306001188354,2.974809564259034,BCL2;EFCAB7
594,GO_Biological_Process_2021,protein N-linked glycosylation via asparagine (GO:0018279),1/30,0.248027194221987,0.4475183869212635,0,0,3.628393250183419,5.058767133765583,UGGT2
595,GO_Biological_Process_2021,negative regulation of cytoskeleton organization (GO:0051494),1/30,0.248027194221987,0.4475183869212635,0,0,3.628393250183419,5.058767133765583,TWF1
596,GO_Biological_Process_2021,cardiac muscle cell action potential (GO:0086001),1/30,0.248027194221987,0.4475183869212635,0,0,3.628393250183419,5.058767133765583,CACNA1C
597,GO_Biological_Process_2021,negative regulation of Notch signaling pathway (GO:0045746),1/30,0.248027194221987,0.4475183869212635,0,0,3.628393250183419,5.058767133765583,BEND6
598,GO_Biological_Process_2021,positive regulation of B cell proliferation (GO:0030890),1/30,0.248027194221987,0.4475183869212635,0,0,3.628393250183419,5.058767133765583,BCL2
599,GO_Biological_Process_2021,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),1/30,0.248027194221987,0.4475183869212635,0,0,3.628393250183419,5.058767133765583,BCL2
600,GO_Biological_Process_2021,regulation of vasoconstriction (GO:0019229),1/30,0.248027194221987,0.4475183869212635,0,0,3.628393250183419,5.058767133765583,CHRM3
601,GO_Biological_Process_2021,positive regulation of protein import (GO:1904591),1/30,0.248027194221987,0.4475183869212635,0,0,3.628393250183419,5.058767133765583,EFCAB7
602,GO_Biological_Process_2021,positive regulation of small GTPase mediated signal transduction (GO:0051057),1/30,0.248027194221987,0.4475183869212635,0,0,3.628393250183419,5.058767133765583,ERBIN
603,GO_Biological_Process_2021,cell junction assembly (GO:0034329),2/102,0.2508530547945053,0.4478286703257689,0,0,2.108128342245989,2.915305282288427,PARD6B;CDH8
604,GO_Biological_Process_2021,cellular response to organonitrogen compound (GO:0071417),2/103,0.2543528731999853,0.4478286703257689,0,0,2.087149891459734,2.8573764752786133,IMPACT;CPEB4
605,GO_Biological_Process_2021,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),3/185,0.2549159003044859,0.4478286703257689,0,0,1.739542715349167,2.3776445417157213,COG6;MIA2;MIA3
606,GO_Biological_Process_2021,negative regulation of axon extension (GO:0030517),1/31,0.2551440019839143,0.4478286703257689,0,0,3.5072695035460995,4.790674740907671,SEMA6D
607,GO_Biological_Process_2021,protein palmitoylation (GO:0018345),1/31,0.2551440019839143,0.4478286703257689,0,0,3.5072695035460995,4.790674740907671,ZDHHC17
608,GO_Biological_Process_2021,receptor signaling pathway via JAK-STAT (GO:0007259),1/31,0.2551440019839143,0.4478286703257689,0,0,3.5072695035460995,4.790674740907671,IFNAR1
609,GO_Biological_Process_2021,regulation of calcium ion-dependent exocytosis (GO:0017158),1/31,0.2551440019839143,0.4478286703257689,0,0,3.5072695035460995,4.790674740907671,STXBP3
610,GO_Biological_Process_2021,regulation of cellular component size (GO:0032535),1/31,0.2551440019839143,0.4478286703257689,0,0,3.5072695035460995,4.790674740907671,RDX
611,GO_Biological_Process_2021,cardiac muscle cell action potential involved in contraction (GO:0086002),1/31,0.2551440019839143,0.4478286703257689,0,0,3.5072695035460995,4.790674740907671,CACNA1C
612,GO_Biological_Process_2021,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),1/31,0.2551440019839143,0.4478286703257689,0,0,3.5072695035460995,4.790674740907671,STYX
613,GO_Biological_Process_2021,cellular nitrogen compound biosynthetic process (GO:0044271),1/31,0.2551440019839143,0.4478286703257689,0,0,3.5072695035460995,4.790674740907671,ASAH1
614,GO_Biological_Process_2021,peptidyl-asparagine modification (GO:0018196),1/31,0.2551440019839143,0.4478286703257689,0,0,3.5072695035460995,4.790674740907671,UGGT2
615,GO_Biological_Process_2021,phospholipid translocation (GO:0045332),1/31,0.2551440019839143,0.4478286703257689,0,0,3.5072695035460995,4.790674740907671,ATP9A
616,GO_Biological_Process_2021,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),1/31,0.2551440019839143,0.4478286703257689,0,0,3.5072695035460995,4.790674740907671,TMTC3
617,GO_Biological_Process_2021,regulation of insulin secretion (GO:0050796),2/104,0.2578537884033945,0.4478286703257689,0,0,2.066582782845759,2.8009689440643366,ITPR2;CACNA1C
618,GO_Biological_Process_2021,translational elongation (GO:0006414),2/104,0.2578537884033945,0.4478286703257689,0,0,2.066582782845759,2.8009689440643366,MRPS25;MRPS6
619,GO_Biological_Process_2021,activation of GTPase activity (GO:0090630),2/105,0.2613554689674783,0.4478286703257689,0,0,2.046415035564093,2.7460308187974345,TBCK;RABGAP1L
620,GO_Biological_Process_2021,regulation of JNK cascade (GO:0046328),2/105,0.2613554689674783,0.4478286703257689,0,0,2.046415035564093,2.7460308187974345,TAOK3;ZMYND11
621,GO_Biological_Process_2021,positive regulation of cellular metabolic process (GO:0031325),2/105,0.2613554689674783,0.4478286703257689,0,0,2.046415035564093,2.7460308187974345,MAGI2;IFNAR1
622,GO_Biological_Process_2021,mitochondrial translation (GO:0032543),2/105,0.2613554689674783,0.4478286703257689,0,0,2.046415035564093,2.7460308187974345,MRPS25;MRPS6
623,GO_Biological_Process_2021,activation of phospholipase C activity (GO:0007202),1/32,0.2621938079021275,0.4478286703257689,0,0,3.393960192175704,4.543397183606022,NTRK2
624,GO_Biological_Process_2021,negative regulation of chemotaxis (GO:0050922),1/32,0.2621938079021275,0.4478286703257689,0,0,3.393960192175704,4.543397183606022,SEMA6D
625,GO_Biological_Process_2021,negative regulation of developmental growth (GO:0048640),1/32,0.2621938079021275,0.4478286703257689,0,0,3.393960192175704,4.543397183606022,WWC2
626,GO_Biological_Process_2021,B cell proliferation (GO:0042100),1/32,0.2621938079021275,0.4478286703257689,0,0,3.393960192175704,4.543397183606022,BCL2
627,GO_Biological_Process_2021,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),1/32,0.2621938079021275,0.4478286703257689,0,0,3.393960192175704,4.543397183606022,PIAS2
628,GO_Biological_Process_2021,regulation of dendritic spine morphogenesis (GO:0061001),1/32,0.2621938079021275,0.4478286703257689,0,0,3.393960192175704,4.543397183606022,CAPRIN2
629,GO_Biological_Process_2021,peptidyl-proline modification (GO:0018208),1/32,0.2621938079021275,0.4478286703257689,0,0,3.393960192175704,4.543397183606022,PPWD1
630,GO_Biological_Process_2021,ERBB2 signaling pathway (GO:0038128),1/32,0.2621938079021275,0.4478286703257689,0,0,3.393960192175704,4.543397183606022,ERBIN
631,GO_Biological_Process_2021,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/32,0.2621938079021275,0.4478286703257689,0,0,3.393960192175704,4.543397183606022,ERBIN
632,GO_Biological_Process_2021,gene silencing by miRNA (GO:0035195),1/32,0.2621938079021275,0.4478286703257689,0,0,3.393960192175704,4.543397183606022,TNRC6B
633,GO_Biological_Process_2021,response to amino acid (GO:0043200),1/32,0.2621938079021275,0.4478286703257689,0,0,3.393960192175704,4.543397183606022,CPEB4
634,GO_Biological_Process_2021,intra-Golgi vesicle-mediated transport (GO:0006891),1/32,0.2621938079021275,0.4478286703257689,0,0,3.393960192175704,4.543397183606022,COG6
635,GO_Biological_Process_2021,mitochondrial membrane organization (GO:0007006),1/32,0.2621938079021275,0.4478286703257689,0,0,3.393960192175704,4.543397183606022,BCL2
636,GO_Biological_Process_2021,protein K63-linked deubiquitination (GO:0070536),1/32,0.2621938079021275,0.4478286703257689,0,0,3.393960192175704,4.543397183606022,USP25
637,GO_Biological_Process_2021,regulation of cell cycle process (GO:0010564),2/106,0.2648575895752122,0.4516693690561613,0,0,2.026635129576306,2.692512438079982,CAV2;MAP9
638,GO_Biological_Process_2021,response to calcium ion (GO:0051592),2/107,0.2683598308997783,0.4519519083273356,0,0,2.007231983702572,2.640366236169961,PPP3CA;ADAM9
639,GO_Biological_Process_2021,apoptotic cell clearance (GO:0043277),1/33,0.2691772395184866,0.4519519083273356,0,0,3.287732712765957,4.31477186353451,XKR4
640,GO_Biological_Process_2021,apoptotic mitochondrial changes (GO:0008637),1/33,0.2691772395184866,0.4519519083273356,0,0,3.287732712765957,4.31477186353451,BCL2
641,GO_Biological_Process_2021,neuron projection extension (GO:1990138),1/33,0.2691772395184866,0.4519519083273356,0,0,3.287732712765957,4.31477186353451,IMPACT
642,GO_Biological_Process_2021,positive regulation of cytokine production involved in immune response (GO:0002720),1/33,0.2691772395184866,0.4519519083273356,0,0,3.287732712765957,4.31477186353451,MAP3K7
643,GO_Biological_Process_2021,lytic vacuole organization (GO:0080171),1/33,0.2691772395184866,0.4519519083273356,0,0,3.287732712765957,4.31477186353451,AKTIP
644,GO_Biological_Process_2021,vasculogenesis (GO:0001570),1/33,0.2691772395184866,0.4519519083273356,0,0,3.287732712765957,4.31477186353451,ITGB8
645,GO_Biological_Process_2021,mitotic G2 DNA damage checkpoint signaling (GO:0007095),1/33,0.2691772395184866,0.4519519083273356,0,0,3.287732712765957,4.31477186353451,TAOK3
646,GO_Biological_Process_2021,primary alcohol metabolic process (GO:0034308),1/33,0.2691772395184866,0.4519519083273356,0,0,3.287732712765957,4.31477186353451,PECR
647,GO_Biological_Process_2021,negative chemotaxis (GO:0050919),1/33,0.2691772395184866,0.4519519083273356,0,0,3.287732712765957,4.31477186353451,SEMA6D
648,GO_Biological_Process_2021,regulation of amyloid-beta formation (GO:1902003),1/34,0.2760949183840337,0.4537632495495902,0,0,3.1879432624113475,4.102916659978313,NTRK2
649,GO_Biological_Process_2021,B cell receptor signaling pathway (GO:0050853),1/34,0.2760949183840337,0.4537632495495902,0,0,3.1879432624113475,4.102916659978313,BCL2
650,GO_Biological_Process_2021,regulation of cell adhesion mediated by integrin (GO:0033628),1/34,0.2760949183840337,0.4537632495495902,0,0,3.1879432624113475,4.102916659978313,ADAM9
651,GO_Biological_Process_2021,cell-substrate junction assembly (GO:0007044),1/34,0.2760949183840337,0.4537632495495902,0,0,3.1879432624113475,4.102916659978313,DST
652,GO_Biological_Process_2021,cellular response to amino acid stimulus (GO:0071230),1/34,0.2760949183840337,0.4537632495495902,0,0,3.1879432624113475,4.102916659978313,CPEB4
653,GO_Biological_Process_2021,central nervous system neuron differentiation (GO:0021953),1/34,0.2760949183840337,0.4537632495495902,0,0,3.1879432624113475,4.102916659978313,NTRK2
654,GO_Biological_Process_2021,regulation of lamellipodium assembly (GO:0010591),1/34,0.2760949183840337,0.4537632495495902,0,0,3.1879432624113475,4.102916659978313,TWF1
655,GO_Biological_Process_2021,phosphatidylserine metabolic process (GO:0006658),1/34,0.2760949183840337,0.4537632495495902,0,0,3.1879432624113475,4.102916659978313,SERINC1
656,GO_Biological_Process_2021,female gamete generation (GO:0007292),1/34,0.2760949183840337,0.4537632495495902,0,0,3.1879432624113475,4.102916659978313,MCM9
657,GO_Biological_Process_2021,regulation of transmembrane transport (GO:0034762),1/34,0.2760949183840337,0.4537632495495902,0,0,3.1879432624113475,4.102916659978313,BCL2
658,GO_Biological_Process_2021,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),1/34,0.2760949183840337,0.4537632495495902,0,0,3.1879432624113475,4.102916659978313,BCL2
659,GO_Biological_Process_2021,positive regulation of protein dephosphorylation (GO:0035307),1/34,0.2760949183840337,0.4537632495495902,0,0,3.1879432624113475,4.102916659978313,MAGI2
660,GO_Biological_Process_2021,termination of RNA polymerase II transcription (GO:0006369),1/34,0.2760949183840337,0.4537632495495902,0,0,3.1879432624113475,4.102916659978313,CPSF2
661,GO_Biological_Process_2021,protein localization to chromosome (GO:0034502),1/34,0.2760949183840337,0.4537632495495902,0,0,3.1879432624113475,4.102916659978313,MCM9
662,GO_Biological_Process_2021,cellular response to tumor necrosis factor (GO:0071356),3/194,0.2778609725336466,0.4559769805680354,0,0,1.65681472724202,2.1217739162100617,ASAH1;ERBIN;NFE2L2
663,GO_Biological_Process_2021,response to endoplasmic reticulum stress (GO:0034976),2/110,0.2788641746776099,0.4569340693512644,0,0,1.9511784511784511,2.4917142854180496,TMTC3;BCL2
664,GO_Biological_Process_2021,protein localization to membrane (GO:0072657),3/195,0.2804241561213996,0.4574247204514884,0,0,1.6481014784946235,2.095481885996075,RDX;MAGI2;RAPGEF6
665,GO_Biological_Process_2021,Fc-epsilon receptor signaling pathway (GO:0038095),2/111,0.2823638232802172,0.4574247204514884,0,0,1.9331796104596968,2.444619454835973,PPP3CA;MAP3K7
666,GO_Biological_Process_2021,negative regulation of Ras protein signal transduction (GO:0046580),1/35,0.2829474603528049,0.4574247204514884,0,0,3.094023779724656,3.906186615672604,SCAI
667,GO_Biological_Process_2021,regulation of ion transmembrane transport (GO:0034765),1/35,0.2829474603528049,0.4574247204514884,0,0,3.094023779724656,3.906186615672604,CHRM3
668,GO_Biological_Process_2021,regulation of lipid biosynthetic process (GO:0046890),1/35,0.2829474603528049,0.4574247204514884,0,0,3.094023779724656,3.906186615672604,ASAH1
669,GO_Biological_Process_2021,regulation of mitotic spindle organization (GO:0060236),1/35,0.2829474603528049,0.4574247204514884,0,0,3.094023779724656,3.906186615672604,MAP9
670,GO_Biological_Process_2021,positive regulation of cell cycle G1/S phase transition (GO:1902808),1/35,0.2829474603528049,0.4574247204514884,0,0,3.094023779724656,3.906186615672604,RDX
671,GO_Biological_Process_2021,semaphorin-plexin signaling pathway (GO:0071526),1/35,0.2829474603528049,0.4574247204514884,0,0,3.094023779724656,3.906186615672604,SEMA6D
672,GO_Biological_Process_2021,intracellular pH reduction (GO:0051452),1/35,0.2829474603528049,0.4574247204514884,0,0,3.094023779724656,3.906186615672604,ATP6V1A
673,GO_Biological_Process_2021,regulation of macroautophagy (GO:0016241),2/112,0.2858620834012417,0.4594701000909301,0,0,1.9155080213903743,2.3986868944594413,ATP6V1A;MAP3K7
674,GO_Biological_Process_2021,Fc receptor signaling pathway (GO:0038093),2/112,0.2858620834012417,0.4594701000909301,0,0,1.9155080213903743,2.3986868944594413,PPP3CA;MAP3K7
675,GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),7/566,0.2883975215562582,0.4594701000909301,0,0,1.3246181367827163,1.64705067964759,IMPACT;CAPRIN2;MAGI2;BCL2;MIA3;SMARCA2;IFIT3
676,GO_Biological_Process_2021,regulation of androgen receptor signaling pathway (GO:0060765),1/36,0.2897354754914663,0.4594701000909301,0,0,3.005471124620061,3.723138334881813,PIAS2
677,GO_Biological_Process_2021,axonal transport (GO:0098930),1/36,0.2897354754914663,0.4594701000909301,0,0,3.005471124620061,3.723138334881813,DST
678,GO_Biological_Process_2021,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/36,0.2897354754914663,0.4594701000909301,0,0,3.005471124620061,3.723138334881813,CDH8
679,GO_Biological_Process_2021,embryonic limb morphogenesis (GO:0030326),1/36,0.2897354754914663,0.4594701000909301,0,0,3.005471124620061,3.723138334881813,CACNA1C
680,GO_Biological_Process_2021,platelet aggregation (GO:0070527),1/36,0.2897354754914663,0.4594701000909301,0,0,3.005471124620061,3.723138334881813,STXBP3
681,GO_Biological_Process_2021,regulation of protein import into nucleus (GO:0042306),1/36,0.2897354754914663,0.4594701000909301,0,0,3.005471124620061,3.723138334881813,EFCAB7
682,GO_Biological_Process_2021,regulation of receptor internalization (GO:0002090),1/36,0.2897354754914663,0.4594701000909301,0,0,3.005471124620061,3.723138334881813,MAGI2
683,GO_Biological_Process_2021,membrane assembly (GO:0071709),1/36,0.2897354754914663,0.4594701000909301,0,0,3.005471124620061,3.723138334881813,PTPRD
684,GO_Biological_Process_2021,transferrin transport (GO:0033572),1/36,0.2897354754914663,0.4594701000909301,0,0,3.005471124620061,3.723138334881813,ATP6V1A
685,GO_Biological_Process_2021,positive regulation of T cell mediated immunity (GO:0002711),1/36,0.2897354754914663,0.4594701000909301,0,0,3.005471124620061,3.723138334881813,MAP3K7
686,GO_Biological_Process_2021,activation of protein kinase activity (GO:0032147),2/114,0.29285330395136,0.4594701000909301,0,0,1.8811115355233,2.310161971561719,TAOK3;MAP3K7
687,GO_Biological_Process_2021,cellular response to transforming growth factor beta stimulus (GO:0071560),2/114,0.29285330395136,0.4594701000909301,0,0,1.8811115355233,2.310161971561719,ADAM9;MAP3K7
688,GO_Biological_Process_2021,response to lipid (GO:0033993),2/114,0.29285330395136,0.4594701000909301,0,0,1.8811115355233,2.310161971561719,ERBIN;IFNAR1
689,GO_Biological_Process_2021,regulation of macromolecule metabolic process (GO:0060255),3/200,0.2932709854088831,0.4594701000909301,0,0,1.6058621254298346,1.969843996438265,ZNF827;NOVA1;TRIM22
690,GO_Biological_Process_2021,cellular response to molecule of bacterial origin (GO:0071219),2/115,0.2963457108606588,0.4594701000909301,0,0,1.8643698831101223,2.267499905839761,PDE4B;ADAM9
691,GO_Biological_Process_2021,proton transmembrane transport (GO:1902600),1/37,0.2964595682571994,0.4594701000909301,0,0,2.921838061465721,3.5525005418174813,ATP6V1A
692,GO_Biological_Process_2021,negative regulation of endothelial cell proliferation (GO:0001937),1/37,0.2964595682571994,0.4594701000909301,0,0,2.921838061465721,3.5525005418174813,CAV2
693,GO_Biological_Process_2021,negative regulation of epithelial cell apoptotic process (GO:1904036),1/37,0.2964595682571994,0.4594701000909301,0,0,2.921838061465721,3.5525005418174813,NFE2L2
694,GO_Biological_Process_2021,neural crest cell migration (GO:0001755),1/37,0.2964595682571994,0.4594701000909301,0,0,2.921838061465721,3.5525005418174813,SEMA6D
695,GO_Biological_Process_2021,regulation of microtubule cytoskeleton organization (GO:0070507),1/37,0.2964595682571994,0.4594701000909301,0,0,2.921838061465721,3.5525005418174813,MAPRE2
696,GO_Biological_Process_2021,"phagocytosis, engulfment (GO:0006911)",1/37,0.2964595682571994,0.4594701000909301,0,0,2.921838061465721,3.5525005418174813,XKR4
697,GO_Biological_Process_2021,phagosome maturation (GO:0090382),1/37,0.2964595682571994,0.4594701000909301,0,0,2.921838061465721,3.5525005418174813,ATP6V1A
698,GO_Biological_Process_2021,regulation of transport (GO:0051049),1/37,0.2964595682571994,0.4594701000909301,0,0,2.921838061465721,3.5525005418174813,REEP5
699,GO_Biological_Process_2021,glutamate receptor signaling pathway (GO:0007215),1/37,0.2964595682571994,0.4594701000909301,0,0,2.921838061465721,3.5525005418174813,CPEB4
700,GO_Biological_Process_2021,glutamine family amino acid metabolic process (GO:0009064),1/37,0.2964595682571994,0.4594701000909301,0,0,2.921838061465721,3.5525005418174813,GLS
701,GO_Biological_Process_2021,skeletal muscle tissue development (GO:0007519),1/37,0.2964595682571994,0.4594701000909301,0,0,2.921838061465721,3.5525005418174813,CAV2
702,GO_Biological_Process_2021,regulation of apoptotic signaling pathway (GO:2001233),1/38,0.3031203373806736,0.4644998972819336,0,0,2.842725704427832,3.393149603893526,BCL2
703,GO_Biological_Process_2021,regulation of cell communication (GO:0010646),1/38,0.3031203373806736,0.4644998972819336,0,0,2.842725704427832,3.393149603893526,GRK5
704,GO_Biological_Process_2021,negative regulation of proteasomal protein catabolic process (GO:1901799),1/38,0.3031203373806736,0.4644998972819336,0,0,2.842725704427832,3.393149603893526,USP25
705,GO_Biological_Process_2021,regulation of phosphoprotein phosphatase activity (GO:0043666),1/38,0.3031203373806736,0.4644998972819336,0,0,2.842725704427832,3.393149603893526,MAGI2
706,GO_Biological_Process_2021,spliceosomal snRNP assembly (GO:0000387),1/38,0.3031203373806736,0.4644998972819336,0,0,2.842725704427832,3.393149603893526,PRPF3
707,GO_Biological_Process_2021,lymphocyte proliferation (GO:0046651),1/38,0.3031203373806736,0.4644998972819336,0,0,2.842725704427832,3.393149603893526,BCL2
708,GO_Biological_Process_2021,lysosome organization (GO:0007040),1/38,0.3031203373806736,0.4644998972819336,0,0,2.842725704427832,3.393149603893526,AKTIP
709,GO_Biological_Process_2021,synaptic vesicle endocytosis (GO:0048488),1/38,0.3031203373806736,0.4644998972819336,0,0,2.842725704427832,3.393149603893526,ITSN2
710,GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),6/482,0.3051376084019926,0.466933499214301,0,0,1.331795013087202,1.5808305975612134,NTRK2;NWD1;RDX;ITGB8;NFE2L2;TNRC6B
711,GO_Biological_Process_2021,proteasomal protein catabolic process (GO:0010498),3/205,0.3061572475025996,0.4678357939365566,0,0,1.5657138294474608,1.8532672390939755,KBTBD6;WWP1;NFE2L2
712,GO_Biological_Process_2021,regulation of cellular component biogenesis (GO:0044087),1/39,0.3097183761096093,0.4686698097458344,0,0,2.767777155655095,3.244089070477027,RDX
713,GO_Biological_Process_2021,regulation of heart rate by cardiac conduction (GO:0086091),1/39,0.3097183761096093,0.4686698097458344,0,0,2.767777155655095,3.244089070477027,CACNA1C
714,GO_Biological_Process_2021,regulation of ion transmembrane transporter activity (GO:0032412),1/39,0.3097183761096093,0.4686698097458344,0,0,2.767777155655095,3.244089070477027,CHRM3
715,GO_Biological_Process_2021,regulation of viral entry into host cell (GO:0046596),1/39,0.3097183761096093,0.4686698097458344,0,0,2.767777155655095,3.244089070477027,TRIM22
716,GO_Biological_Process_2021,response to peptide (GO:1901652),1/39,0.3097183761096093,0.4686698097458344,0,0,2.767777155655095,3.244089070477027,ERBIN
717,GO_Biological_Process_2021,membrane protein proteolysis (GO:0033619),1/39,0.3097183761096093,0.4686698097458344,0,0,2.767777155655095,3.244089070477027,ADAM9
718,GO_Biological_Process_2021,protein acylation (GO:0043543),1/39,0.3097183761096093,0.4686698097458344,0,0,2.767777155655095,3.244089070477027,ZDHHC17
719,GO_Biological_Process_2021,cellular response to lipopolysaccharide (GO:0071222),2/120,0.3137651136235864,0.4741339494756416,0,0,1.7849179733526692,2.0689173765723803,PDE4B;ADAM9
720,GO_Biological_Process_2021,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/40,0.316254272081253,0.4745995145164183,0,0,2.696672122204037,3.1044324903080134,ZMYND11
721,GO_Biological_Process_2021,negative regulation of protein kinase B signaling (GO:0051898),1/40,0.316254272081253,0.4745995145164183,0,0,2.696672122204037,3.1044324903080134,MAGI2
722,GO_Biological_Process_2021,nucleocytoplasmic transport (GO:0006913),1/40,0.316254272081253,0.4745995145164183,0,0,2.696672122204037,3.1044324903080134,ATXN1
723,GO_Biological_Process_2021,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),1/40,0.316254272081253,0.4745995145164183,0,0,2.696672122204037,3.1044324903080134,BCL2
724,GO_Biological_Process_2021,intraciliary transport involved in cilium assembly (GO:0035735),1/40,0.316254272081253,0.4745995145164183,0,0,2.696672122204037,3.1044324903080134,DYNC2LI1
725,GO_Biological_Process_2021,regulation of mitochondrial membrane potential (GO:0051881),1/41,0.3227286075001341,0.4829831154885088,0,0,2.629122340425532,2.973388909431432,BCL2
726,GO_Biological_Process_2021,JNK cascade (GO:0007254),1/41,0.3227286075001341,0.4829831154885088,0,0,2.629122340425532,2.973388909431432,MAP3K7
727,GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),4/306,0.328193301550309,0.4869412243965544,0,0,1.3967424378020403,1.5561840931691573,CHRM3;STXBP3;NOVA1;CDH8
728,GO_Biological_Process_2021,ATP-dependent chromatin remodeling (GO:0043044),1/42,0.3291419591356655,0.4869412243965544,0,0,2.564867669953295,2.850250581210622,SMARCA2
729,GO_Biological_Process_2021,ceramide biosynthetic process (GO:0046513),1/42,0.3291419591356655,0.4869412243965544,0,0,2.564867669953295,2.850250581210622,ASAH1
730,GO_Biological_Process_2021,nucleic acid-templated transcription (GO:0097659),1/42,0.3291419591356655,0.4869412243965544,0,0,2.564867669953295,2.850250581210622,THRB
731,GO_Biological_Process_2021,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/42,0.3291419591356655,0.4869412243965544,0,0,2.564867669953295,2.850250581210622,PTPRD
732,GO_Biological_Process_2021,histone H3 acetylation (GO:0043966),1/42,0.3291419591356655,0.4869412243965544,0,0,2.564867669953295,2.850250581210622,MAP3K7
733,GO_Biological_Process_2021,positive regulation of protein tyrosine kinase activity (GO:0061098),1/42,0.3291419591356655,0.4869412243965544,0,0,2.564867669953295,2.850250581210622,NTRK2
734,GO_Biological_Process_2021,mitochondrial gene expression (GO:0140053),1/42,0.3291419591356655,0.4869412243965544,0,0,2.564867669953295,2.850250581210622,MRPS6
735,GO_Biological_Process_2021,positive regulation of protein modification process (GO:0031401),3/214,0.3294014165035515,0.4869412243965544,0,0,1.4982418590429598,1.6637648643545508,NTRK2;FAM161A;AKTIP
736,GO_Biological_Process_2021,negative regulation of cell growth (GO:0030308),2/126,0.3345419696013373,0.4906161955277787,0,0,1.6980334655856475,1.8593346526660195,CAPRIN2;SMARCA2
737,GO_Biological_Process_2021,negative regulation of growth (GO:0045926),2/126,0.3345419696013373,0.4906161955277787,0,0,1.6980334655856475,1.8593346526660195,CAPRIN2;SMARCA2
738,GO_Biological_Process_2021,negative regulation of type I interferon production (GO:0032480),1/43,0.335494898412378,0.4906161955277787,0,0,2.5036727456940224,2.73438250533161,TAX1BP1
739,GO_Biological_Process_2021,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),1/43,0.335494898412378,0.4906161955277787,0,0,2.5036727456940224,2.73438250533161,MCM9
740,GO_Biological_Process_2021,positive regulation of axonogenesis (GO:0050772),1/43,0.335494898412378,0.4906161955277787,0,0,2.5036727456940224,2.73438250533161,NTRK2
741,GO_Biological_Process_2021,signal release from synapse (GO:0099643),1/43,0.335494898412378,0.4906161955277787,0,0,2.5036727456940224,2.73438250533161,STXBP3
742,GO_Biological_Process_2021,positive regulation of phospholipase C activity (GO:0010863),1/43,0.335494898412378,0.4906161955277787,0,0,2.5036727456940224,2.73438250533161,NTRK2
743,GO_Biological_Process_2021,natural killer cell activation (GO:0030101),1/43,0.335494898412378,0.4906161955277787,0,0,2.5036727456940224,2.73438250533161,SNX27
744,GO_Biological_Process_2021,regulation of endothelial cell apoptotic process (GO:2000351),1/44,0.3417879913863361,0.4951602325277412,0,0,2.4453240969816923,2.625213489652861,NFE2L2
745,GO_Biological_Process_2021,neurotransmitter secretion (GO:0007269),1/44,0.3417879913863361,0.4951602325277412,0,0,2.4453240969816923,2.625213489652861,STXBP3
746,GO_Biological_Process_2021,homotypic cell-cell adhesion (GO:0034109),1/44,0.3417879913863361,0.4951602325277412,0,0,2.4453240969816923,2.625213489652861,STXBP3
747,GO_Biological_Process_2021,positive regulation of mRNA catabolic process (GO:0061014),1/44,0.3417879913863361,0.4951602325277412,0,0,2.4453240969816923,2.625213489652861,TNRC6B
748,GO_Biological_Process_2021,lymphocyte chemotaxis (GO:0048247),1/44,0.3417879913863361,0.4951602325277412,0,0,2.4453240969816923,2.625213489652861,CXCL16
749,GO_Biological_Process_2021,positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.3417879913863361,0.4951602325277412,0,0,2.4453240969816923,2.625213489652861,MAGI2
750,GO_Biological_Process_2021,mitotic spindle assembly (GO:0090307),1/44,0.3417879913863361,0.4951602325277412,0,0,2.4453240969816923,2.625213489652861,MAP9
751,GO_Biological_Process_2021,positive regulation of macromolecule biosynthetic process (GO:0010557),2/129,0.3448642368667688,0.4989525129136231,0,0,1.6576697966230156,1.7647626516086876,EPM2AIP1;NAMPT
752,GO_Biological_Process_2021,neural crest cell development (GO:0014032),1/45,0.3480217988046306,0.5012481881553859,0,0,2.389627659574468,2.522228482958168,SEMA6D
753,GO_Biological_Process_2021,positive regulation of nervous system development (GO:0051962),1/45,0.3480217988046306,0.5012481881553859,0,0,2.389627659574468,2.522228482958168,PTPRD
754,GO_Biological_Process_2021,mitotic G2/M transition checkpoint (GO:0044818),1/45,0.3480217988046306,0.5012481881553859,0,0,2.389627659574468,2.522228482958168,TAOK3
755,GO_Biological_Process_2021,protein glycosylation (GO:0006486),2/130,0.3482937777991468,0.5012481881553859,0,0,1.6446356951871657,1.734612013939959,MGAT4A;POMK
756,GO_Biological_Process_2021,alpha-amino acid metabolic process (GO:1901605),1/46,0.3541968763481647,0.5077288556874878,0,0,2.3364066193853428,2.424961973536866,GLS
757,GO_Biological_Process_2021,regulation of B cell proliferation (GO:0030888),1/46,0.3541968763481647,0.5077288556874878,0,0,2.3364066193853428,2.424961973536866,BCL2
758,GO_Biological_Process_2021,positive regulation of nucleocytoplasmic transport (GO:0046824),1/46,0.3541968763481647,0.5077288556874878,0,0,2.3364066193853428,2.424961973536866,EFCAB7
759,GO_Biological_Process_2021,regulation of cell adhesion (GO:0030155),2/133,0.3585459868415123,0.5124462567311214,0,0,1.6067273543699228,1.6480175986237933,PPP3CA;MIA3
760,GO_Biological_Process_2021,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),2/133,0.3585459868415123,0.5124462567311214,0,0,1.6067273543699228,1.6480175986237933,ADAM9;MAP3K7
761,GO_Biological_Process_2021,negative regulation of cold-induced thermogenesis (GO:0120163),1/47,0.3603137742640697,0.5124462567311214,0,0,2.2854995374653098,2.33299229092702,NOVA1
762,GO_Biological_Process_2021,epidermal growth factor receptor signaling pathway (GO:0007173),1/47,0.3603137742640697,0.5124462567311214,0,0,2.2854995374653098,2.33299229092702,ERBIN
763,GO_Biological_Process_2021,regulation of synapse assembly (GO:0051963),1/47,0.3603137742640697,0.5124462567311214,0,0,2.2854995374653098,2.33299229092702,PTPRD
764,GO_Biological_Process_2021,glycosphingolipid metabolic process (GO:0006687),1/47,0.3603137742640697,0.5124462567311214,0,0,2.2854995374653098,2.33299229092702,ASAH1
765,GO_Biological_Process_2021,negative regulation of MAP kinase activity (GO:0043407),1/48,0.3663730379163756,0.5197051698214038,0,0,2.2367587143503846,2.245936661804606,HIPK3
766,GO_Biological_Process_2021,myelination (GO:0042552),1/48,0.3663730379163756,0.5197051698214038,0,0,2.2367587143503846,2.245936661804606,ADGRG6
767,GO_Biological_Process_2021,protein localization to plasma membrane (GO:0072659),2/136,0.368739639488554,0.5217018566496057,0,0,1.5705164019474818,1.566848410673538,RDX;RAPGEF6
768,GO_Biological_Process_2021,cellular calcium ion homeostasis (GO:0006874),2/136,0.368739639488554,0.5217018566496057,0,0,1.5705164019474818,1.566848410673538,CAV2;BCL2
769,GO_Biological_Process_2021,adherens junction organization (GO:0034332),1/49,0.3723752074302826,0.5254788919379345,0,0,2.1900487588652484,2.1634469174820667,CDH8
770,GO_Biological_Process_2021,regulation of stress-activated MAPK cascade (GO:0032872),1/49,0.3723752074302826,0.5254788919379345,0,0,2.1900487588652484,2.1634469174820667,TAOK3
771,GO_Biological_Process_2021,cellular protein localization (GO:0034613),4/329,0.3774788694767466,0.5304291881010269,0,0,1.2963659043659044,1.2629724089561725,TBCK;RABGAP1L;STXBP3;SNX27
772,GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),7/625,0.3782885868304508,0.5304291881010269,0,0,1.194485934777197,1.161157289589596,PPP3CA;NTRK2;GRK5;CCPG1;NAMPT;BCL2;CXCL16
773,GO_Biological_Process_2021,actin polymerization or depolymerization (GO:0008154),1/50,0.3783208179838206,0.5304291881010269,0,0,2.1452453321754232,2.085205747179162,TWF1
774,GO_Biological_Process_2021,neuron migration (GO:0001764),1/50,0.3783208179838206,0.5304291881010269,0,0,2.1452453321754232,2.085205747179162,NTRK2
775,GO_Biological_Process_2021,iron ion transport (GO:0006826),1/50,0.3783208179838206,0.5304291881010269,0,0,2.1452453321754232,2.085205747179162,ATP6V1A
776,GO_Biological_Process_2021,protein dephosphorylation (GO:0006470),2/139,0.3788699459919783,0.5305154456103892,0,0,1.5358913306530309,1.4906781966352622,PTPRD;PPP3CA
777,GO_Biological_Process_2021,enzyme linked receptor protein signaling pathway (GO:0007167),2/140,0.3822318552628632,0.5324572043105242,0,0,1.5246841819731844,1.466331321898649,PTPRD;NTRK2
778,GO_Biological_Process_2021,protein localization to cell periphery (GO:1990778),2/140,0.3822318552628632,0.5324572043105242,0,0,1.5246841819731844,1.466331321898649,RDX;RAPGEF6
779,GO_Biological_Process_2021,regulation of axonogenesis (GO:0050770),1/51,0.3842103997133104,0.5324572043105242,0,0,2.102234042553192,2.0109234239301528,NTRK2
780,GO_Biological_Process_2021,DNA duplex unwinding (GO:0032508),1/51,0.3842103997133104,0.5324572043105242,0,0,2.102234042553192,2.0109234239301528,MCM9
781,GO_Biological_Process_2021,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/51,0.3842103997133104,0.5324572043105242,0,0,2.102234042553192,2.0109234239301528,BCL2
782,GO_Biological_Process_2021,ameboidal-type cell migration (GO:0001667),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,SEMA6D
783,GO_Biological_Process_2021,amide biosynthetic process (GO:0043604),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,ASAH1
784,GO_Biological_Process_2021,cartilage development (GO:0051216),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,ITGB8
785,GO_Biological_Process_2021,negative regulation of protein-containing complex assembly (GO:0031333),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,IMPACT
786,GO_Biological_Process_2021,regulation of intrinsic apoptotic signaling pathway (GO:2001242),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,BCL2
787,GO_Biological_Process_2021,endocytic recycling (GO:0032456),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,SNX27
788,GO_Biological_Process_2021,plasma membrane bounded cell projection morphogenesis (GO:0120039),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,TAOK3
789,GO_Biological_Process_2021,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,PDE4D
790,GO_Biological_Process_2021,positive regulation of developmental growth (GO:0048639),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,ITSN2
791,GO_Biological_Process_2021,glycolipid metabolic process (GO:0006664),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,ASAH1
792,GO_Biological_Process_2021,response to peptide hormone (GO:0043434),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,EPM2AIP1
793,GO_Biological_Process_2021,sprouting angiogenesis (GO:0002040),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,MIA3
794,GO_Biological_Process_2021,positive regulation of protein localization to cell periphery (GO:1904377),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,EFCAB7
795,GO_Biological_Process_2021,protein homotetramerization (GO:0051289),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,GLS
796,GO_Biological_Process_2021,myeloid cell differentiation (GO:0030099),1/52,0.3900444777899704,0.5324572043105242,0,0,2.060909470171047,1.9403349327010695,SNRK
797,GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),3/238,0.3911170913099117,0.5332523751192781,0,0,1.343582704186685,1.2612859761891122,NTRK2;STYX;ZDHHC17
798,GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),2/143,0.3922707870845602,0.5341559653917416,0,0,1.4920165358212918,1.3962333925556445,CAV2;CXCL16
799,GO_Biological_Process_2021,bicellular tight junction assembly (GO:0070830),1/53,0.3958235725596017,0.5361659398181654,0,0,2.0211743044189854,1.873197445207917,PARD6B
800,GO_Biological_Process_2021,positive regulation of B cell activation (GO:0050871),1/53,0.3958235725596017,0.5361659398181654,0,0,2.0211743044189854,1.873197445207917,BCL2
801,GO_Biological_Process_2021,positive regulation of macroautophagy (GO:0016239),1/53,0.3958235725596017,0.5361659398181654,0,0,2.0211743044189854,1.873197445207917,MAP3K7
802,GO_Biological_Process_2021,IRE1-mediated unfolded protein response (GO:0036498),1/53,0.3958235725596017,0.5361659398181654,0,0,2.0211743044189854,1.873197445207917,DNAJC3
803,GO_Biological_Process_2021,axonogenesis (GO:0007409),3/240,0.3962108599391589,0.5361659398181654,0,0,1.3321083435415817,1.2332775402148477,PARD6B;SEMA6D;ZDHHC17
804,GO_Biological_Process_2021,regulation of cellular amino acid metabolic process (GO:0006521),1/54,0.4015481994798117,0.5413685762503533,0,0,1.9829385788839824,1.809288095265265,PPM1K
805,GO_Biological_Process_2021,regulation of megakaryocyte differentiation (GO:0045652),1/54,0.4015481994798117,0.5413685762503533,0,0,1.9829385788839824,1.809288095265265,TNRC6B
806,GO_Biological_Process_2021,regulation of proteasomal protein catabolic process (GO:0061136),1/54,0.4015481994798117,0.5413685762503533,0,0,1.9829385788839824,1.809288095265265,TMTC3
807,GO_Biological_Process_2021,protein sumoylation (GO:0016925),1/55,0.4072188691837333,0.5456331646205687,0,0,1.9461189913317571,1.748402012562394,PIAS2
808,GO_Biological_Process_2021,regulation of cardiac conduction (GO:1903779),1/55,0.4072188691837333,0.5456331646205687,0,0,1.9461189913317571,1.748402012562394,ITPR2
809,GO_Biological_Process_2021,ceramide metabolic process (GO:0006672),1/55,0.4072188691837333,0.5456331646205687,0,0,1.9461189913317571,1.748402012562394,ASAH1
810,GO_Biological_Process_2021,glycoprotein metabolic process (GO:0009100),1/55,0.4072188691837333,0.5456331646205687,0,0,1.9461189913317571,1.748402012562394,MGAT4A
811,GO_Biological_Process_2021,interstrand cross-link repair (GO:0036297),1/55,0.4072188691837333,0.5456331646205687,0,0,1.9461189913317571,1.748402012562394,MCM9
812,GO_Biological_Process_2021,regulation of cytosolic calcium ion concentration (GO:0051480),2/148,0.4088374927789938,0.5464560100043553,0,0,1.4405538055820086,1.2884853877887883,CAV2;CACNA1C
813,GO_Biological_Process_2021,positive regulation of intracellular protein transport (GO:0090316),2/148,0.4088374927789938,0.5464560100043553,0,0,1.4405538055820086,1.2884853877887883,BCL2;EFCAB7
814,GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),6/546,0.4125260589515899,0.5477630040083724,0,0,1.170066788099575,1.0360425432414713,NTRK2;CAV2;BCL2;MAP3K7;ZDHHC17;TRIM22
815,GO_Biological_Process_2021,blood vessel morphogenesis (GO:0048514),1/56,0.4128360875798395,0.5477630040083724,0,0,1.9106382978723404,1.6903505811944235,ITGB8
816,GO_Biological_Process_2021,negative regulation of metabolic process (GO:0009892),1/56,0.4128360875798395,0.5477630040083724,0,0,1.9106382978723404,1.6903505811944235,NOVA1
817,GO_Biological_Process_2021,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/56,0.4128360875798395,0.5477630040083724,0,0,1.9106382978723404,1.6903505811944235,BCL2
818,GO_Biological_Process_2021,tight junction assembly (GO:0120192),1/56,0.4128360875798395,0.5477630040083724,0,0,1.9106382978723404,1.6903505811944235,PARD6B
819,GO_Biological_Process_2021,mitochondrial transport (GO:0006839),1/56,0.4128360875798395,0.5477630040083724,0,0,1.9106382978723404,1.6903505811944235,BCL2
820,GO_Biological_Process_2021,brain development (GO:0007420),2/150,0.4154032521299532,0.5497821101198107,0,0,1.4209423327070383,1.2483057093981609,ATXN1;POMK
821,GO_Biological_Process_2021,nervous system development (GO:0007399),5/447,0.4155384388554445,0.5497821101198107,0,0,1.1907952980523313,1.0457328014152123,CHRM3;ATXN1;ADGRG6;WWP1;MTR
822,GO_Biological_Process_2021,regulation of mitotic nuclear division (GO:0007088),1/57,0.4184003558632383,0.5497821101198107,0,0,1.8764247720364744,1.6349598943406722,CAV2
823,GO_Biological_Process_2021,dicarboxylic acid metabolic process (GO:0043648),1/57,0.4184003558632383,0.5497821101198107,0,0,1.8764247720364744,1.6349598943406722,MTHFD2L
824,GO_Biological_Process_2021,positive regulation of cell junction assembly (GO:1901890),1/57,0.4184003558632383,0.5497821101198107,0,0,1.8764247720364744,1.6349598943406722,PTPRD
825,GO_Biological_Process_2021,renal system development (GO:0072001),1/57,0.4184003558632383,0.5497821101198107,0,0,1.8764247720364744,1.6349598943406722,PYGO1
826,GO_Biological_Process_2021,positive regulation of proteolysis (GO:0045862),1/57,0.4184003558632383,0.5497821101198107,0,0,1.8764247720364744,1.6349598943406722,ADAM9
827,GO_Biological_Process_2021,protein K48-linked ubiquitination (GO:0070936),1/57,0.4184003558632383,0.5497821101198107,0,0,1.8764247720364744,1.6349598943406722,KBTBD6
828,GO_Biological_Process_2021,cellular response to DNA damage stimulus (GO:0006974),4/350,0.4222194908409659,0.5523550197517041,0,0,1.2163724418059678,1.0487927857885733,TAOK3;AKTIP;MCM9;BCL2
829,GO_Biological_Process_2021,negative regulation of hydrolase activity (GO:0051346),1/58,0.423912170489589,0.5523550197517041,0,0,1.84341172079134,1.5820693798039756,RDX
830,GO_Biological_Process_2021,cellular iron ion homeostasis (GO:0006879),1/58,0.423912170489589,0.5523550197517041,0,0,1.84341172079134,1.5820693798039756,ATP6V1A
831,GO_Biological_Process_2021,nucleosome assembly (GO:0006334),1/58,0.423912170489589,0.5523550197517041,0,0,1.84341172079134,1.5820693798039756,NAP1L2
832,GO_Biological_Process_2021,eye development (GO:0001654),1/58,0.423912170489589,0.5523550197517041,0,0,1.84341172079134,1.5820693798039756,CACNA1C
833,GO_Biological_Process_2021,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),1/58,0.423912170489589,0.5523550197517041,0,0,1.84341172079134,1.5820693798039756,TAX1BP1
834,GO_Biological_Process_2021,positive regulation of mitotic cell cycle phase transition (GO:1901992),1/58,0.423912170489589,0.5523550197517041,0,0,1.84341172079134,1.5820693798039756,RDX
835,GO_Biological_Process_2021,dephosphorylation (GO:0016311),2/153,0.4251834262621793,0.5533487652790086,0,0,1.3924992031731416,1.1909135156821835,PTPRD;PPP3CA
836,GO_Biological_Process_2021,phospholipid transport (GO:0015914),1/59,0.4293720233296841,0.554818006392751,0,0,1.8115370506236244,1.5315305740460652,ATP9A
837,GO_Biological_Process_2021,positive regulation of apoptotic signaling pathway (GO:2001235),1/59,0.4293720233296841,0.554818006392751,0,0,1.8115370506236244,1.5315305740460652,BCL2
838,GO_Biological_Process_2021,fatty acid oxidation (GO:0019395),1/59,0.4293720233296841,0.554818006392751,0,0,1.8115370506236244,1.5315305740460652,PECR
839,GO_Biological_Process_2021,response to reactive oxygen species (GO:0000302),1/59,0.4293720233296841,0.554818006392751,0,0,1.8115370506236244,1.5315305740460652,ADAM9
840,GO_Biological_Process_2021,selective autophagy (GO:0061912),1/59,0.4293720233296841,0.554818006392751,0,0,1.8115370506236244,1.5315305740460652,ACBD5
841,GO_Biological_Process_2021,mitotic DNA damage checkpoint signaling (GO:0044773),1/59,0.4293720233296841,0.554818006392751,0,0,1.8115370506236244,1.5315305740460652,TAOK3
842,GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),4/354,0.4306668318248121,0.5558309763053328,0,0,1.202223938223938,1.0127780909265176,KBTBD6;RNF19A;WWP1;NFE2L2
843,GO_Biological_Process_2021,positive regulation of NF-kappaB transcription factor activity (GO:0051092),2/155,0.4316565199063786,0.556448215234763,0,0,1.374156792841914,1.154463612728904,MAP3K7;TRIM22
844,GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),8/764,0.4347519160566446,0.5584900555477408,0,0,1.114034318454208,0.9279679929815704,NTRK2;GRK5;CCPG1;MAGI2;NAMPT;BCL2;SMARCA2;IFIT3
845,GO_Biological_Process_2021,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),1/60,0.4347804016993901,0.5584900555477408,0,0,1.7807428777497296,1.4832060277160146,CHRM3
846,GO_Biological_Process_2021,apical junction assembly (GO:0043297),1/60,0.4347804016993901,0.5584900555477408,0,0,1.7807428777497296,1.4832060277160146,PARD6B
847,GO_Biological_Process_2021,mitotic spindle organization (GO:0007052),2/157,0.4380909552783694,0.5613949750028855,0,0,1.356287735035363,1.1193832334796712,CEP126;MAP9
848,GO_Biological_Process_2021,"regulation of DNA-templated transcription, initiation (GO:2000142)",1/61,0.4401377883064901,0.5613949750028855,0,0,1.7509751773049644,1.4369683265067992,TNRC6B
849,GO_Biological_Process_2021,O-glycan processing (GO:0016266),1/61,0.4401377883064901,0.5613949750028855,0,0,1.7509751773049644,1.4369683265067992,GALNT13
850,GO_Biological_Process_2021,pattern recognition receptor signaling pathway (GO:0002221),1/61,0.4401377883064901,0.5613949750028855,0,0,1.7509751773049644,1.4369683265067992,MAP3K7
851,GO_Biological_Process_2021,iron ion homeostasis (GO:0055072),1/61,0.4401377883064901,0.5613949750028855,0,0,1.7509751773049644,1.4369683265067992,ATP6V1A
852,GO_Biological_Process_2021,protein lipidation (GO:0006497),1/61,0.4401377883064901,0.5613949750028855,0,0,1.7509751773049644,1.4369683265067992,ZDHHC17
853,GO_Biological_Process_2021,cellular response to growth factor stimulus (GO:0071363),2/158,0.4412934120159422,0.562209873856376,0,0,1.3475250239956122,1.102336500925882,NTRK2;MAGI2
854,GO_Biological_Process_2021,I-kappaB kinase/NF-kappaB signaling (GO:0007249),1/62,0.4454446613525643,0.566172653681764,0,0,1.7221834670387164,1.3926992126250894,MAP3K7
855,GO_Biological_Process_2021,stress-activated MAPK cascade (GO:0051403),1/62,0.4454446613525643,0.566172653681764,0,0,1.7221834670387164,1.3926992126250894,MAP3K7
856,GO_Biological_Process_2021,actin cytoskeleton reorganization (GO:0031532),1/63,0.4507014946724221,0.5721857948700062,0,0,1.6943205216197663,1.3502887955420633,CDC42BPA
857,GO_Biological_Process_2021,regulation of cilium assembly (GO:1902017),1/64,0.4559087575394071,0.575439359864124,0,0,1.6673421141506248,1.3096348430658042,DYNC2LI1
858,GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway (GO:2001236),1/64,0.4559087575394071,0.575439359864124,0,0,1.6673421141506248,1.3096348430658042,ZMYND11
859,GO_Biological_Process_2021,diterpenoid metabolic process (GO:0016101),1/64,0.4559087575394071,0.575439359864124,0,0,1.6673421141506248,1.3096348430658042,PECR
860,GO_Biological_Process_2021,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/64,0.4559087575394071,0.575439359864124,0,0,1.6673421141506248,1.3096348430658042,TNRC6B
861,GO_Biological_Process_2021,tRNA processing (GO:0008033),1/64,0.4559087575394071,0.575439359864124,0,0,1.6673421141506248,1.3096348430658042,TRNT1
862,GO_Biological_Process_2021,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",1/65,0.4610669150334794,0.581275554526565,0,0,1.6412067819148937,1.2706421403022687,CHRM3
863,GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),2/165,0.4634259891258896,0.5831547368489265,0,0,1.289196548669663,0.991532133318033,GRK5;ADGRG6
864,GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),3/267,0.4636294553072806,0.5831547368489265,0,0,1.194220430107527,0.9179609803250616,BCL2;CXXC4;BEND6
865,GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),5/474,0.4654693820613643,0.583659324856922,0,0,1.1206776675628072,0.8569922522367271,NTRK2;GRK5;CCPG1;NAMPT;BCL2
866,GO_Biological_Process_2021,central nervous system development (GO:0007417),3/268,0.4660679026993719,0.583659324856922,0,0,1.18965307364577,0.9082096385294935,ATXN1;POMK;WWP1
867,GO_Biological_Process_2021,ERBB signaling pathway (GO:0038127),1/66,0.4661764276660525,0.583659324856922,0,0,1.6158756137479542,1.233221913564407,ERBIN
868,GO_Biological_Process_2021,positive regulation of cell cycle (GO:0045787),1/66,0.4661764276660525,0.583659324856922,0,0,1.6158756137479542,1.233221913564407,CCPG1
869,GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),7/684,0.4693638679458905,0.5869745842817573,0,0,1.0870355641404386,0.822208670096561,IMPACT;ATXN1;THRB;WWC2;SMARCA2;ZNF136;ZNF674
870,GO_Biological_Process_2021,positive regulation of catabolic process (GO:0009896),1/67,0.4712377518528906,0.5886414167806486,0,0,1.591312056737589,1.19729130649007,WWP1
871,GO_Biological_Process_2021,peptidyl-serine modification (GO:0018209),2/169,0.475841797277981,0.5921845228614375,0,0,1.2580614172724072,0.9343242697822708,GALNT13;HIPK3
872,GO_Biological_Process_2021,regulation of myeloid cell differentiation (GO:0045637),1/68,0.4762513396174245,0.5921845228614375,0,0,1.5674817402349952,1.162772908212185,TNRC6B
873,GO_Biological_Process_2021,interferon-gamma-mediated signaling pathway (GO:0060333),1/68,0.4762513396174245,0.5921845228614375,0,0,1.5674817402349952,1.162772908212185,TRIM22
874,GO_Biological_Process_2021,positive regulation of protein localization to nucleus (GO:1900182),1/68,0.4762513396174245,0.5921845228614375,0,0,1.5674817402349952,1.162772908212185,EFCAB7
875,GO_Biological_Process_2021,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),2/170,0.4789186576760565,0.5948213465200336,0,0,1.2505092946269416,0.920655596378632,PTPRD;CDH8
876,GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),5/482,0.4800392829414505,0.5949599898426992,0,0,1.101426488013855,0.8083229543568192,ASAH1;BCL2;ERBIN;IFNAR1;NFE2L2
877,GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),3/274,0.4805952273987957,0.5949599898426992,0,0,1.1629567908582312,0.8521331970619114,NTRK2;TAOK3;CAV2
878,GO_Biological_Process_2021,cellular response to decreased oxygen levels (GO:0036294),1/69,0.4812176388433596,0.5949599898426992,0,0,1.544352315394243,1.1295943235827153,CPEB4
879,GO_Biological_Process_2021,positive regulation of protein transport (GO:0051222),1/69,0.4812176388433596,0.5949599898426992,0,0,1.544352315394243,1.1295943235827153,ADAM9
880,GO_Biological_Process_2021,neutrophil chemotaxis (GO:0030593),1/70,0.4861370932432568,0.5976465055917102,0,0,1.5218933086648163,1.0976877837318262,PDE4B
881,GO_Biological_Process_2021,COPII-coated vesicle budding (GO:0090114),1/70,0.4861370932432568,0.5976465055917102,0,0,1.5218933086648163,1.0976877837318262,MIA3
882,GO_Biological_Process_2021,"DNA-templated transcription, termination (GO:0006353)",1/70,0.4861370932432568,0.5976465055917102,0,0,1.5218933086648163,1.0976877837318262,CPSF2
883,GO_Biological_Process_2021,kidney development (GO:0001822),1/70,0.4861370932432568,0.5976465055917102,0,0,1.5218933086648163,1.0976877837318262,PYGO1
884,GO_Biological_Process_2021,snRNA transcription by RNA polymerase II (GO:0042795),1/70,0.4861370932432568,0.5976465055917102,0,0,1.5218933086648163,1.0976877837318262,RPRD2
885,GO_Biological_Process_2021,protein tetramerization (GO:0051262),1/71,0.4910101422937567,0.5997012328488086,0,0,1.5000759878419452,1.0669897919270015,GLS
886,GO_Biological_Process_2021,regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/71,0.4910101422937567,0.5997012328488086,0,0,1.5000759878419452,1.0669897919270015,RDX
887,GO_Biological_Process_2021,regulation of TOR signaling (GO:0032006),1/71,0.4910101422937567,0.5997012328488086,0,0,1.5000759878419452,1.0669897919270015,TBCK
888,GO_Biological_Process_2021,histone acetylation (GO:0016573),1/71,0.4910101422937567,0.5997012328488086,0,0,1.5000759878419452,1.0669897919270015,MAP3K7
889,GO_Biological_Process_2021,snRNA transcription (GO:0009301),1/71,0.4910101422937567,0.5997012328488086,0,0,1.5000759878419452,1.0669897919270015,RPRD2
890,GO_Biological_Process_2021,neuron differentiation (GO:0030182),2/174,0.4911156235921769,0.5997012328488086,0,0,1.2211789578410646,0.868350673698162,PTPRD;NTRK2
891,GO_Biological_Process_2021,negative regulation of epithelial cell proliferation (GO:0050680),1/72,0.4958372214681416,0.6020880546398861,0,0,1.4788732394366195,1.0374408001084885,CAV2
892,GO_Biological_Process_2021,negative regulation of supramolecular fiber organization (GO:1902904),1/72,0.4958372214681416,0.6020880546398861,0,0,1.4788732394366195,1.0374408001084885,TWF1
893,GO_Biological_Process_2021,extrinsic apoptotic signaling pathway (GO:0097191),1/72,0.4958372214681416,0.6020880546398861,0,0,1.4788732394366195,1.0374408001084885,BCL2
894,GO_Biological_Process_2021,positive regulation of protein secretion (GO:0050714),1/72,0.4958372214681416,0.6020880546398861,0,0,1.4788732394366195,1.0374408001084885,ADAM9
895,GO_Biological_Process_2021,positive regulation of secretion by cell (GO:1903532),1/72,0.4958372214681416,0.6020880546398861,0,0,1.4788732394366195,1.0374408001084885,ADAM9
896,GO_Biological_Process_2021,negative regulation of cell adhesion (GO:0007162),1/73,0.5006187620991769,0.6038505689178542,0,0,1.4582594562647757,1.0089849149873038,MIA3
897,GO_Biological_Process_2021,regulation of actin filament polymerization (GO:0030833),1/73,0.5006187620991769,0.6038505689178542,0,0,1.4582594562647757,1.0089849149873038,TWF1
898,GO_Biological_Process_2021,chromatin assembly (GO:0031497),1/73,0.5006187620991769,0.6038505689178542,0,0,1.4582594562647757,1.0089849149873038,NAP1L2
899,GO_Biological_Process_2021,regulation of Rho protein signal transduction (GO:0035023),1/73,0.5006187620991769,0.6038505689178542,0,0,1.4582594562647757,1.0089849149873038,SCAI
900,GO_Biological_Process_2021,granulocyte chemotaxis (GO:0071621),1/73,0.5006187620991769,0.6038505689178542,0,0,1.4582594562647757,1.0089849149873038,PDE4B
901,GO_Biological_Process_2021,positive regulation of JNK cascade (GO:0046330),1/73,0.5006187620991769,0.6038505689178542,0,0,1.4582594562647757,1.0089849149873038,TAOK3
902,GO_Biological_Process_2021,regulation of translation (GO:0006417),2/178,0.5031328034207659,0.6055357361584612,0,0,1.193181818181818,0.8195979284956892,IMPACT;EIF4G3
903,GO_Biological_Process_2021,regulation of cytokine-mediated signaling pathway (GO:0001959),1/74,0.5053551915734217,0.6055357361584612,0,0,1.4382104342757214,0.9815696286816826,TAX1BP1
904,GO_Biological_Process_2021,negative regulation of protein binding (GO:0032091),1/74,0.5053551915734217,0.6055357361584612,0,0,1.4382104342757214,0.9815696286816826,STYX
905,GO_Biological_Process_2021,NIK/NF-kappaB signaling (GO:0038061),1/74,0.5053551915734217,0.6055357361584612,0,0,1.4382104342757214,0.9815696286816826,MAP3K7
906,GO_Biological_Process_2021,sphingolipid biosynthetic process (GO:0030148),1/74,0.5053551915734217,0.6055357361584612,0,0,1.4382104342757214,0.9815696286816826,ASAH1
907,GO_Biological_Process_2021,mitotic nuclear division (GO:0140014),1/74,0.5053551915734217,0.6055357361584612,0,0,1.4382104342757214,0.9815696286816826,MAP9
908,GO_Biological_Process_2021,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),1/75,0.510046933272438,0.6098143553850687,0,0,1.4187032777458308,0.95514557315215,NFE2L2
909,GO_Biological_Process_2021,positive regulation of lymphocyte proliferation (GO:0050671),1/75,0.510046933272438,0.6098143553850687,0,0,1.4187032777458308,0.95514557315215,BCL2
910,GO_Biological_Process_2021,actomyosin structure organization (GO:0031032),1/76,0.5146944064870527,0.6140213972126242,0,0,1.3997163120567375,0.929666295456086,CDC42BPA
911,GO_Biological_Process_2021,regulation of RNA splicing (GO:0043484),1/76,0.5146944064870527,0.6140213972126242,0,0,1.3997163120567375,0.929666295456086,PTBP3
912,GO_Biological_Process_2021,cellular response to UV (GO:0034644),1/77,0.5192980268305403,0.6174822439252763,0,0,1.3812290033594623,0.9050880504159952,IMPACT
913,GO_Biological_Process_2021,neutrophil migration (GO:1990266),1/77,0.5192980268305403,0.6174822439252763,0,0,1.3812290033594623,0.9050880504159952,PDE4B
914,GO_Biological_Process_2021,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/77,0.5192980268305403,0.6174822439252763,0,0,1.3812290033594623,0.9050880504159952,NTRK2
915,GO_Biological_Process_2021,recombinational repair (GO:0000725),1/79,0.5283753513164063,0.6269055422380045,0,0,1.3456764866339337,0.8584721012735822,MCM9
916,GO_Biological_Process_2021,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),1/79,0.5283753513164063,0.6269055422380045,0,0,1.3456764866339337,0.8584721012735822,RNF19A
917,GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),3/296,0.5321890622682727,0.6287859604455214,0,0,1.0744247495320929,0.6777003650562962,GRK5;CCPG1;MAGI2
918,GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),4/404,0.5326305789163137,0.6287859604455214,0,0,1.0492432432432433,0.6609468508199761,ATP6V1A;NTRK2;CAV2;NAMPT
919,GO_Biological_Process_2021,regulation of organelle organization (GO:0033043),1/80,0.532849867215782,0.6287859604455214,0,0,1.3285752760570966,0.8363588215459095,RDX
920,GO_Biological_Process_2021,glycerophospholipid metabolic process (GO:0006650),1/80,0.532849867215782,0.6287859604455214,0,0,1.3285752760570966,0.8363588215459095,SERINC1
921,GO_Biological_Process_2021,response to interferon-gamma (GO:0034341),1/80,0.532849867215782,0.6287859604455214,0,0,1.3285752760570966,0.8363588215459095,CXCL16
922,GO_Biological_Process_2021,regulation of G protein-coupled receptor signaling pathway (GO:0008277),1/82,0.5416726071913932,0.6381623272328251,0,0,1.2956396112424482,0.794348231541045,GRK5
923,GO_Biological_Process_2021,protein modification by small protein conjugation (GO:0032446),4/409,0.5423513931841206,0.6381623272328251,0,0,1.0360226893560227,0.6338813247750154,WWP1;PIAS2;TRIM22;NFE2L2
924,GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",9/948,0.5425552873992309,0.6381623272328251,0,0,1.004898828541001,0.6144607501009319,IMPACT;ATXN1;THRB;WWC2;WWP1;ZMYND11;SMARCA2;ZNF136;ZNF674
925,GO_Biological_Process_2021,regulation of Notch signaling pathway (GO:0008593),1/83,0.5460216205299468,0.6415459213138036,0,0,1.2797742605085625,0.7743871894330244,BEND6
926,GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),2/194,0.549339322420398,0.6438264365004066,0,0,1.092858734402852,0.654664953974446,ITGB8;TNRC6B
927,GO_Biological_Process_2021,regulation of cytokinesis (GO:0032465),1/84,0.5503295826703843,0.6438264365004066,0,0,1.2642912073827224,0.7550826750058026,MAP9
928,GO_Biological_Process_2021,nuclear export (GO:0051168),1/84,0.5503295826703843,0.6438264365004066,0,0,1.2642912073827224,0.7550826750058026,ATXN1
929,GO_Biological_Process_2021,response to insulin (GO:0032868),1/84,0.5503295826703843,0.6438264365004066,0,0,1.2642912073827224,0.7550826750058026,EPM2AIP1
930,GO_Biological_Process_2021,B cell activation (GO:0042113),1/85,0.5545968791911786,0.6467324807717068,0,0,1.249176798378926,0.7364069274950137,BCL2
931,GO_Biological_Process_2021,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",1/85,0.5545968791911786,0.6467324807717068,0,0,1.249176798378926,0.7364069274950137,ATP9A
932,GO_Biological_Process_2021,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",1/85,0.5545968791911786,0.6467324807717068,0,0,1.249176798378926,0.7364069274950137,MAGI2
933,GO_Biological_Process_2021,negative regulation of cellular amide metabolic process (GO:0034249),1/86,0.5588238918519959,0.6509640196305905,0,0,1.2344180225281602,0.7183336427853815,NTRK2
934,GO_Biological_Process_2021,regulation of signal transduction (GO:0009966),2/198,0.5604134737141171,0.652117496685518,0,0,1.0703372257994106,0.6198113321607526,GRK5;ZDHHC17
935,GO_Biological_Process_2021,protein targeting to membrane (GO:0006612),1/87,0.5630109989953528,0.6530447408389592,0,0,1.220002474022761,0.700837881065439,ACBD5
936,GO_Biological_Process_2021,calcium ion transmembrane transport (GO:0070588),1/87,0.5630109989953528,0.6530447408389592,0,0,1.220002474022761,0.700837881065439,CACNA1C
937,GO_Biological_Process_2021,ERAD pathway (GO:0036503),1/87,0.5630109989953528,0.6530447408389592,0,0,1.220002474022761,0.700837881065439,UGGT2
938,GO_Biological_Process_2021,negative regulation of binding (GO:0051100),1/88,0.5671585753182062,0.6550621337008581,0,0,1.2059183174370265,0.6838959826123543,STYX
939,GO_Biological_Process_2021,"retrograde transport, endosome to Golgi (GO:0042147)",1/88,0.5671585753182062,0.6550621337008581,0,0,1.2059183174370265,0.6838959826123543,HEATR5A
940,GO_Biological_Process_2021,sensory perception of mechanical stimulus (GO:0050954),1/88,0.5671585753182062,0.6550621337008581,0,0,1.2059183174370265,0.6838959826123543,USP53
941,GO_Biological_Process_2021,metal ion transport (GO:0030001),1/88,0.5671585753182062,0.6550621337008581,0,0,1.2059183174370265,0.6838959826123543,CACNA1C
942,GO_Biological_Process_2021,regulation of cation channel activity (GO:2001257),1/89,0.5712669920587159,0.6556615714048041,0,0,1.1921542553191489,0.6674854887829307,PDE4D
943,GO_Biological_Process_2021,collagen fibril organization (GO:0030199),1/89,0.5712669920587159,0.6556615714048041,0,0,1.1921542553191489,0.6674854887829307,DST
944,GO_Biological_Process_2021,regulation of type I interferon production (GO:0032479),1/89,0.5712669920587159,0.6556615714048041,0,0,1.1921542553191489,0.6674854887829307,TAX1BP1
945,GO_Biological_Process_2021,second-messenger-mediated signaling (GO:0019932),1/89,0.5712669920587159,0.6556615714048041,0,0,1.1921542553191489,0.6674854887829307,CHRM3
946,GO_Biological_Process_2021,protein import (GO:0017038),1/89,0.5712669920587159,0.6556615714048041,0,0,1.1921542553191489,0.6674854887829307,ACBD5
947,GO_Biological_Process_2021,generation of neurons (GO:0048699),2/202,0.5712933544960976,0.6556615714048041,0,0,1.048716577540107,0.5871265406440149,PTPRD;NTRK2
948,GO_Biological_Process_2021,cellular macromolecule biosynthetic process (GO:0034645),3/314,0.5722084152517259,0.656019763744866,0,0,1.0113058811326625,0.5645635222975114,THRB;MCM9;MRPS6
949,GO_Biological_Process_2021,cellular amino acid catabolic process (GO:0009063),1/90,0.5753366170598933,0.6575275623541637,0,0,1.1786994979679657,0.6515850689252642,GLS
950,GO_Biological_Process_2021,negative regulation of translation (GO:0017148),1/90,0.5753366170598933,0.6575275623541637,0,0,1.1786994979679657,0.6515850689252642,CPEB4
951,GO_Biological_Process_2021,mitochondrial respiratory chain complex assembly (GO:0033108),1/90,0.5753366170598933,0.6575275623541637,0,0,1.1786994979679657,0.6515850689252642,COX20
952,GO_Biological_Process_2021,regulation of actin cytoskeleton organization (GO:0032956),1/91,0.5793678146194836,0.6600546411581133,0,0,1.1655437352245863,0.6361744528980651,TWF1
953,GO_Biological_Process_2021,sensory perception of sound (GO:0007605),1/91,0.5793678146194836,0.6600546411581133,0,0,1.1655437352245863,0.6361744528980651,USP53
954,GO_Biological_Process_2021,toll-like receptor signaling pathway (GO:0002224),1/91,0.5793678146194836,0.6600546411581133,0,0,1.1655437352245863,0.6361744528980651,MAP3K7
955,GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),4/430,0.582019885694645,0.6623824640541567,0,0,0.9838852937444488,0.5325285685136262,ATXN1;WWC2;SMARCA2;TRIM22
956,GO_Biological_Process_2021,regulation of endothelial cell proliferation (GO:0001936),1/92,0.583360945693056,0.6625226606618423,0,0,1.1526771101239186,0.6212343676056309,CAV2
957,GO_Biological_Process_2021,T cell activation (GO:0042110),1/92,0.583360945693056,0.6625226606618423,0,0,1.1526771101239186,0.6212343676056309,PPP3CA
958,GO_Biological_Process_2021,regulation of protein kinase B signaling (GO:0051896),2/207,0.5846185648099927,0.6630822797296253,0,0,1.0228772662058172,0.5490760878268363,NTRK2;MAGI2
959,GO_Biological_Process_2021,transcription by RNA polymerase II (GO:0006366),3/320,0.5850725997614341,0.6630822797296253,0,0,0.9918591635290526,0.5316556915238423,THRB;CPSF2;RPRD2
960,GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),3/321,0.5871927746654202,0.6642413806130372,0,0,0.9886893893284642,0.5263803135355062,KBTBD6;WWP1;NFE2L2
961,GO_Biological_Process_2021,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/93,0.5873163677846891,0.6642413806130372,0,0,1.1400901942645698,0.606746478551064,CAPRIN2
962,GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),3/322,0.5893060772660206,0.6645279602607237,0,0,0.985539488320356,0.5211627174767324,ITGB8;TNRC6B;PTBP3
963,GO_Biological_Process_2021,negative regulation of cell death (GO:0060548),1/94,0.5912344352319674,0.6645279602607237,0,0,1.1277739647677878,0.5926933346363952,IMPACT
964,GO_Biological_Process_2021,regulation of kinase activity (GO:0043549),1/94,0.5912344352319674,0.6645279602607237,0,0,1.1277739647677878,0.5926933346363952,NTRK2
965,GO_Biological_Process_2021,nucleosome organization (GO:0034728),1/94,0.5912344352319674,0.6645279602607237,0,0,1.1277739647677878,0.5926933346363952,NAP1L2
966,GO_Biological_Process_2021,hemopoiesis (GO:0030097),1/94,0.5912344352319674,0.6645279602607237,0,0,1.1277739647677878,0.5926933346363952,SNRK
967,GO_Biological_Process_2021,interleukin-1-mediated signaling pathway (GO:0070498),1/94,0.5912344352319674,0.6645279602607237,0,0,1.1277739647677878,0.5926933346363952,MAP3K7
968,GO_Biological_Process_2021,regulation of intracellular signal transduction (GO:1902531),4/437,0.5948018110301324,0.6675109925251641,0,0,0.9676299856438424,0.5027099225453892,TBCK;NTRK2;TAOK3;WWC2
969,GO_Biological_Process_2021,ciliary basal body-plasma membrane docking (GO:0097711),1/95,0.5951154988505599,0.6675109925251641,0,0,1.1157197827071073,0.5790583179277774,CEP83
970,GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),2/212,0.5976375765906913,0.6696495193930713,0,0,0.9982683982683984,0.5138793900193189,PTPRD;PPP3CA
971,GO_Biological_Process_2021,cellular transition metal ion homeostasis (GO:0046916),1/96,0.5989599063424442,0.6697516732791153,0,0,1.103919372900336,0.5658255953630718,ATP6V1A
972,GO_Biological_Process_2021,regulation of vesicle-mediated transport (GO:0060627),1/96,0.5989599063424442,0.6697516732791153,0,0,1.103919372900336,0.5658255953630718,ATP9A
973,GO_Biological_Process_2021,negative regulation of multicellular organismal process (GO:0051241),2/214,0.6027593325725359,0.6726272679881936,0,0,0.9887498738775098,0.5005420454849014,NOVA1;WWC2
974,GO_Biological_Process_2021,double-strand break repair via homologous recombination (GO:0000724),1/97,0.6027680021033904,0.6726272679881936,0,0,1.092364804964539,0.5529800747843862,MCM9
975,GO_Biological_Process_2021,positive regulation of stress-activated MAPK cascade (GO:0032874),1/99,0.6102766196965284,0.6796120391298084,0,0,1.0699630916196263,0.5283937292260591,TAOK3
976,GO_Biological_Process_2021,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),1/99,0.6102766196965284,0.6796120391298084,0,0,1.0699630916196263,0.5283937292260591,CPSF2
977,GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),20/2206,0.6128804073207853,0.681813786467295,0,0,0.9541623131601314,0.467143991351196,THRB;ZNF382;WWC2;TSHZ2;EFCAB7;SMARCA2;PIAS2;NPAS3;PPP3CA;IMPACT;ATXN1;ZNF827;CAPRIN2;NAMPT;ZNF546;ZNF136;ZNF334;ZNF674;NFE2L2;TNRC6B
978,GO_Biological_Process_2021,cellular response to lipid (GO:0071396),2/219,0.6153491543167056,0.6838609600577892,0,0,0.965721185835038,0.4689208341372071,PDE4B;ADAM9
979,GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),3/335,0.6161454364929518,0.6840471784738077,0,0,0.946317528177225,0.4582753139597605,PDE4D;PDE4B;MAP3K7
980,GO_Biological_Process_2021,cellular response to chemical stress (GO:0062197),1/101,0.6176440429444264,0.6841577832426732,0,0,1.0484574468085106,0.5051918498335729,NFE2L2
981,GO_Biological_Process_2021,"transcription, DNA-templated (GO:0006351)",2/221,0.6202993492251841,0.6841577832426732,0,0,0.9568041413327472,0.456924780086112,THRB;HIPK3
982,GO_Biological_Process_2021,regulation of cell death (GO:0010941),1/102,0.6212756340475746,0.6841577832426732,0,0,1.0380240151674742,0.4940791278583512,IMPACT
983,GO_Biological_Process_2021,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/102,0.6212756340475746,0.6841577832426732,0,0,1.0380240151674742,0.4940791278583512,RNF19A
984,GO_Biological_Process_2021,regulation of protein catabolic process (GO:0042176),1/102,0.6212756340475746,0.6841577832426732,0,0,1.0380240151674742,0.4940791278583512,WWP1
985,GO_Biological_Process_2021,positive regulation of cellular protein metabolic process (GO:0032270),1/102,0.6212756340475746,0.6841577832426732,0,0,1.0380240151674742,0.4940791278583512,RDX
986,GO_Biological_Process_2021,intrinsic apoptotic signaling pathway (GO:0097193),1/102,0.6212756340475746,0.6841577832426732,0,0,1.0380240151674742,0.4940791278583512,BCL2
987,GO_Biological_Process_2021,positive regulation of vasculature development (GO:1904018),1/102,0.6212756340475746,0.6841577832426732,0,0,1.0380240151674742,0.4940791278583512,ITGB8
988,GO_Biological_Process_2021,chromatin remodeling (GO:0006338),1/103,0.6248729131870127,0.687423386802295,0,0,1.0277951606174385,0.4832764676004407,SMARCA2
989,GO_Biological_Process_2021,mRNA transport (GO:0051028),1/104,0.628436202782708,0.6906450390177639,0,0,1.0177649246023548,0.4727729395465809,CPSF2
990,GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),8/908,0.6304072675222768,0.6921121161092201,0,0,0.9287170042971148,0.4285000068532183,PPP3CA;THRB;ZNF827;CAPRIN2;NAMPT;EFCAB7;SMARCA2;NFE2L2
991,GO_Biological_Process_2021,peptidyl-lysine modification (GO:0018205),1/106,0.6354620883439773,0.6948570373047712,0,0,0.9982776089159068,0.4526219095334873,PIAS2
992,GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.6354620883439773,0.6948570373047712,0,0,0.9982776089159068,0.4526219095334873,NTRK2
993,GO_Biological_Process_2021,RNA export from nucleus (GO:0006405),1/106,0.6354620883439773,0.6948570373047712,0,0,0.9982776089159068,0.4526219095334873,CPSF2
994,GO_Biological_Process_2021,small GTPase mediated signal transduction (GO:0007264),1/106,0.6354620883439773,0.6948570373047712,0,0,0.9982776089159068,0.4526219095334873,RAPGEF6
995,GO_Biological_Process_2021,mRNA export from nucleus (GO:0006406),1/107,0.6389253142273043,0.6979425119270151,0,0,0.988809714973906,0.4429548242151346,CPSF2
996,GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),4/464,0.6418879074668599,0.6995827047168497,0,0,0.9095652173913044,0.403248089230015,ATXN1;WWP1;ZMYND11;SMARCA2
997,GO_Biological_Process_2021,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),1/108,0.6423558106729161,0.6995827047168497,0,0,0.9795187910121296,0.4335476591441499,MAGI2
998,GO_Biological_Process_2021,DNA replication (GO:0006260),1/108,0.6423558106729161,0.6995827047168497,0,0,0.9795187910121296,0.4335476591441499,MCM9
999,GO_Biological_Process_2021,apoptotic process (GO:0006915),2/231,0.6443185279611976,0.7010185584217831,0,0,0.9145552623590126,0.4020038010701062,BCL2;MAP3K7
1000,GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),4/468,0.648554017149092,0.7049218488094027,0,0,0.901537744641193,0.3903748436321982,ATXN1;WWC2;SMARCA2;TRIM22
1001,GO_Biological_Process_2021,regulation of Wnt signaling pathway (GO:0030111),1/111,0.6524539857620987,0.7084530304482669,0,0,0.9526595744680852,0.4067996063609487,CXXC4
1002,GO_Biological_Process_2021,protein-containing complex subunit organization (GO:0043933),1/112,0.655756612516465,0.7113292067975213,0,0,0.9440291355184972,0.3983477982956184,PARD6B
1003,GO_Biological_Process_2021,positive regulation of kinase activity (GO:0033674),1/114,0.6622685009193002,0.7175822017510549,0,0,0.9272265110148749,0.3820954086982489,NTRK2
1004,GO_Biological_Process_2021,calcium ion transport (GO:0006816),1/115,0.6654783470283221,0.7175822017510549,0,0,0.919046285927585,0.3742808445545937,CACNA1C
1005,GO_Biological_Process_2021,cellular amide metabolic process (GO:0043603),1/115,0.6654783470283221,0.7175822017510549,0,0,0.919046285927585,0.3742808445545937,MTHFD2L
1006,GO_Biological_Process_2021,cellular response to lectin (GO:1990858),1/115,0.6654783470283221,0.7175822017510549,0,0,0.919046285927585,0.3742808445545937,MAP3K7
1007,GO_Biological_Process_2021,stimulatory C-type lectin receptor signaling pathway (GO:0002223),1/115,0.6654783470283221,0.7175822017510549,0,0,0.919046285927585,0.3742808445545937,MAP3K7
1008,GO_Biological_Process_2021,positive regulation of protein metabolic process (GO:0051247),1/115,0.6654783470283221,0.7175822017510549,0,0,0.919046285927585,0.3742808445545937,WWP1
1009,GO_Biological_Process_2021,regulation of protein-containing complex assembly (GO:0043254),1/116,0.6686578459645697,0.7195843090103381,0,0,0.9110083256244218,0.3666651732428617,IMPACT
1010,GO_Biological_Process_2021,positive regulation of angiogenesis (GO:0045766),1/116,0.6686578459645697,0.7195843090103381,0,0,0.9110083256244218,0.3666651732428617,ITGB8
1011,GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),2/244,0.673739221437816,0.7243362380675333,0,0,0.8648517258142927,0.3415404585830414,CHRM3;NOVA1
1012,GO_Biological_Process_2021,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.6749269414822505,0.7248968532405612,0,0,0.8953446081105656,0.352005474747918,ADGRG6
1013,GO_Biological_Process_2021,innate immune response activating cell surface receptor signaling pathway (GO:0002220),1/119,0.6780171009159583,0.7268558225058008,0,0,0.8877118644067796,0.3449495341410912,MAP3K7
1014,GO_Biological_Process_2021,positive regulation of DNA-binding transcription factor activity (GO:0051091),2/246,0.6780870035325257,0.7268558225058008,0,0,0.8576751117734724,0.3331893490892453,MAP3K7;TRIM22
1015,GO_Biological_Process_2021,cytoskeleton organization (GO:0007010),1/120,0.6810780389255715,0.7286262599321748,0,0,0.8802074021097801,0.3380686372858019,DST
1016,GO_Biological_Process_2021,macroautophagy (GO:0016236),1/120,0.6810780389255715,0.7286262599321748,0,0,0.8802074021097801,0.3380686372858019,ACBD5
1017,GO_Biological_Process_2021,cellular response to interferon-gamma (GO:0071346),1/121,0.6841100304177073,0.7297740225231526,0,0,0.8728280141843971,0.331357382106564,TRIM22
1018,GO_Biological_Process_2021,protein homooligomerization (GO:0051260),1/121,0.6841100304177073,0.7297740225231526,0,0,0.8728280141843971,0.331357382106564,GLS
1019,GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),3/371,0.6841631461154556,0.7297740225231526,0,0,0.8521651472650772,0.3234468421284321,NTRK2;AKTIP;CAPRIN2
1020,GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),2/253,0.6929353341811528,0.7377907230482146,0,0,0.8334576133966807,0.305727752418524,NTRK2;AKTIP
1021,GO_Biological_Process_2021,fatty acid metabolic process (GO:0006631),1/124,0.693035035804481,0.7377907230482146,0,0,0.8514097906936516,0.3121904503146862,ACBD5
1022,GO_Biological_Process_2021,protein targeting (GO:0006605),1/125,0.6959539387839963,0.739451059957996,0,0,0.8445006863417982,0.306107684509338,AP4B1
1023,GO_Biological_Process_2021,cellular response to oxidative stress (GO:0034599),1/125,0.6959539387839963,0.739451059957996,0,0,0.8445006863417982,0.306107684509338,NFE2L2
1024,GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),3/379,0.6980046106298807,0.7403540523739881,0,0,0.833690803019904,0.2997364965518418,MAGI2;SMARCA2;IFIT3
1025,GO_Biological_Process_2021,circulatory system development (GO:0072359),1/126,0.698845231422873,0.7403540523739881,0,0,0.8377021276595744,0.3001704321034689,CACNA1C
1026,GO_Biological_Process_2021,synapse organization (GO:0050808),1/126,0.698845231422873,0.7403540523739881,0,0,0.8377021276595744,0.3001704321034689,PTPRD
1027,GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),5/621,0.702299167584322,0.7432893913732902,0,0,0.8467585403726708,0.2992409127036626,BCL2;MAP3K7;IFIT3;TRIM22;IFNAR1
1028,GO_Biological_Process_2021,positive regulation of cell differentiation (GO:0045597),2/258,0.7031940327537458,0.7435132241361277,0,0,0.8169702540106952,0.2876735416784707,IMPACT;BEND6
1029,GO_Biological_Process_2021,microtubule cytoskeleton organization involved in mitosis (GO:1902850),1/128,0.7045460225809678,0.7442194879301874,0,0,0.8244262020438935,0.2887153941557143,CEP126
1030,GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),6/742,0.7068612544665955,0.7457396941451552,0,0,0.8497416250890948,0.2947931104745036,DNAJC3;GRK5;BCL2;TAX1BP1;HIPK3;IFIT3
1031,GO_Biological_Process_2021,muscle contraction (GO:0006936),1/129,0.7073560334170956,0.7457396941451552,0,0,0.8179438164893617,0.2831894541028257,SSPN
1032,GO_Biological_Process_2021,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/130,0.7101394586064358,0.7479494007394019,0,0,0.8115619330364506,0.2777927053690378,CAPRIN2
1033,GO_Biological_Process_2021,regulation of cell motility (GO:2000145),1/133,0.7183327108105824,0.755847185069549,0,0,0.7929964539007093,0.2623410152356916,PARD6B
1034,GO_Biological_Process_2021,protein-containing complex assembly (GO:0065003),2/267,0.7209444948495534,0.7571308980659401,0,0,0.7888608616688528,0.2581098530642436,PYGO1;PARD6B
1035,GO_Biological_Process_2021,protein deubiquitination (GO:0016579),2/267,0.7209444948495534,0.7571308980659401,0,0,0.7888608616688528,0.2581098530642436,USP25;MAP3K7
1036,GO_Biological_Process_2021,organic substance transport (GO:0071702),1/136,0.726295560297345,0.7620150140824603,0,0,0.7752561071710008,0.2479255379679686,MIA3
1037,GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),2/274,0.7341282308319215,0.769490862374885,0,0,0.7682840515885498,0.2374547535899423,ATP6V1A;CACNA1C
1038,GO_Biological_Process_2021,transcription initiation from RNA polymerase II promoter (GO:0006367),1/140,0.7365654035129455,0.7713023667200045,0,0,0.7527935098729527,0.230172068790832,THRB
1039,GO_Biological_Process_2021,protein modification by small protein removal (GO:0070646),2/276,0.7377969892708764,0.7718491580064554,0,0,0.7625980717436278,0.2318958353663747,USP25;MAP3K7
1040,GO_Biological_Process_2021,Ras protein signal transduction (GO:0007265),1/142,0.7415556545411675,0.77429227652667,0,0,0.7420401388260148,0.2218737588465124,RAPGEF6
1041,GO_Biological_Process_2021,chromatin organization (GO:0006325),1/142,0.7415556545411675,0.77429227652667,0,0,0.7420401388260148,0.2218737588465124,SMARCA2
1042,GO_Biological_Process_2021,protein-DNA complex assembly (GO:0065004),1/143,0.7440154038560083,0.7746303917658727,0,0,0.7367770452502248,0.2178602128892719,NAP1L2
1043,GO_Biological_Process_2021,neuron development (GO:0048666),1/143,0.7440154038560083,0.7746303917658727,0,0,0.7367770452502248,0.2178602128892719,NTRK2
1044,GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),1/143,0.7440154038560083,0.7746303917658727,0,0,0.7367770452502248,0.2178602128892719,MIA3
1045,GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration (GO:0007204),1/147,0.7536237023290797,0.7838839274704004,0,0,0.7164456426697756,0.2026553219440914,CACNA1C
1046,GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),1/150,0.7605937192718881,0.7903781915642926,0,0,0.7019134656575753,0.1920827900285196,IMPACT
1047,GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),4/547,0.7631914284888018,0.7923208723242523,0,0,0.7672291075605993,0.2073408965650504,ATXN1;WWP1;ZMYND11;SMARCA2
1048,GO_Biological_Process_2021,positive regulation of Wnt signaling pathway (GO:0030177),1/153,0.7673675658306428,0.7958969605564722,0,0,0.6879549272116461,0.1821631497513753,CAPRIN2
1049,GO_Biological_Process_2021,positive regulation of protein kinase activity (GO:0045860),1/154,0.769582875087977,0.7974344458054465,0,0,0.6834237240995689,0.1789932055228445,TAOK3
1050,GO_Biological_Process_2021,cellular response to interleukin-1 (GO:0071347),1/155,0.7717771987998114,0.7989472809649809,0,0,0.6789513677811551,0.1758887157720408,MAP3K7
1051,GO_Biological_Process_2021,peptidyl-serine phosphorylation (GO:0018105),1/156,0.7739507346509168,0.8004357407796554,0,0,0.6745367192862045,0.1728480496546758,HIPK3
1052,GO_Biological_Process_2021,skeletal system development (GO:0001501),1/158,0.7782362249014093,0.8036729797504105,0,0,0.6658761349776392,0.1669519070823661,ITGB8
1053,GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),2/300,0.7785581991332102,0.8036729797504105,0,0,0.7003194200193805,0.1752980272390155,DST;ITGB8
1054,GO_Biological_Process_2021,innate immune response (GO:0045087),2/302,0.7816928600188384,0.8061439163037879,0,0,0.6955793226381461,0.1713165808393957,TRIM22;CXCL16
1055,GO_Biological_Process_2021,MAPK cascade (GO:0000165),2/303,0.783245632112925,0.806980348237559,0,0,0.693232895695276,0.169362984065927,TAOK3;MAP3K7
1056,GO_Biological_Process_2021,peptide biosynthetic process (GO:0043043),1/162,0.7865662489534199,0.8088696397555017,0,0,0.649200475749967,0.1558589643744136,MRPS6
1057,GO_Biological_Process_2021,rRNA metabolic process (GO:0016072),1/162,0.7865662489534199,0.8088696397555017,0,0,0.649200475749967,0.1558589643744136,DIS3L
1058,GO_Biological_Process_2021,double-strand break repair (GO:0006302),1/164,0.7906137874011564,0.8114979251815643,0,0,0.6411695601096462,0.150640024136328,MCM9
1059,GO_Biological_Process_2021,heart development (GO:0007507),1/164,0.7906137874011564,0.8114979251815643,0,0,0.6411695601096462,0.150640024136328,CACNA1C
1060,GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",9/1183,0.7929802594823717,0.8131597759819231,0,0,0.7937393526405452,0.1841133602240424,PPP3CA;THRB;ZNF827;CAPRIN2;NAMPT;EFCAB7;SMARCA2;NPAS3;NFE2L2
1061,GO_Biological_Process_2021,"DNA-templated transcription, initiation (GO:0006352)",1/168,0.7984812189323998,0.8180297233507071,0,0,0.6256848006115429,0.1408065051781769,THRB
1062,GO_Biological_Process_2021,neuron projection development (GO:0031175),1/171,0.8041881799757737,0.8231013544813188,0,0,0.6145494367959949,0.1339238316068236,TAOK3
1063,GO_Biological_Process_2021,positive regulation of ERK1 and ERK2 cascade (GO:0070374),1/172,0.8060545439893193,0.8242362254326874,0,0,0.6109244743063332,0.1317176786910959,NTRK2
1064,GO_Biological_Process_2021,mitochondrion organization (GO:0007005),1/175,0.8115481255392498,0.8290745169828205,0,0,0.600299584250428,0.1253495102812481,CAV2
1065,GO_Biological_Process_2021,regulation of mitotic cell cycle (GO:0007346),1/178,0.8168868977862024,0.8337457268211896,0,0,0.5900348599591297,0.1193372821155399,CAV2
1066,GO_Biological_Process_2021,regulation of immune response (GO:0050776),1/179,0.818632840099593,0.8347446392018344,0,0,0.5866901745158977,0.1174082020703086,PIANP
1067,GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.8203622222639346,0.8357248106958436,0,0,0.5833828598597409,0.1155152327579985,EPM2AIP1
1068,GO_Biological_Process_2021,negative regulation of cytokine production (GO:0001818),1/182,0.8237719297106102,0.8384133391254854,0,0,0.5768778652874104,0.1118344496529624,TAX1BP1
1069,GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),3/481,0.8361630485120252,0.8502293427860592,0,0,0.6523484950735592,0.1167257931261618,DNAJC3;ASAH1;STXBP3
1070,GO_Biological_Process_2021,negative regulation of Wnt signaling pathway (GO:0030178),1/191,0.8383361131593657,0.8516430355904667,0,0,0.5493001119820828,0.0968614775023558,CXXC4
1071,GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),3/485,0.8402613618619478,0.8528025762180963,0,0,0.6468009637264088,0.1125707212029616,DNAJC3;ASAH1;STXBP3
1072,GO_Biological_Process_2021,regulation of programmed cell death (GO:0043067),1/194,0.8429196470406751,0.8542695230101445,0,0,0.5406790872009701,0.0923932123242137,ASAH1
1073,GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),3/488,0.8432770842949404,0.8542695230101445,0,0,0.6427003658131027,0.1095545029455311,DNAJC3;ASAH1;STXBP3
1074,GO_Biological_Process_2021,supramolecular fiber organization (GO:0097435),2/351,0.8472195860473304,0.8574650322041817,0,0,0.5964175719779967,0.0988832698724626,CEP126;DST
1075,GO_Biological_Process_2021,modification-dependent protein catabolic process (GO:0019941),1/201,0.8531180323750113,0.8626323598736173,0,0,0.5215691489361702,0.0828551021369719,RNF19A
1076,GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),1/203,0.8559089369108723,0.8638487229675595,0,0,0.516352433115652,0.0803399414795445,ITGB8
1077,GO_Biological_Process_2021,axon guidance (GO:0007411),1/203,0.8559089369108723,0.8638487229675595,0,0,0.516352433115652,0.0803399414795445,SEMA6D
1078,GO_Biological_Process_2021,translation (GO:0006412),1/214,0.870342074301622,0.8776016467471406,0,0,0.4894116471880931,0.0679640843815714,MRPS6
1079,GO_Biological_Process_2021,extracellular structure organization (GO:0043062),1/216,0.8728073108093094,0.8792725501486375,0,0,0.4848095002474022,0.0659537114147382,ITGB8
1080,GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),1/217,0.8740223876234882,0.8796821070623082,0,0,0.4825403861308117,0.0649737196770029,ITGB8
1081,GO_Biological_Process_2021,membrane organization (GO:0061024),1/242,0.9009155867653236,0.9059114218120812,0,0,0.4319325505429505,0.0450694465848968,TMCC1
1082,GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),1/252,0.909997794001126,0.9141990765219068,0,0,0.4145121641095193,0.0390939286973355,CAV2
1083,GO_Biological_Process_2021,regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.910859149582424,0.914220253455422,0,0,0.4128461668355285,0.0385462098970723,CAPRIN2
1084,GO_Biological_Process_2021,cellular component assembly (GO:0022607),1/261,0.9174612083830834,0.9199979674846036,0,0,0.3999795417348609,0.0344562294786402,PARD6B
1085,GO_Biological_Process_2021,proteolysis (GO:0006508),1/287,0.9357380472673152,0.9374613217558372,0,0,0.3631342062193126,0.0241192671083011,USP25
1086,GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",15/2244,0.9455908995272044,0.9464608083584164,0,0,0.679986386349221,0.038042012730143,ZNF382;WWC2;TSHZ2;WWP1;SMARCA2;PIAS2;NPAS3;ATXN1;ZNF546;ZMYND11;ZNF136;ZNF334;ZNF674;TRIM22;NFE2L2
1087,GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),2/511,0.9559620519480778,0.9559620519480778,0,0,0.4055766260781862,0.0182659793841453,SMARCA2;NPAS3
1088,GO_Cellular_Component_2021,astral microtubule (GO:0000235),2/7,0.001808145106218,0.1265701574352648,0,0,42.36577540106952,267.5590956523504,FAM161A;MAP9
1089,GO_Cellular_Component_2021,hemidesmosome (GO:0030056),2/7,0.001808145106218,0.1265701574352648,0,0,42.36577540106952,267.5590956523504,DST;ERBIN
1090,GO_Cellular_Component_2021,voltage-gated calcium channel complex (GO:0005891),3/31,0.0030727909454141,0.1433969107859943,0,0,11.39573732718894,65.92626663221358,PDE4D;PDE4B;CACNA1C
1091,GO_Cellular_Component_2021,calcium channel complex (GO:0034704),3/45,0.0088079719773247,0.3082790192063654,0,0,7.591781874039938,35.92505628620668,PDE4D;PDE4B;CACNA1C
1092,GO_Cellular_Component_2021,cell-substrate junction (GO:0030055),8/394,0.0340755282578618,0.5607372494295298,0,0,2.2242578650559643,7.516158347712226,DST;CAV2;RDX;ERBIN;ADAM9;TWF1;ITGB8;MAPRE2
1093,GO_Cellular_Component_2021,asymmetric synapse (GO:0032279),4/133,0.0375885562124442,0.5607372494295298,0,0,3.29888958726168,10.82384025621346,NTRK2;MAGI2;CACNA1C;CPEB4
1094,GO_Cellular_Component_2021,early endosome (GO:0005769),6/266,0.0410283164682355,0.5607372494295298,0,0,2.465447667087011,7.873389386185562,NTRK2;ASAH1;RABGAP1L;MON2;SNX27;ATP9A
1095,GO_Cellular_Component_2021,postsynaptic density (GO:0014069),4/138,0.042112141563565,0.5607372494295298,0,0,3.174989915288423,10.05652395935089,NTRK2;MAGI2;CACNA1C;CPEB4
1096,GO_Cellular_Component_2021,filtration diaphragm (GO:0036056),1/5,0.0463696956816514,0.5607372494295298,0,0,26.33909574468085,80.89023777113094,MAGI2
1097,GO_Cellular_Component_2021,slit diaphragm (GO:0036057),1/5,0.0463696956816514,0.5607372494295298,0,0,26.33909574468085,80.89023777113094,MAGI2
1098,GO_Cellular_Component_2021,trans-Golgi network membrane (GO:0032588),3/99,0.0675100092214759,0.5607372494295298,0,0,3.312331989247312,8.928322667270274,COG6;AP4B1;ATP9A
1099,GO_Cellular_Component_2021,"proton-transporting V-type ATPase, V1 domain (GO:0033180)",1/8,0.0731583372077776,0.5607372494295298,0,0,15.048632218844984,39.35411729295222,ATP6V1A
1100,GO_Cellular_Component_2021,"vacuolar proton-transporting V-type ATPase, V1 domain (GO:0000221)",1/8,0.0731583372077776,0.5607372494295298,0,0,15.048632218844984,39.35411729295222,ATP6V1A
1101,GO_Cellular_Component_2021,cilium (GO:0005929),5/237,0.0747463324827882,0.5607372494295298,0,0,2.293267428785607,5.947944835008276,DYNC2LI1;FAM161A;FAM161B;EFCAB7;KIF27
1102,GO_Cellular_Component_2021,focal adhesion (GO:0005925),7/387,0.0751685584082635,0.5607372494295298,0,0,1.9667004048583,5.089864390593134,DST;CAV2;RDX;ADAM9;TWF1;ITGB8;MAPRE2
1103,GO_Cellular_Component_2021,platelet dense tubular network membrane (GO:0031095),1/9,0.0819204792179246,0.5607372494295298,0,0,13.16688829787234,32.943637049750684,ITPR2
1104,GO_Cellular_Component_2021,microbody membrane (GO:0031903),2/52,0.0866723609268016,0.5607372494295298,0,0,4.226951871657754,10.337519033042998,PECR;ACBD5
1105,GO_Cellular_Component_2021,basement membrane (GO:0005604),2/52,0.0866723609268016,0.5607372494295298,0,0,4.226951871657754,10.337519033042998,DST;ERBIN
1106,GO_Cellular_Component_2021,sarcolemma (GO:0042383),2/52,0.0866723609268016,0.5607372494295298,0,0,4.226951871657754,10.337519033042998,CAV2;SSPN
1107,GO_Cellular_Component_2021,peroxisomal membrane (GO:0005778),2/53,0.0895314881378626,0.5607372494295298,0,0,4.143860752857293,9.999819289476129,PECR;ACBD5
1108,GO_Cellular_Component_2021,npBAF complex (GO:0071564),1/11,0.0991983332467463,0.5607372494295298,0,0,10.532446808510638,24.33663040229913,SMARCA2
1109,GO_Cellular_Component_2021,nuclear inclusion body (GO:0042405),1/11,0.0991983332467463,0.5607372494295298,0,0,10.532446808510638,24.33663040229913,ATXN1
1110,GO_Cellular_Component_2021,platelet dense tubular network (GO:0031094),1/11,0.0991983332467463,0.5607372494295298,0,0,10.532446808510638,24.33663040229913,ITPR2
1111,GO_Cellular_Component_2021,intracellular vesicle (GO:0097708),1/11,0.0991983332467463,0.5607372494295298,0,0,10.532446808510638,24.33663040229913,ITSN2
1112,GO_Cellular_Component_2021,filopodium (GO:0030175),2/58,0.1042268357813296,0.5607372494295298,0,0,3.772918258212376,8.531268592903112,RDX;TWF1
1113,GO_Cellular_Component_2021,mitotic spindle (GO:0072686),3/120,0.1051245034674155,0.5607372494295298,0,0,2.714915908464296,6.115646409524227,TBCK;FAM161A;MAP9
1114,GO_Cellular_Component_2021,spindle microtubule (GO:0005876),2/61,0.1133371047089062,0.5607372494295298,0,0,3.580531133871114,7.796207936901682,FAM161A;MAP9
1115,GO_Cellular_Component_2021,cell-cell junction (GO:0005911),5/271,0.1147936802282319,0.5607372494295298,0,0,1.9966696632886565,4.3220287841655765,USP53;MAGI2;TWF1;CDC42BPA;CDH8
1116,GO_Cellular_Component_2021,Ada2/Gcn5/Ada3 transcription activator complex (GO:0005671),1/13,0.1161527159532597,0.5607372494295298,0,0,8.776152482269504,18.893734929477525,MAP3K7
1117,GO_Cellular_Component_2021,mRNA cleavage and polyadenylation specificity factor complex (GO:0005847),1/14,0.124510492276309,0.5623054489897829,0,0,8.100654664484452,16.87662276492899,CPSF2
1118,GO_Cellular_Component_2021,nBAF complex (GO:0071565),1/14,0.124510492276309,0.5623054489897829,0,0,8.100654664484452,16.87662276492899,SMARCA2
1119,GO_Cellular_Component_2021,endoplasmic reticulum lumen (GO:0005788),5/285,0.1337591703626245,0.5851963703364825,0,0,1.8954774844720497,3.8131592216805617,DNAJC3;MGAT4A;MIA3;UGGT2;KTN1
1120,GO_Cellular_Component_2021,cytoplasmic dynein complex (GO:0005868),1/19,0.1651347170981347,0.6221547984118281,0,0,5.848995271867612,10.534003466039604,DYNC2LI1
1121,GO_Cellular_Component_2021,SWI/SNF complex (GO:0016514),1/19,0.1651347170981347,0.6221547984118281,0,0,5.848995271867612,10.534003466039604,SMARCA2
1122,GO_Cellular_Component_2021,vacuolar proton-transporting V-type ATPase complex (GO:0016471),1/19,0.1651347170981347,0.6221547984118281,0,0,5.848995271867612,10.534003466039604,ATP6V1A
1123,GO_Cellular_Component_2021,bicellular tight junction (GO:0005923),2/78,0.1681640613837833,0.6221547984118281,0,0,2.777230509428652,4.951288822333974,PARD6B;MAGI2
1124,GO_Cellular_Component_2021,intracellular organelle lumen (GO:0070013),11/848,0.1801667797154249,0.6221547984118281,0,0,1.400896728551676,2.400958102573037,DNAJC3;ASAH1;MGAT4A;MTHFD2L;MIA3;TRNT1;PPM1K;UGGT2;AP4B1;GLS;KTN1
1125,GO_Cellular_Component_2021,actin-based cell projection (GO:0098858),2/83,0.1850533113527485,0.6221547984118281,0,0,2.6051363306265265,4.395155009023892,RDX;TWF1
1126,GO_Cellular_Component_2021,intermediate filament cytoskeleton (GO:0045111),2/84,0.1884605501631794,0.6221547984118281,0,0,2.573235946263206,4.294387465326928,DST;SMARCA2
1127,GO_Cellular_Component_2021,trans-Golgi network (GO:0005802),4/239,0.1906565899056197,0.6221547984118281,0,0,1.80112708453134,2.9849744663237163,COG6;GOLGA1;AP4B1;ATP9A
1128,GO_Cellular_Component_2021,tight junction (GO:0070160),2/85,0.1918764625944428,0.6221547984118281,0,0,2.5421042458604477,4.196768893526201,PARD6B;MAGI2
1129,GO_Cellular_Component_2021,endoplasmic reticulum tubular network (GO:0071782),1/23,0.1962795291870694,0.6221547984118281,0,0,4.784574468085107,7.790318149286441,REEP5
1130,GO_Cellular_Component_2021,Golgi-associated vesicle membrane (GO:0030660),1/24,0.203883421235608,0.6221547984118281,0,0,4.57631822386679,7.277292875760221,ZDHHC17
1131,GO_Cellular_Component_2021,intrinsic component of external side of plasma membrane (GO:0031233),1/24,0.203883421235608,0.6221547984118281,0,0,4.57631822386679,7.277292875760221,ADAM9
1132,GO_Cellular_Component_2021,microtubule cytoskeleton (GO:0015630),5/331,0.204649992165373,0.6221547984118281,0,0,1.624183115497466,2.576691986001042,DST;MTUS1;FAM161B;MAPRE2;KIF27
1133,GO_Cellular_Component_2021,cytoskeleton (GO:0005856),8/600,0.2084919099580721,0.6221547984118281,0,0,1.4348962221890398,2.249709273343002,DST;MTUS1;TWF1;FAM161B;CDC42BPA;SMARCA2;SAXO2;MAPRE2
1134,GO_Cellular_Component_2021,H4 histone acetyltransferase complex (GO:1902562),1/25,0.2114157508984971,0.6221547984118281,0,0,4.385416666666667,6.814624823124887,MAP3K7
1135,GO_Cellular_Component_2021,endosome lumen (GO:0031904),1/26,0.2188771881168769,0.6221547984118281,0,0,4.209787234042553,6.395696064943001,AP4B1
1136,GO_Cellular_Component_2021,myofibril (GO:0030016),1/27,0.2262683966074298,0.6221547984118281,0,0,4.047667757774141,6.01496943456091,TWF1
1137,GO_Cellular_Component_2021,early endosome membrane (GO:0031901),2/97,0.2333824524117058,0.6221547984118281,0,0,2.2196453701097663,3.22975435891768,MON2;ATP9A
1138,GO_Cellular_Component_2021,sarcoplasmic reticulum membrane (GO:0033017),1/28,0.2335900338821068,0.6221547984118281,0,0,3.897557131599685,5.667779610083707,ITPR2
1139,GO_Cellular_Component_2021,apical junction complex (GO:0043296),2/98,0.236871595914967,0.6221547984118281,0,0,2.1964126559714794,3.163354937056446,PARD6B;MAGI2
1140,GO_Cellular_Component_2021,rough endoplasmic reticulum (GO:0005791),1/29,0.2408427513052744,0.6221547984118281,0,0,3.7581686930091194,5.350170451555993,TMCC1
1141,GO_Cellular_Component_2021,dendrite (GO:0030425),4/270,0.2523436249383023,0.6221547984118281,0,0,1.5887014834383255,2.18758400162614,CHRM3;NTRK2;MAGI2;CPEB4
1142,GO_Cellular_Component_2021,catenin complex (GO:0016342),1/31,0.2551440019839143,0.6221547984118281,0,0,3.5072695035460995,4.790674740907671,CDH8
1143,GO_Cellular_Component_2021,ciliary membrane (GO:0060170),1/31,0.2551440019839143,0.6221547984118281,0,0,3.5072695035460995,4.790674740907671,EFCAB7
1144,GO_Cellular_Component_2021,Golgi stack (GO:0005795),1/31,0.2551440019839143,0.6221547984118281,0,0,3.5072695035460995,4.790674740907671,MGAT4A
1145,GO_Cellular_Component_2021,spliceosomal tri-snRNP complex (GO:0097526),1/32,0.2621938079021275,0.6221547984118281,0,0,3.393960192175704,4.543397183606022,PRPF3
1146,GO_Cellular_Component_2021,U4/U6 x U5 tri-snRNP complex (GO:0046540),1/32,0.2621938079021275,0.6221547984118281,0,0,3.393960192175704,4.543397183606022,PRPF3
1147,GO_Cellular_Component_2021,heterotrimeric G-protein complex (GO:0005834),1/33,0.2691772395184866,0.6259649472779404,0,0,3.287732712765957,4.31477186353451,GNG12
1148,GO_Cellular_Component_2021,spindle (GO:0005819),3/192,0.2727418698853883,0.6259649472779404,0,0,1.6745178358081585,2.1755829080139875,TBCK;FAM161A;MAP9
1149,GO_Cellular_Component_2021,aggresome (GO:0016235),1/35,0.2829474603528049,0.6337963526375825,0,0,3.094023779724656,3.906186615672604,ZDHHC17
1150,GO_Cellular_Component_2021,Golgi membrane (GO:0000139),6/472,0.2887463938302872,0.6337963526375825,0,0,1.3610778864419897,1.690739805879142,GALNT13;COG6;MGAT4A;AP4B1;ZDHHC17;ATP9A
1151,GO_Cellular_Component_2021,Cul3-RING ubiquitin ligase complex (GO:0031463),1/36,0.2897354754914663,0.6337963526375825,0,0,3.005471124620061,3.723138334881813,KBTBD6
1152,GO_Cellular_Component_2021,nuclear membrane (GO:0031965),3/204,0.3035776155989115,0.6538594797515018,0,0,1.5735836944310704,1.8758973932778769,GRK5;BCL2;SCAI
1153,GO_Cellular_Component_2021,cortical actin cytoskeleton (GO:0030864),1/42,0.3291419591356655,0.6981799133180784,0,0,2.564867669953295,2.850250581210622,RDX
1154,GO_Cellular_Component_2021,peroxisome (GO:0005777),2/128,0.3414289530957894,0.7024235679694723,0,0,1.6709107885578474,1.7955869086341008,PECR;ACBD5
1155,GO_Cellular_Component_2021,sarcoplasmic reticulum (GO:0016529),1/45,0.3480217988046306,0.7024235679694723,0,0,2.389627659574468,2.522228482958168,ITPR2
1156,GO_Cellular_Component_2021,small ribosomal subunit (GO:0015935),1/45,0.3480217988046306,0.7024235679694723,0,0,2.389627659574468,2.522228482958168,MRPS6
1157,GO_Cellular_Component_2021,endoplasmic reticulum membrane (GO:0005789),8/712,0.3599134859952918,0.7024235679694723,0,0,1.199585635359116,1.225846475967894,VMA21;ADGRG6;POMK;ITPR2;MIA2;SERINC1;MIA3;KTN1
1158,GO_Cellular_Component_2021,Golgi-associated vesicle (GO:0005798),1/47,0.3603137742640697,0.7024235679694723,0,0,2.2854995374653098,2.33299229092702,ZDHHC17
1159,GO_Cellular_Component_2021,intermediate filament (GO:0005882),1/50,0.3783208179838206,0.7024235679694723,0,0,2.1452453321754232,2.085205747179162,DST
1160,GO_Cellular_Component_2021,U2-type precatalytic spliceosome (GO:0071005),1/50,0.3783208179838206,0.7024235679694723,0,0,2.1452453321754232,2.085205747179162,PRPF3
1161,GO_Cellular_Component_2021,precatalytic spliceosome (GO:0071011),1/52,0.3900444777899704,0.7024235679694723,0,0,2.060909470171047,1.9403349327010695,PRPF3
1162,GO_Cellular_Component_2021,sperm flagellum (GO:0036126),1/52,0.3900444777899704,0.7024235679694723,0,0,2.060909470171047,1.9403349327010695,SAXO2
1163,GO_Cellular_Component_2021,cytoplasmic side of plasma membrane (GO:0009898),1/55,0.4072188691837333,0.7024235679694723,0,0,1.9461189913317571,1.748402012562394,PPP3CA
1164,GO_Cellular_Component_2021,tertiary granule lumen (GO:1904724),1/55,0.4072188691837333,0.7024235679694723,0,0,1.9461189913317571,1.748402012562394,ASAH1
1165,GO_Cellular_Component_2021,extracellular membrane-bounded organelle (GO:0065010),1/56,0.4128360875798395,0.7024235679694723,0,0,1.9106382978723404,1.6903505811944235,DNAJC3
1166,GO_Cellular_Component_2021,mitochondrial matrix (GO:0005759),4/348,0.4179848139232376,0.7024235679694723,0,0,1.223570081709617,1.0673326350919283,MTHFD2L;TRNT1;PPM1K;GLS
1167,GO_Cellular_Component_2021,9+2 motile cilium (GO:0097729),1/57,0.4184003558632383,0.7024235679694723,0,0,1.8764247720364744,1.6349598943406722,SAXO2
1168,GO_Cellular_Component_2021,microvillus (GO:0005902),1/57,0.4184003558632383,0.7024235679694723,0,0,1.8764247720364744,1.6349598943406722,RDX
1169,GO_Cellular_Component_2021,basolateral plasma membrane (GO:0016323),2/151,0.4186725601103661,0.7024235679694723,0,0,1.4113340272045365,1.228800755396664,PIANP;ERBIN
1170,GO_Cellular_Component_2021,cortical cytoskeleton (GO:0030863),1/58,0.423912170489589,0.7024235679694723,0,0,1.84341172079134,1.5820693798039756,RDX
1171,GO_Cellular_Component_2021,recycling endosome membrane (GO:0055038),1/58,0.423912170489589,0.7024235679694723,0,0,1.84341172079134,1.5820693798039756,ATP9A
1172,GO_Cellular_Component_2021,extracellular vesicle (GO:1903561),1/59,0.4293720233296841,0.7024235679694723,0,0,1.8115370506236244,1.5315305740460652,DNAJC3
1173,GO_Cellular_Component_2021,caveola (GO:0005901),1/60,0.4347804016993901,0.7024235679694723,0,0,1.7807428777497296,1.4832060277160146,CAV2
1174,GO_Cellular_Component_2021,polymeric cytoskeletal fiber (GO:0099513),3/256,0.4365060743810292,0.7024235679694723,0,0,1.246844319775596,1.0335753240642396,DST;TWF1;KIF27
1175,GO_Cellular_Component_2021,vacuolar lumen (GO:0005775),2/161,0.4508405381054218,0.717246310622262,0,0,1.3218982275586049,1.0530790873761913,DNAJC3;ASAH1
1176,GO_Cellular_Component_2021,tertiary granule (GO:0070820),2/164,0.4602953262582756,0.7240600637770628,0,0,1.2972205717303755,1.0064965542540858,ASAH1;STXBP3
1177,GO_Cellular_Component_2021,motile cilium (GO:0031514),1/68,0.4762513396174245,0.7403348289897841,0,0,1.5674817402349952,1.162772908212185,DYNC2LI1
1178,GO_Cellular_Component_2021,glutamatergic synapse (GO:0098978),1/69,0.4812176388433596,0.7403348289897841,0,0,1.544352315394243,1.1295943235827153,PTPRD
1179,GO_Cellular_Component_2021,actin filament (GO:0005884),1/72,0.4958372214681416,0.745602411637072,0,0,1.4788732394366195,1.0374408001084885,TWF1
1180,GO_Cellular_Component_2021,cation channel complex (GO:0034703),1/73,0.5006187620991769,0.745602411637072,0,0,1.4582594562647757,1.0089849149873038,PDE4D
1181,GO_Cellular_Component_2021,vesicle membrane (GO:0012506),1/73,0.5006187620991769,0.745602411637072,0,0,1.4582594562647757,1.0089849149873038,ITPR2
1182,GO_Cellular_Component_2021,microtubule (GO:0005874),2/182,0.5149666048639715,0.758898154536379,0,0,1.1664289958407603,0.7741043652259432,FAM161A;KIF27
1183,GO_Cellular_Component_2021,P-body (GO:0000932),1/80,0.532849867215782,0.7616265817729849,0,0,1.3285752760570966,0.8363588215459095,TNRC6B
1184,GO_Cellular_Component_2021,endocytic vesicle (GO:0030139),2/189,0.5352255145706716,0.7616265817729849,0,0,1.1223655237496069,0.7015537612068022,HEATR5A;RAPGEF6
1185,GO_Cellular_Component_2021,plasma membrane raft (GO:0044853),1/82,0.5416726071913932,0.7616265817729849,0,0,1.2956396112424482,0.794348231541045,CAV2
1186,GO_Cellular_Component_2021,nucleolus (GO:0005730),7/733,0.5425900740942597,0.7616265817729849,0,0,1.0110722610722611,0.618170765551013,MOB1B;NWD1;ATXN1;NOVA1;MTUS1;TWF1;RBM7
1187,GO_Cellular_Component_2021,nucleus (GO:0005634),42/4484,0.554691942679208,0.7616265817729849,0,0,0.9885508458223452,0.5825949058289512,THRB;MCM9;TSHZ2;CXXC4;PARD6B;ATXN1;ZNF827;PDE4B;NEK1;ZNF546;RBM7;MAP3K7;SCAI;TRIM22;RBM6;BEND6;USP25;RABGAP1L;DST;AKTIP;PDE4D;STYX;MAGI2;MTUS1;ERBIN;NAP1L2;SMARCA2;HIPK3;PIAS2;PTBP3;MOB1B;SNRK;KBTBD6;NOVA1;PRPF3;BCL2;DZIP1;ZMYND11;ZNF136;ZNF334;CPEB4;NFE2L2
1188,GO_Cellular_Component_2021,lysosomal lumen (GO:0043202),1/86,0.5588238918519959,0.7616265817729849,0,0,1.2344180225281602,0.7183336427853815,ASAH1
1189,GO_Cellular_Component_2021,nuclear lumen (GO:0031981),7/745,0.559918427477677,0.7616265817729849,0,0,0.9940066708359392,0.5764882549009308,MOB1B;NWD1;ATXN1;NOVA1;MTUS1;TWF1;RBM7
1190,GO_Cellular_Component_2021,U2-type spliceosomal complex (GO:0005684),1/89,0.5712669920587159,0.7616265817729849,0,0,1.1921542553191489,0.6674854887829307,PRPF3
1191,GO_Cellular_Component_2021,azurophil granule lumen (GO:0035578),1/90,0.5753366170598933,0.7616265817729849,0,0,1.1786994979679657,0.6515850689252642,DNAJC3
1192,GO_Cellular_Component_2021,platelet alpha granule (GO:0031091),1/90,0.5753366170598933,0.7616265817729849,0,0,1.1786994979679657,0.6515850689252642,STXBP3
1193,GO_Cellular_Component_2021,axon (GO:0030424),2/204,0.5766601261995458,0.7616265817729849,0,0,1.0382273521469794,0.5715464643741285,NTRK2;MAP9
1194,GO_Cellular_Component_2021,cell projection membrane (GO:0031253),1/92,0.583360945693056,0.7632760037105405,0,0,1.1526771101239186,0.6212343676056309,EFCAB7
1195,GO_Cellular_Component_2021,bounding membrane of organelle (GO:0098588),7/767,0.5909158174859898,0.7649966785994857,0,0,0.9641194331983806,0.5072056024944227,GALNT13;COG6;MGAT4A;ITPR2;EFCAB7;MAP3K7;ZDHHC17
1196,GO_Cellular_Component_2021,endosome membrane (GO:0010008),3/325,0.5956045569095996,0.7649966785994857,0,0,0.9762071729112404,0.5058493999039178,MON2;MAP3K7;ATP9A
1197,GO_Cellular_Component_2021,mitochondrial inner membrane (GO:0005743),3/328,0.6018405099622998,0.7653836316245229,0,0,0.9670471464019852,0.4910305691021318,MRPS25;MRPS6;COX20
1198,GO_Cellular_Component_2021,neuron projection (GO:0043005),5/556,0.6068398793594432,0.7653836316245229,0,0,0.949854020358242,0.4744428818414096,CHRM3;NTRK2;MAGI2;MAP9;CPEB4
1199,GO_Cellular_Component_2021,lytic vacuole (GO:0000323),2/219,0.6153491543167056,0.7691864428958819,0,0,0.965721185835038,0.4689208341372071,ASAH1;VMA21
1200,GO_Cellular_Component_2021,vesicle (GO:0031982),2/226,0.63246105352626,0.7834114844006042,0,0,0.9352081741787625,0.4284531266243889,ITSN2;DNAJC3
1201,GO_Cellular_Component_2021,organelle inner membrane (GO:0019866),3/346,0.6379207801547776,0.7834114844006042,0,0,0.9154518950437318,0.4115333181585268,MRPS25;MRPS6;COX20
1202,GO_Cellular_Component_2021,mitochondrial membrane (GO:0031966),4/469,0.6502077868795071,0.7915573057663565,0,0,0.8995524556814879,0.3872243141469142,MRPS25;BCL2;MRPS6;COX20
1203,GO_Cellular_Component_2021,intrinsic component of endoplasmic reticulum membrane (GO:0031227),1/121,0.6841100304177073,0.8231792058170742,0,0,0.8728280141843971,0.331357382106564,SARAF
1204,GO_Cellular_Component_2021,ficolin-1-rich granule lumen (GO:1904813),1/123,0.6900882603684416,0.8231792058170742,0,0,0.8584321590512731,0.3184231990555664,ASAH1
1205,GO_Cellular_Component_2021,mitochondrial outer membrane (GO:0005741),1/126,0.698845231422873,0.8231792058170742,0,0,0.8377021276595744,0.3001704321034689,BCL2
1206,GO_Cellular_Component_2021,cytoplasmic vesicle membrane (GO:0030659),3/380,0.699702324944513,0.8231792058170742,0,0,0.8314366390005989,0.2969062602996225,ITPR2;MAP3K7;ZDHHC17
1207,GO_Cellular_Component_2021,adherens junction (GO:0005912),1/132,0.7156275506032503,0.8340851414423376,0,0,0.7990904661361052,0.2673720165947627,CDH8
1208,GO_Cellular_Component_2021,intracellular membrane-bounded organelle (GO:0043231),46/5192,0.7208878722465918,0.8340851414423376,0,0,0.9167144553852676,0.3000146714478237,ATP6V1A;ITSN2;THRB;MCM9;TSHZ2;MIA3;CXXC4;PARD6B;ATXN1;ZNF827;PDE4B;NEK1;ZNF546;RBM7;MAP3K7;SCAI;TRIM22;RBM6;BEND6;USP25;RABGAP1L;DST;AKTIP;PDE4D;STYX;MAGI2;MTUS1;ERBIN;NAP1L2;SMARCA2;ZDHHC17;HIPK3;PIAS2;PTBP3;MOB1B;SNRK;KBTBD6;NOVA1;PRPF3;BCL2;DZIP1;ZMYND11;ZNF136;ZNF334;CPEB4;NFE2L2
1209,GO_Cellular_Component_2021,organelle outer membrane (GO:0031968),1/142,0.7415556545411675,0.8440470864696215,0,0,0.7420401388260148,0.2218737588465124,BCL2
1210,GO_Cellular_Component_2021,integral component of endoplasmic reticulum membrane (GO:0030176),1/142,0.7415556545411675,0.8440470864696215,0,0,0.7420401388260148,0.2218737588465124,SARAF
1211,GO_Cellular_Component_2021,recycling endosome (GO:0055037),1/145,0.7488652573879355,0.845493032534766,0,0,0.7264701536643026,0.2100924139021512,ATP9A
1212,GO_Cellular_Component_2021,azurophil granule (GO:0042582),1/155,0.7717771987998114,0.8555473623688242,0,0,0.6789513677811551,0.1758887157720408,DNAJC3
1213,GO_Cellular_Component_2021,intracellular non-membrane-bounded organelle (GO:0043232),9/1158,0.7720806217209594,0.8555473623688242,0,0,0.8120974760661445,0.2100622511023208,MOB1B;NWD1;ATXN1;NOVA1;MTUS1;TWF1;CDC42BPA;RBM7;SAXO2
1214,GO_Cellular_Component_2021,cullin-RING ubiquitin ligase complex (GO:0031461),1/157,0.7761036787202905,0.8555473623688242,0,0,0.6701786688488817,0.1698696249971107,KBTBD6
1215,GO_Cellular_Component_2021,specific granule (GO:0042581),1/160,0.7824408907877144,0.8557947242990627,0,0,0.6574334270038806,0.161292677853056,STXBP3
1216,GO_Cellular_Component_2021,membrane raft (GO:0045121),1/163,0.7885996537294453,0.8558445854428088,0,0,0.6451602311531389,0.1532232946664573,CAV2
1217,GO_Cellular_Component_2021,actin cytoskeleton (GO:0015629),2/316,0.8025691402331878,0.864305227943433,0,0,0.6640893763411561,0.1460580055545077,RDX;TWF1
1218,GO_Cellular_Component_2021,ficolin-1-rich granule (GO:0101002),1/184,0.8271172526694632,0.8791650096582411,0,0,0.570515056388792,0.1082887858066383,ASAH1
1219,GO_Cellular_Component_2021,lysosome (GO:0005764),3/477,0.8319751129016627,0.8791650096582411,0,0,0.6579896556417585,0.1210390072757124,ATP6V1A;ASAH1;VMA21
1220,GO_Cellular_Component_2021,late endosome (GO:0005770),1/189,0.835206759175329,0.8791650096582411,0,0,0.5552003168854686,0.0999782350545738,MAGI2
1221,GO_Cellular_Component_2021,integral component of organelle membrane (GO:0031301),1/214,0.870342074301622,0.9093126149419932,0,0,0.4894116471880931,0.0679640843815714,SARAF
1222,GO_Cellular_Component_2021,collagen-containing extracellular matrix (GO:0062023),2/380,0.8770711488015116,0.9095552654237896,0,0,0.5498401380754322,0.0721209706953381,DST;ERBIN
1223,GO_Cellular_Component_2021,integral component of plasma membrane (GO:0005887),10/1454,0.8879804692110236,0.9140975418348772,0,0,0.7105882170878535,0.0844218100012272,PTPRD;CHRM3;NTRK2;IGSF6;CAV2;SEMA6D;ADGRG6;CACNA1C;IFNAR1;KTN1
1224,GO_Cellular_Component_2021,lytic vacuole membrane (GO:0098852),1/267,0.9220914319005562,0.9406049349236196,0,0,0.3908374660054391,0.0317011760504582,ATP6V1A
1225,GO_Cellular_Component_2021,secretory granule membrane (GO:0030667),1/274,0.927167721567568,0.9406049349236196,0,0,0.3806796040838594,0.0287872963442835,ITPR2
1226,GO_Cellular_Component_2021,secretory granule lumen (GO:0034774),1/316,0.9514109856409294,0.9575517488853272,0,0,0.3292131036811888,0.0163978242819709,DNAJC3
1227,GO_Cellular_Component_2021,lysosomal membrane (GO:0005765),1/330,0.9575517488853272,0.9575517488853272,0,0,0.3149776886761948,0.0136623190045455,ATP6V1A
1228,GO_Molecular_Function_2021,ATPase binding (GO:0051117),4/73,0.005061730048437,0.2877270845926077,0,0,6.186290638464551,32.701022744651674,PPP3CA;USP25;PDE4D;RDX
1229,GO_Molecular_Function_2021,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",2/12,0.0055087461361039,0.2877270845926077,0,0,21.17754010695187,110.15324345880153,PDE4D;PDE4B
1230,GO_Molecular_Function_2021,cAMP binding (GO:0030552),2/12,0.0055087461361039,0.2877270845926077,0,0,21.17754010695187,110.15324345880153,PDE4D;PDE4B
1231,GO_Molecular_Function_2021,microtubule binding (GO:0008017),7/232,0.0066564906981674,0.2877270845926077,0,0,3.348034188034188,16.78089259620641,FAM161A;DST;MTUS1;SAXO2;MAPRE2;KIF27;MAP9
1232,GO_Molecular_Function_2021,protein kinase inhibitor activity (GO:0004860),3/43,0.0077663026307003,0.2877270845926077,0,0,7.972177419354839,38.72852762417323,DNAJC3;IBTK;TAOK3
1233,GO_Molecular_Function_2021,protein kinase C binding (GO:0005080),3/45,0.0088079719773247,0.2877270845926077,0,0,7.591781874039938,35.92505628620668,PARD6B;GRK5;ADAM9
1234,GO_Molecular_Function_2021,adrenergic receptor binding (GO:0031690),2/17,0.0110050718155102,0.3081420108342882,0,0,14.114795008912656,63.64924303911214,PDE4D;MAGI2
1235,GO_Molecular_Function_2021,microtubule plus-end binding (GO:0051010),2/20,0.0150924344910985,0.3515280491301022,0,0,11.760546642899584,49.31857782921134,DST;MAPRE2
1236,GO_Molecular_Function_2021,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",2/21,0.0165785435434317,0.3515280491301022,0,0,11.141007599211934,45.67418698737144,PDE4D;PDE4B
1237,GO_Molecular_Function_2021,cyclic nucleotide binding (GO:0030551),2/23,0.0197286150021996,0.3515280491301022,0,0,10.078940667175962,39.56674779525792,PDE4D;PDE4B
1238,GO_Molecular_Function_2021,cyclic-nucleotide phosphodiesterase activity (GO:0004112),2/23,0.0197286150021996,0.3515280491301022,0,0,10.078940667175962,39.56674779525792,PDE4D;PDE4B
1239,GO_Molecular_Function_2021,adenyl ribonucleotide binding (GO:0032559),7/306,0.0266198473608636,0.4075546218904586,0,0,2.5099048109081554,9.101161317090057,TBCK;SNRK;PDE4D;PDE4B;TWF1;TRNT1;CDC42BPA
1240,GO_Molecular_Function_2021,tubulin binding (GO:0015631),7/307,0.0270316841049793,0.4075546218904586,0,0,2.5014102564102565,9.031956116160146,FAM161A;DST;MTUS1;SAXO2;MAPRE2;KIF27;MAP9
1241,GO_Molecular_Function_2021,kinase inhibitor activity (GO:0019210),2/33,0.0387240393950717,0.4313832023178618,0,0,6.824219423839917,22.187548436146106,DNAJC3;TAOK3
1242,GO_Molecular_Function_2021,interferon receptor activity (GO:0004904),1/5,0.0463696956816514,0.4313832023178618,0,0,26.33909574468085,80.89023777113094,IFNAR1
1243,GO_Molecular_Function_2021,beta-2 adrenergic receptor binding (GO:0031698),1/5,0.0463696956816514,0.4313832023178618,0,0,26.33909574468085,80.89023777113094,PDE4D
1244,GO_Molecular_Function_2021,calmodulin-dependent protein phosphatase activity (GO:0033192),1/5,0.0463696956816514,0.4313832023178618,0,0,26.33909574468085,80.89023777113094,PPP3CA
1245,GO_Molecular_Function_2021,voltage-gated calcium channel activity involved in cardiac muscle cell action potential (GO:0086007),1/5,0.0463696956816514,0.4313832023178618,0,0,26.33909574468085,80.89023777113094,CACNA1C
1246,GO_Molecular_Function_2021,protein tyrosine kinase inhibitor activity (GO:0030292),1/5,0.0463696956816514,0.4313832023178618,0,0,26.33909574468085,80.89023777113094,IBTK
1247,GO_Molecular_Function_2021,phosphatidylinositol-3-phosphate binding (GO:0032266),2/39,0.0523948769550082,0.4313832023178618,0,0,5.71585489232548,16.855750053277294,SNX27;PLEKHA5
1248,GO_Molecular_Function_2021,BH domain binding (GO:0051400),1/6,0.0553837340579632,0.4313832023178618,0,0,21.070212765957447,60.96601457084486,BCL2
1249,GO_Molecular_Function_2021,BH3 domain binding (GO:0051434),1/6,0.0553837340579632,0.4313832023178618,0,0,21.070212765957447,60.96601457084486,BCL2
1250,GO_Molecular_Function_2021,S-methyltransferase activity (GO:0008172),1/7,0.0643130171482511,0.4313832023178618,0,0,17.55762411347518,48.17800160116977,MTR
1251,GO_Molecular_Function_2021,MutSalpha complex binding (GO:0032407),1/7,0.0643130171482511,0.4313832023178618,0,0,17.55762411347518,48.17800160116977,MCM9
1252,GO_Molecular_Function_2021,calcium-dependent protein serine/threonine phosphatase activity (GO:0004723),1/7,0.0643130171482511,0.4313832023178618,0,0,17.55762411347518,48.17800160116977,PPP3CA
1253,GO_Molecular_Function_2021,N-acylsphingosine amidohydrolase activity (GO:0017040),1/7,0.0643130171482511,0.4313832023178618,0,0,17.55762411347518,48.17800160116977,ASAH1
1254,GO_Molecular_Function_2021,peroxisome proliferator activated receptor binding (GO:0042975),1/7,0.0643130171482511,0.4313832023178618,0,0,17.55762411347518,48.17800160116977,TACC1
1255,GO_Molecular_Function_2021,G protein-coupled acetylcholine receptor activity (GO:0016907),1/7,0.0643130171482511,0.4313832023178618,0,0,17.55762411347518,48.17800160116977,CHRM3
1256,GO_Molecular_Function_2021,G protein-coupled neurotransmitter receptor activity (GO:0099528),1/7,0.0643130171482511,0.4313832023178618,0,0,17.55762411347518,48.17800160116977,CHRM3
1257,GO_Molecular_Function_2021,neurotrophin binding (GO:0043121),1/8,0.0731583372077776,0.4313832023178618,0,0,15.048632218844984,39.35411729295222,NTRK2
1258,GO_Molecular_Function_2021,poly(G) binding (GO:0034046),1/8,0.0731583372077776,0.4313832023178618,0,0,15.048632218844984,39.35411729295222,ATXN1
1259,GO_Molecular_Function_2021,pre-mRNA intronic binding (GO:0097157),1/8,0.0731583372077776,0.4313832023178618,0,0,15.048632218844984,39.35411729295222,RBM7
1260,GO_Molecular_Function_2021,small ribosomal subunit rRNA binding (GO:0070181),1/9,0.0819204792179246,0.4313832023178618,0,0,13.16688829787234,32.943637049750684,MRPS6
1261,GO_Molecular_Function_2021,glucocorticoid receptor binding (GO:0035259),1/9,0.0819204792179246,0.4313832023178618,0,0,13.16688829787234,32.943637049750684,TACC1
1262,GO_Molecular_Function_2021,protein tyrosine kinase activity (GO:0004713),3/108,0.0827512587982701,0.4313832023178618,0,0,3.027035330261137,7.5431179318007935,NTRK2;TWF1;HIPK3
1263,GO_Molecular_Function_2021,activin receptor binding (GO:0070697),1/10,0.0906002210285699,0.4313832023178618,0,0,11.703309692671397,28.103141488494085,MAGI2
1264,GO_Molecular_Function_2021,SUMO ligase activity (GO:0061665),1/10,0.0906002210285699,0.4313832023178618,0,0,11.703309692671397,28.103141488494085,PIAS2
1265,GO_Molecular_Function_2021,UDP-glucosyltransferase activity (GO:0035251),1/10,0.0906002210285699,0.4313832023178618,0,0,11.703309692671397,28.103141488494085,UGGT2
1266,GO_Molecular_Function_2021,high voltage-gated calcium channel activity (GO:0008331),1/10,0.0906002210285699,0.4313832023178618,0,0,11.703309692671397,28.103141488494085,CACNA1C
1267,GO_Molecular_Function_2021,"inositol 1,4,5 trisphosphate binding (GO:0070679)",1/11,0.0991983332467463,0.4313832023178618,0,0,10.532446808510638,24.33663040229913,ITPR2
1268,GO_Molecular_Function_2021,MAP kinase kinase kinase activity (GO:0004709),1/11,0.0991983332467463,0.4313832023178618,0,0,10.532446808510638,24.33663040229913,MAP3K7
1269,GO_Molecular_Function_2021,carbohydrate kinase activity (GO:0019200),1/11,0.0991983332467463,0.4313832023178618,0,0,10.532446808510638,24.33663040229913,POMK
1270,GO_Molecular_Function_2021,death domain binding (GO:0070513),1/11,0.0991983332467463,0.4313832023178618,0,0,10.532446808510638,24.33663040229913,BCL2
1271,GO_Molecular_Function_2021,retinoid X receptor binding (GO:0046965),1/11,0.0991983332467463,0.4313832023178618,0,0,10.532446808510638,24.33663040229913,TACC1
1272,GO_Molecular_Function_2021,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",2/57,0.1012369831995028,0.4313832023178618,0,0,3.841711229946524,8.798637201039348,ASAH1;GLS
1273,GO_Molecular_Function_2021,protease binding (GO:0002020),3/118,0.1012429964623553,0.4313832023178618,0,0,2.7624123422159887,6.326564442044565,NTRK2;BCL2;ATP9A
1274,GO_Molecular_Function_2021,protein serine/threonine kinase activity (GO:0004674),6/344,0.1085146709229214,0.4525292659764385,0,0,1.8889320011640316,4.19507222313983,SNRK;GRK5;TAOK3;CDC42BPA;MAP3K7;HIPK3
1275,GO_Molecular_Function_2021,SUMO binding (GO:0032183),1/13,0.1161527159532597,0.4685218707111744,0,0,8.776152482269504,18.893734929477525,USP25
1276,GO_Molecular_Function_2021,methylation-dependent protein binding (GO:0140034),2/63,0.1195208853855036,0.4685218707111744,0,0,3.462786008591216,7.355872176414121,PYGO1;ZMYND11
1277,GO_Molecular_Function_2021,PDZ domain binding (GO:0030165),2/63,0.1195208853855036,0.4685218707111744,0,0,3.462786008591216,7.355872176414121,GNG12;CXXC4
1278,GO_Molecular_Function_2021,ATP binding (GO:0005524),5/278,0.1241065132844496,0.4769583647794535,0,0,1.944776238254499,4.057999472617365,TBCK;SNRK;TWF1;TRNT1;CDC42BPA
1279,GO_Molecular_Function_2021,methylated histone binding (GO:0035064),2/68,0.1353272355376895,0.4830083478158912,0,0,3.199643493761141,6.399477259656181,PYGO1;ZMYND11
1280,GO_Molecular_Function_2021,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",1/16,0.1409909273153888,0.4830083478158912,0,0,7.019858156028369,13.752321465591514,ATP6V1A
1281,GO_Molecular_Function_2021,transmembrane receptor protein phosphatase activity (GO:0019198),1/16,0.1409909273153888,0.4830083478158912,0,0,7.019858156028369,13.752321465591514,PTPRD
1282,GO_Molecular_Function_2021,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),1/16,0.1409909273153888,0.4830083478158912,0,0,7.019858156028369,13.752321465591514,PTPRD
1283,GO_Molecular_Function_2021,phosphatidylinositol-5-phosphate binding (GO:0010314),1/16,0.1409909273153888,0.4830083478158912,0,0,7.019858156028369,13.752321465591514,PLEKHA5
1284,GO_Molecular_Function_2021,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",1/16,0.1409909273153888,0.4830083478158912,0,0,7.019858156028369,13.752321465591514,ATP6V1A
1285,GO_Molecular_Function_2021,kinase binding (GO:0019900),7/461,0.1476953422983655,0.4830083478158912,0,0,1.6398678414096917,3.1364171777076955,MOB1B;DNAJC3;IBTK;CAV2;WWC2;TAX1BP1;TRIM22
1286,GO_Molecular_Function_2021,calcium-release channel activity (GO:0015278),1/17,0.1491150502899167,0.4830083478158912,0,0,6.580784574468085,12.52347733311014,ITPR2
1287,GO_Molecular_Function_2021,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",1/18,0.157162741797235,0.4830083478158912,0,0,6.193366708385482,11.46066058904648,PECR
1288,GO_Molecular_Function_2021,retinoic acid receptor binding (GO:0042974),1/18,0.157162741797235,0.4830083478158912,0,0,6.193366708385482,11.46066058904648,TACC1
1289,GO_Molecular_Function_2021,SUMO transferase activity (GO:0019789),1/19,0.1651347170981347,0.4830083478158912,0,0,5.848995271867612,10.534003466039604,PIAS2
1290,GO_Molecular_Function_2021,phosphatidic acid binding (GO:0070300),1/19,0.1651347170981347,0.4830083478158912,0,0,5.848995271867612,10.534003466039604,RAPGEF6
1291,GO_Molecular_Function_2021,transcription coactivator binding (GO:0001223),1/20,0.1730316847300859,0.4830083478158912,0,0,5.5408734602463605,9.720246555313304,THRB
1292,GO_Molecular_Function_2021,ubiquitin-like protein-specific protease activity (GO:0019783),1/20,0.1730316847300859,0.4830083478158912,0,0,5.5408734602463605,9.720246555313304,USP25
1293,GO_Molecular_Function_2021,actinin binding (GO:0042805),1/21,0.1808543467278663,0.4830083478158912,0,0,5.263563829787234,9.001027258222347,CACNA1C
1294,GO_Molecular_Function_2021,acetylcholine receptor activity (GO:0015464),1/22,0.188603398542744,0.4830083478158912,0,0,5.012664640324215,8.361670444603366,CHRM3
1295,GO_Molecular_Function_2021,syntaxin-1 binding (GO:0017075),1/22,0.188603398542744,0.4830083478158912,0,0,5.012664640324215,8.361670444603366,STXBP3
1296,GO_Molecular_Function_2021,mannosyltransferase activity (GO:0000030),1/22,0.188603398542744,0.4830083478158912,0,0,5.012664640324215,8.361670444603366,TMTC3
1297,GO_Molecular_Function_2021,poly(U) RNA binding (GO:0008266),1/22,0.188603398542744,0.4830083478158912,0,0,5.012664640324215,8.361670444603366,ATXN1
1298,GO_Molecular_Function_2021,semaphorin receptor binding (GO:0030215),1/23,0.1962795291870694,0.4830083478158912,0,0,4.784574468085107,7.790318149286441,SEMA6D
1299,GO_Molecular_Function_2021,carboxy-lyase activity (GO:0016831),1/23,0.1962795291870694,0.4830083478158912,0,0,4.784574468085107,7.790318149286441,CSAD
1300,GO_Molecular_Function_2021,phosphatase inhibitor activity (GO:0019212),1/23,0.1962795291870694,0.4830083478158912,0,0,4.784574468085107,7.790318149286441,STYX
1301,GO_Molecular_Function_2021,DNA replication origin binding (GO:0003688),1/23,0.1962795291870694,0.4830083478158912,0,0,4.784574468085107,7.790318149286441,MCM9
1302,GO_Molecular_Function_2021,phosphatidylinositol phospholipase C activity (GO:0004435),1/23,0.1962795291870694,0.4830083478158912,0,0,4.784574468085107,7.790318149286441,CHRM3
1303,GO_Molecular_Function_2021,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),1/23,0.1962795291870694,0.4830083478158912,0,0,4.784574468085107,7.790318149286441,ATP6V1A
1304,GO_Molecular_Function_2021,protein kinase binding (GO:0019901),7/506,0.2036208205927908,0.4830083478158912,0,0,1.4885154925235085,2.3689660612422205,DNAJC3;PARD6B;IBTK;GRK5;CAV2;ADAM9;TRIM22
1305,GO_Molecular_Function_2021,alpha-actinin binding (GO:0051393),1/24,0.203883421235608,0.4830083478158912,0,0,4.57631822386679,7.277292875760221,CACNA1C
1306,GO_Molecular_Function_2021,methyl-CpG binding (GO:0008327),1/24,0.203883421235608,0.4830083478158912,0,0,4.57631822386679,7.277292875760221,CXXC4
1307,GO_Molecular_Function_2021,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",1/24,0.203883421235608,0.4830083478158912,0,0,4.57631822386679,7.277292875760221,PLEKHA5
1308,GO_Molecular_Function_2021,actin monomer binding (GO:0003785),1/25,0.2114157508984971,0.4830083478158912,0,0,4.385416666666667,6.814624823124887,TWF1
1309,GO_Molecular_Function_2021,chemorepellent activity (GO:0045499),1/25,0.2114157508984971,0.4830083478158912,0,0,4.385416666666667,6.814624823124887,SEMA6D
1310,GO_Molecular_Function_2021,phospholipase C activity (GO:0004629),1/25,0.2114157508984971,0.4830083478158912,0,0,4.385416666666667,6.814624823124887,CHRM3
1311,GO_Molecular_Function_2021,poly-pyrimidine tract binding (GO:0008187),1/25,0.2114157508984971,0.4830083478158912,0,0,4.385416666666667,6.814624823124887,ATXN1
1312,GO_Molecular_Function_2021,protein-cysteine S-palmitoyltransferase activity (GO:0019706),1/25,0.2114157508984971,0.4830083478158912,0,0,4.385416666666667,6.814624823124887,ZDHHC17
1313,GO_Molecular_Function_2021,GTPase activator activity (GO:0005096),5/336,0.2130240873914594,0.4830083478158912,0,0,1.5992381452778142,2.4729819592395383,TBCK;RABGAP1L;DENND5B;ELMOD1;RAPGEF6
1314,GO_Molecular_Function_2021,phosphatidylinositol binding (GO:0035091),2/92,0.2159926444446865,0.4830083478158912,0,0,2.3435531788472965,3.591520850779919,SNX27;ITPR2
1315,GO_Molecular_Function_2021,phosphatidylinositol-4-phosphate binding (GO:0070273),1/26,0.2188771881168769,0.4830083478158912,0,0,4.209787234042553,6.395696064943001,PLEKHA5
1316,GO_Molecular_Function_2021,phosphatidylinositol bisphosphate binding (GO:1902936),2/94,0.2229358450352153,0.4830083478158912,0,0,2.2923738665426643,3.4405580061036805,PLEKHA5;TWF1
1317,GO_Molecular_Function_2021,metal ion transmembrane transporter activity (GO:0046873),1/27,0.2262683966074298,0.4830083478158912,0,0,4.047667757774141,6.01496943456091,ITPR2
1318,GO_Molecular_Function_2021,thyroid hormone receptor binding (GO:0046966),1/28,0.2335900338821068,0.4830083478158912,0,0,3.897557131599685,5.667779610083707,TACC1
1319,GO_Molecular_Function_2021,poly-purine tract binding (GO:0070717),1/28,0.2335900338821068,0.4830083478158912,0,0,3.897557131599685,5.667779610083707,ATXN1
1320,GO_Molecular_Function_2021,protein kinase regulator activity (GO:0019887),2/98,0.236871595914967,0.4830083478158912,0,0,2.1964126559714794,3.163354937056446,DNAJC3;TAOK3
1321,GO_Molecular_Function_2021,mRNA binding (GO:0003729),4/263,0.2380244564050637,0.4830083478158912,0,0,1.632223729521027,2.3428643207138,NOVA1;EIF4G3;CPEB4;PTBP3
1322,GO_Molecular_Function_2021,ubiquitin conjugating enzyme binding (GO:0031624),1/29,0.2408427513052744,0.4830083478158912,0,0,3.7581686930091194,5.350170451555993,RNF19A
1323,GO_Molecular_Function_2021,palmitoyltransferase activity (GO:0016409),1/29,0.2408427513052744,0.4830083478158912,0,0,3.7581686930091194,5.350170451555993,ZDHHC17
1324,GO_Molecular_Function_2021,pre-mRNA binding (GO:0036002),1/29,0.2408427513052744,0.4830083478158912,0,0,3.7581686930091194,5.350170451555993,RBM7
1325,GO_Molecular_Function_2021,phosphatidylinositol phosphate binding (GO:1901981),2/102,0.2508530547945053,0.4830083478158912,0,0,2.108128342245989,2.915305282288427,SNX27;PLEKHA5
1326,GO_Molecular_Function_2021,ubiquitin-like protein ligase activity (GO:0061659),4/270,0.2523436249383023,0.4830083478158912,0,0,1.5887014834383255,2.18758400162614,RNF19A;WWP1;PIAS2;TRIM22
1327,GO_Molecular_Function_2021,kinase activator activity (GO:0019209),1/31,0.2551440019839143,0.4830083478158912,0,0,3.5072695035460995,4.790674740907671,MOB1B
1328,GO_Molecular_Function_2021,RNA binding (GO:0003723),16/1406,0.2556076000990446,0.4830083478158912,0,0,1.22566640329355,1.671946031264489,PNISR;CPSF2;RDX;TRNT1;IFIT3;KTN1;PTBP3;NOVA1;PRPF3;SREK1;RBM7;EIF4G3;DZIP3;CPEB4;TNRC6B;RBM6
1329,GO_Molecular_Function_2021,RNA polymerase II complex binding (GO:0000993),1/32,0.2621938079021275,0.4830083478158912,0,0,3.393960192175704,4.543397183606022,RPRD2
1330,GO_Molecular_Function_2021,thiol-dependent deubiquitinase (GO:0004843),2/106,0.2648575895752122,0.4830083478158912,0,0,2.026635129576306,2.692512438079982,USP25;USP53
1331,GO_Molecular_Function_2021,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),3/190,0.2676333724597379,0.4830083478158912,0,0,1.6925996204933589,2.231078606172439,TACC1;PIAS2;NFE2L2
1332,GO_Molecular_Function_2021,RNA polymerase core enzyme binding (GO:0043175),1/33,0.2691772395184866,0.4830083478158912,0,0,3.287732712765957,4.31477186353451,RPRD2
1333,GO_Molecular_Function_2021,serotonin receptor activity (GO:0099589),1/33,0.2691772395184866,0.4830083478158912,0,0,3.287732712765957,4.31477186353451,CHRM3
1334,GO_Molecular_Function_2021,basal RNA polymerase II transcription machinery binding (GO:0001099),1/33,0.2691772395184866,0.4830083478158912,0,0,3.287732712765957,4.31477186353451,RPRD2
1335,GO_Molecular_Function_2021,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",1/33,0.2691772395184866,0.4830083478158912,0,0,3.287732712765957,4.31477186353451,DIS3L
1336,GO_Molecular_Function_2021,G protein-coupled serotonin receptor activity (GO:0004993),1/33,0.2691772395184866,0.4830083478158912,0,0,3.287732712765957,4.31477186353451,CHRM3
1337,GO_Molecular_Function_2021,3'-5'-exoribonuclease activity (GO:0000175),1/34,0.2760949183840337,0.4830083478158912,0,0,3.1879432624113475,4.102916659978313,DIS3L
1338,GO_Molecular_Function_2021,ubiquitin conjugating enzyme activity (GO:0061631),1/35,0.2829474603528049,0.4830083478158912,0,0,3.094023779724656,3.906186615672604,AKTIP
1339,GO_Molecular_Function_2021,ubiquitin-like protein conjugating enzyme binding (GO:0044390),1/35,0.2829474603528049,0.4830083478158912,0,0,3.094023779724656,3.906186615672604,RNF19A
1340,GO_Molecular_Function_2021,"catalytic activity, acting on a tRNA (GO:0140101)",1/35,0.2829474603528049,0.4830083478158912,0,0,3.094023779724656,3.906186615672604,DUS4L
1341,GO_Molecular_Function_2021,estrogen receptor binding (GO:0030331),1/35,0.2829474603528049,0.4830083478158912,0,0,3.094023779724656,3.906186615672604,TACC1
1342,GO_Molecular_Function_2021,kinase activity (GO:0016301),2/112,0.2858620834012417,0.4830083478158912,0,0,1.9155080213903743,2.3986868944594413,POMK;NEK1
1343,GO_Molecular_Function_2021,deubiquitinase activity (GO:0101005),2/112,0.2858620834012417,0.4830083478158912,0,0,1.9155080213903743,2.3986868944594413,USP25;USP53
1344,GO_Molecular_Function_2021,omega peptidase activity (GO:0008242),2/113,0.2893586701205943,0.4847376012276623,0,0,1.89815483933131,2.353879583703657,USP25;USP53
1345,GO_Molecular_Function_2021,phosphatase binding (GO:0019902),2/114,0.29285330395136,0.4864343014785302,0,0,1.8811115355233,2.310161971561719,MAGI2;DZIP3
1346,GO_Molecular_Function_2021,voltage-gated calcium channel activity (GO:0005245),1/37,0.2964595682571994,0.4882863477177402,0,0,2.921838061465721,3.5525005418174813,CACNA1C
1347,GO_Molecular_Function_2021,ubiquitin-like protein conjugating enzyme activity (GO:0061650),1/38,0.3031203373806736,0.4921971921619358,0,0,2.842725704427832,3.393149603893526,AKTIP
1348,GO_Molecular_Function_2021,signaling receptor complex adaptor activity (GO:0030159),1/39,0.3097183761096093,0.4921971921619358,0,0,2.767777155655095,3.244089070477027,MAGI2
1349,GO_Molecular_Function_2021,G protein-coupled amine receptor activity (GO:0008227),1/39,0.3097183761096093,0.4921971921619358,0,0,2.767777155655095,3.244089070477027,CHRM3
1350,GO_Molecular_Function_2021,hexosyltransferase activity (GO:0016758),2/119,0.3102877703355498,0.4921971921619358,0,0,1.8002650943827414,2.1067694453079877,MGAT4A;TMTC3
1351,GO_Molecular_Function_2021,ubiquitin-protein transferase activity (GO:0004842),5/392,0.3127607863968769,0.4921971921619358,0,0,1.3638916975620716,1.5852740170767807,RNF19A;AKTIP;WWP1;DZIP3;TRIM22
1352,GO_Molecular_Function_2021,DNA-binding transcription factor binding (GO:0140297),3/208,0.3139012705114386,0.4921971921619358,0,0,1.5425649095200629,1.7873341232354878,BCL2;PIAS2;NFE2L2
1353,GO_Molecular_Function_2021,translation initiation factor activity (GO:0003743),1/41,0.3227286075001341,0.502022278333542,0,0,2.629122340425532,2.973388909431432,EIF4G3
1354,GO_Molecular_Function_2021,rRNA binding (GO:0019843),1/42,0.3291419591356655,0.5079671180361451,0,0,2.564867669953295,2.850250581210622,MRPS6
1355,GO_Molecular_Function_2021,snRNA binding (GO:0017069),1/43,0.335494898412378,0.5137265631939539,0,0,2.5036727456940224,2.73438250533161,RBM7
1356,GO_Molecular_Function_2021,single-stranded RNA binding (GO:0003727),1/45,0.3480217988046306,0.5287773067109117,0,0,2.389627659574468,2.522228482958168,RBM7
1357,GO_Molecular_Function_2021,channel activity (GO:0015267),1/46,0.3541968763481647,0.5299434180476359,0,0,2.3364066193853428,2.424961973536866,BCL2
1358,GO_Molecular_Function_2021,chemokine activity (GO:0008009),1/46,0.3541968763481647,0.5299434180476359,0,0,2.3364066193853428,2.424961973536866,CXCL16
1359,GO_Molecular_Function_2021,cadherin binding (GO:0045296),4/322,0.3624781159304674,0.5319193735674786,0,0,1.3253782083970764,1.3449821112168396,RDX;TWF1;CDH8;KTN1
1360,GO_Molecular_Function_2021,ribosome binding (GO:0043022),1/48,0.3663730379163756,0.5319193735674786,0,0,2.2367587143503846,2.245936661804606,CPEB4
1361,GO_Molecular_Function_2021,3'-5' exonuclease activity (GO:0008408),1/48,0.3663730379163756,0.5319193735674786,0,0,2.2367587143503846,2.245936661804606,DIS3L
1362,GO_Molecular_Function_2021,acetylglucosaminyltransferase activity (GO:0008375),1/48,0.3663730379163756,0.5319193735674786,0,0,2.2367587143503846,2.245936661804606,MGAT4A
1363,GO_Molecular_Function_2021,tRNA binding (GO:0000049),1/49,0.3723752074302826,0.5366583871789367,0,0,2.1900487588652484,2.1634469174820667,TRNT1
1364,GO_Molecular_Function_2021,chemokine receptor binding (GO:0042379),1/50,0.3783208179838206,0.5373508367964218,0,0,2.1452453321754232,2.085205747179162,CXCL16
1365,GO_Molecular_Function_2021,GTPase regulator activity (GO:0030695),3/233,0.3783388544791133,0.5373508367964218,0,0,1.373141654978962,1.3346456897924204,TBCK;RABGAP1L;ELMOD1
1366,GO_Molecular_Function_2021,polyubiquitin modification-dependent protein binding (GO:0031593),1/51,0.3842103997133104,0.5417643046317183,0,0,2.102234042553192,2.0109234239301528,DZIP3
1367,GO_Molecular_Function_2021,transcription coregulator binding (GO:0001221),1/53,0.3958235725596017,0.5502228384516449,0,0,2.0211743044189854,1.873197445207917,THRB
1368,GO_Molecular_Function_2021,nuclear receptor coactivator activity (GO:0030374),1/53,0.3958235725596017,0.5502228384516449,0,0,2.0211743044189854,1.873197445207917,TACC1
1369,GO_Molecular_Function_2021,magnesium ion binding (GO:0000287),2/146,0.4022363873589808,0.5542183093537572,0,0,1.4607100415923946,1.3302910347612389,SNRK;CDC42BPA
1370,GO_Molecular_Function_2021,calcium ion transmembrane transporter activity (GO:0015085),1/55,0.4072188691837333,0.5542183093537572,0,0,1.9461189913317571,1.748402012562394,ITPR2
1371,GO_Molecular_Function_2021,guanyl-nucleotide exchange factor activity (GO:0005085),2/149,0.4121248549131044,0.5542183093537572,0,0,1.4306813634544726,1.26819734965734,DENND5B;RAPGEF6
1372,GO_Molecular_Function_2021,microtubule motor activity (GO:0003777),1/56,0.4128360875798395,0.5542183093537572,0,0,1.9106382978723404,1.6903505811944235,KIF27
1373,GO_Molecular_Function_2021,receptor tyrosine kinase binding (GO:0030971),1/56,0.4128360875798395,0.5542183093537572,0,0,1.9106382978723404,1.6903505811944235,MAP3K7
1374,GO_Molecular_Function_2021,transmembrane receptor protein kinase activity (GO:0019199),1/60,0.4347804016993901,0.5743891685862014,0,0,1.7807428777497296,1.4832060277160146,NTRK2
1375,GO_Molecular_Function_2021,transmembrane receptor protein tyrosine kinase activity (GO:0004714),1/60,0.4347804016993901,0.5743891685862014,0,0,1.7807428777497296,1.4832060277160146,NTRK2
1376,GO_Molecular_Function_2021,purine ribonucleoside triphosphate binding (GO:0035639),5/460,0.4397025569275276,0.5743891685862014,0,0,1.1559961777353085,0.9498321059319028,TBCK;SNRK;TWF1;TRNT1;CDC42BPA
1377,GO_Molecular_Function_2021,SH3 domain binding (GO:0017124),1/62,0.4454446613525643,0.5743891685862014,0,0,1.7221834670387164,1.3926992126250894,ADAM9
1378,GO_Molecular_Function_2021,syntaxin binding (GO:0019905),1/62,0.4454446613525643,0.5743891685862014,0,0,1.7221834670387164,1.3926992126250894,STXBP3
1379,GO_Molecular_Function_2021,protein serine/threonine phosphatase activity (GO:0004722),1/62,0.4454446613525643,0.5743891685862014,0,0,1.7221834670387164,1.3926992126250894,PPP3CA
1380,GO_Molecular_Function_2021,ubiquitin protein ligase activity (GO:0061630),3/263,0.4538286456418614,0.5813752584693126,0,0,1.2128411910669976,0.9581876995247076,RNF19A;WWP1;TRIM22
1381,GO_Molecular_Function_2021,motor activity (GO:0003774),1/66,0.4661764276660525,0.5933154533931578,0,0,1.6158756137479542,1.233221913564407,KIF27
1382,GO_Molecular_Function_2021,small GTPase binding (GO:0031267),2/175,0.4941369228722759,0.6170938205024559,0,0,1.2140582980433372,0.8558414476449981,RABGAP1L;RAPGEF6
1383,GO_Molecular_Function_2021,protein tyrosine kinase binding (GO:1990782),1/72,0.4958372214681416,0.6170938205024559,0,0,1.4788732394366195,1.0374408001084885,MAP3K7
1384,GO_Molecular_Function_2021,actin binding (GO:0003779),2/177,0.500145568895374,0.6170938205024559,0,0,1.200061115355233,0.8314696463156648,RDX;TWF1
1385,GO_Molecular_Function_2021,DNA binding (GO:0003677),8/811,0.5016572263676788,0.6170938205024559,0,0,1.0462423370922576,0.7217379394933845,THRB;MCM9;TSHZ2;BCL2;ZMYND11;SMARCA2;NFE2L2;RBM6
1386,GO_Molecular_Function_2021,ubiquitin binding (GO:0043130),1/74,0.5053551915734217,0.6170938205024559,0,0,1.4382104342757214,0.9815696286816826,USP25
1387,GO_Molecular_Function_2021,protein tyrosine phosphatase activity (GO:0004725),1/74,0.5053551915734217,0.6170938205024559,0,0,1.4382104342757214,0.9815696286816826,PTPRD
1388,GO_Molecular_Function_2021,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",1/75,0.510046933272438,0.6170938205024559,0,0,1.4187032777458308,0.95514557315215,TWF1
1389,GO_Molecular_Function_2021,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",1/75,0.510046933272438,0.6170938205024559,0,0,1.4187032777458308,0.95514557315215,POMK
1390,GO_Molecular_Function_2021,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",1/76,0.5146944064870527,0.6188963415427136,0,0,1.3997163120567375,0.929666295456086,ZDHHC17
1391,GO_Molecular_Function_2021,protein heterodimerization activity (GO:0046982),2/188,0.5323668699272142,0.6362433323520365,0,0,1.12845724800184,0.7114047516147257,BCL2;NPAS3
1392,GO_Molecular_Function_2021,metalloendopeptidase activity (GO:0004222),1/82,0.5416726071913932,0.6400000648078514,0,0,1.2956396112424482,0.794348231541045,ADAM9
1393,GO_Molecular_Function_2021,metal ion binding (GO:0046872),5/517,0.5420408712148129,0.6400000648078514,0,0,1.0242760699728262,0.6272808742549616,PPP3CA;SNRK;ITPR2;CDC42BPA;CDH8
1394,GO_Molecular_Function_2021,calcium channel activity (GO:0005262),1/84,0.5503295826703843,0.6420511797821151,0,0,1.2642912073827224,0.7550826750058026,CACNA1C
1395,GO_Molecular_Function_2021,UDP-glycosyltransferase activity (GO:0008194),1/84,0.5503295826703843,0.6420511797821151,0,0,1.2642912073827224,0.7550826750058026,MGAT4A
1396,GO_Molecular_Function_2021,mRNA 3'-UTR binding (GO:0003730),1/85,0.5545968791911786,0.6432011143282308,0,0,1.249176798378926,0.7364069274950137,CPEB4
1397,GO_Molecular_Function_2021,cytokine receptor activity (GO:0004896),1/88,0.5671585753182062,0.6517190914538319,0,0,1.2059183174370265,0.6838959826123543,IFNAR1
1398,GO_Molecular_Function_2021,GTPase binding (GO:0051020),2/201,0.5685916563194146,0.6517190914538319,0,0,1.0540402547496843,0.595103490203929,RABGAP1L;RAPGEF6
1399,GO_Molecular_Function_2021,transcription regulatory region nucleic acid binding (GO:0001067),2/212,0.5976375765906913,0.6789800483463478,0,0,0.9982683982683984,0.5138793900193189,SMARCA2;NFE2L2
1400,GO_Molecular_Function_2021,single-stranded DNA binding (GO:0003697),1/97,0.6027680021033904,0.6789800483463478,0,0,1.092364804964539,0.5529800747843862,MCM9
1401,GO_Molecular_Function_2021,voltage-gated cation channel activity (GO:0022843),1/97,0.6027680021033904,0.6789800483463478,0,0,1.092364804964539,0.5529800747843862,CACNA1C
1402,GO_Molecular_Function_2021,cysteine-type peptidase activity (GO:0008234),1/98,0.6065401271846599,0.6793249424468192,0,0,1.0810484755428822,0.5405073635769386,USP25
1403,GO_Molecular_Function_2021,cysteine-type endopeptidase activity (GO:0004197),1/105,0.6319658223338088,0.703780120326287,0,0,1.0079275777414076,0.4625580885820212,USP25
1404,GO_Molecular_Function_2021,calcium ion binding (GO:0005509),3/348,0.6417866369870864,0.710678987850107,0,0,0.9100514258999532,0.403607235575238,PPP3CA;ITPR2;CDH8
1405,GO_Molecular_Function_2021,nuclear receptor binding (GO:0016922),1/120,0.6810780389255715,0.7490813740886627,0,0,0.8802074021097801,0.3380686372858019,TACC1
1406,GO_Molecular_Function_2021,metallopeptidase activity (GO:0008237),1/121,0.6841100304177073,0.7490813740886627,0,0,0.8728280141843971,0.331357382106564,ADAM9
1407,GO_Molecular_Function_2021,ubiquitin protein ligase binding (GO:0031625),2/265,0.7170784682092283,0.7808187764944929,0,0,0.7949411358044773,0.2643735773090668,USP25;BCL2
1408,GO_Molecular_Function_2021,ubiquitin-like protein ligase binding (GO:0044389),2/282,0.7485464482210488,0.8105806842614671,0,0,0.7460275019098549,0.216065993553022,USP25;BCL2
1409,GO_Molecular_Function_2021,transcription cis-regulatory region binding (GO:0000976),4/549,0.7656749221788581,0.8245729931156933,0,0,0.7643342424993801,0.2040753952721754,SMARCA2;ZNF674;NPAS3;NFE2L2
1410,GO_Molecular_Function_2021,endopeptidase activity (GO:0004175),2/315,0.8011384745261967,0.8580499508586588,0,0,0.6662452375664178,0.1477208733163962,USP25;ADAM9
1411,GO_Molecular_Function_2021,cytokine activity (GO:0005125),1/173,0.8079032118314192,0.8605925517334684,0,0,0.6073416625432954,0.1295538811561102,CXCL16
1412,GO_Molecular_Function_2021,zinc ion binding (GO:0008270),2/336,0.8293300404163929,0.8786415563330433,0,0,0.6236831150533159,0.1167142397144369,ZMYND11;CXXC4
1413,GO_Molecular_Function_2021,protein homodimerization activity (GO:0042803),4/636,0.8552450931940356,0.9012260121829624,0,0,0.6561409510776599,0.1025989183502663,NTRK2;CAV2;BCL2;TRIM22
1414,GO_Molecular_Function_2021,sequence-specific DNA binding (GO:0043565),4/707,0.905168465221152,0.9466742461043504,0,0,0.5876898235361963,0.0585540072910333,THRB;BCL2;CXXC4;NFE2L2
1415,GO_Molecular_Function_2021,sequence-specific double-stranded DNA binding (GO:1990837),4/712,0.908034480957234,0.9466742461043504,0,0,0.5833867766071156,0.0562810296086474,THRB;MCM9;SMARCA2;NFE2L2
1416,GO_Molecular_Function_2021,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",1/256,0.913394323328426,0.94722374271096,0,0,0.4079265748852733,0.0369530865929276,ZNF674
1417,GO_Molecular_Function_2021,transition metal ion binding (GO:0046914),2/445,0.9255275503367728,0.9547547361368816,0,0,0.4675945485930879,0.0361877870943216,ZMYND11;CXXC4
1418,GO_Molecular_Function_2021,G protein-coupled receptor activity (GO:0004930),1/283,0.9332137662632704,0.9576434460083822,0,0,0.3683604949449223,0.0254614410813045,ADGRG6
1419,GO_Molecular_Function_2021,receptor ligand activity (GO:0048018),1/307,0.9470046304656384,0.9629143340448048,0,0,0.3390522875816993,0.0184618365359461,SEMA6D
1420,GO_Molecular_Function_2021,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),8/1359,0.9481758493400372,0.9629143340448048,0,0,0.603931607853401,0.0321384009937233,THRB;ZNF382;ZNF546;ZNF136;ZNF334;ZNF674;NPAS3;NFE2L2
1421,GO_Molecular_Function_2021,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),6/1149,0.9638480595797768,0.9687908701417244,0,0,0.5354904407440874,0.0197176208842229,THRB;ZNF382;ZNF546;ZNF136;ZNF334;NFE2L2
1422,GO_Molecular_Function_2021,cis-regulatory region sequence-specific DNA binding (GO:0000987),6/1149,0.9638480595797768,0.9687908701417244,0,0,0.5354904407440874,0.0197176208842229,THRB;ZNF382;ZNF546;ZNF136;ZNF334;NFE2L2
1423,GO_Molecular_Function_2021,double-stranded DNA binding (GO:0003690),2/651,0.9861550523594648,0.9861550523594648,0,0,0.3157799329284873,0.0044025036684427,THRB;ZMYND11
1424,KEGG_2021_Human,Cholinergic synapse,5/113,0.0044067450533395,0.3933905852448158,0,0,4.957477858293076,26.892428310425863,CHRM3;BCL2;ITPR2;CACNA1C;GNG12
1425,KEGG_2021_Human,Glutamatergic synapse,5/114,0.0045743091307536,0.3933905852448158,0,0,4.911747108097328,26.46105323728204,PPP3CA;ITPR2;CACNA1C;GNG12;GLS
1426,KEGG_2021_Human,NOD-like receptor signaling pathway,6/181,0.0075700601737608,0.4340167832956209,0,0,3.6788758782201407,17.96598997660943,NAMPT;BCL2;ERBIN;ITPR2;MAP3K7;IFNAR1
1427,KEGG_2021_Human,Morphine addiction,4/91,0.0109065110526377,0.4689799752634253,0,0,4.901894998446722,22.14869943877665,GRK5;PDE4D;PDE4B;GNG12
1428,KEGG_2021_Human,One carbon pool by folate,2/20,0.0150924344910985,0.5191797464937898,0,0,11.760546642899584,49.31857782921134,MTHFD2L;MTR
1429,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",4/106,0.0181907985252171,0.5214695577228912,0,0,4.177848436671966,16.739967674335094,PDE4D;BCL2;PDE4B;ITPR2
1430,KEGG_2021_Human,Long-term potentiation,3/67,0.0255844142914928,0.5934895856982769,0,0,4.9765625,18.242943118595804,PPP3CA;ITPR2;CACNA1C
1431,KEGG_2021_Human,Renin secretion,3/69,0.027604166776664,0.5934895856982769,0,0,4.825268817204301,17.321694738535985,PPP3CA;ITPR2;CACNA1C
1432,KEGG_2021_Human,Dopaminergic synapse,4/132,0.0367191957021067,0.6640795869213381,0,0,3.324831081081081,10.98675674147827,PPP3CA;ITPR2;CACNA1C;GNG12
1433,KEGG_2021_Human,Fluid shear stress and atherosclerosis,4/139,0.0430522296645031,0.6640795869213381,0,0,3.151311311311311,9.911949481151266,CAV2;BCL2;MAP3K7;NFE2L2
1434,KEGG_2021_Human,D-Glutamine and D-glutamate metabolism,1/5,0.0463696956816514,0.6640795869213381,0,0,26.33909574468085,80.89023777113094,GLS
1435,KEGG_2021_Human,Human immunodeficiency virus 1 infection,5/212,0.0511435170148511,0.6640795869213381,0,0,2.573513967653854,7.651364661622833,PPP3CA;BCL2;ITPR2;GNG12;MAP3K7
1436,KEGG_2021_Human,GABAergic synapse,3/89,0.0522690785665264,0.6640795869213381,0,0,3.699362340585146,10.918114208280244,CACNA1C;GNG12;GLS
1437,KEGG_2021_Human,MAPK signaling pathway,6/294,0.0609238600538665,0.6640795869213381,0,0,2.222563752276867,6.219023179608074,PPP3CA;NTRK2;TAOK3;CACNA1C;GNG12;MAP3K7
1438,KEGG_2021_Human,Calcium signaling pathway,5/240,0.0779185966202023,0.6640795869213381,0,0,2.263644773358002,5.777026616484846,CHRM3;PPP3CA;NTRK2;ITPR2;CACNA1C
1439,KEGG_2021_Human,Protein processing in endoplasmic reticulum,4/171,0.0792727854286005,0.6640795869213381,0,0,2.543324162485839,6.446971689234909,DNAJC3;BCL2;UGGT2;NFE2L2
1440,KEGG_2021_Human,Serotonergic synapse,3/113,0.0918015193628852,0.6640795869213381,0,0,2.888709677419355,6.898603931260273,ITPR2;CACNA1C;GNG12
1441,KEGG_2021_Human,Hedgehog signaling pathway,2/56,0.0982717803756786,0.6640795869213381,0,0,3.9130520895226777,9.07835272884671,BCL2;EFCAB7
1442,KEGG_2021_Human,Taurine and hypotaurine metabolism,1/11,0.0991983332467463,0.6640795869213381,0,0,10.532446808510638,24.33663040229913,CSAD
1443,KEGG_2021_Human,Herpes simplex virus 1 infection,8/498,0.1008646043541159,0.6640795869213381,0,0,1.7427894914872026,3.997917636748944,ZNF382;BCL2;ZNF546;MAP3K7;ZNF136;ZNF334;ZNF674;IFNAR1
1444,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,4/193,0.1107165269769335,0.6640795869213381,0,0,2.2447590447590446,4.940225648488715,PPP3CA;ITPR2;GNG12;IFNAR1
1445,KEGG_2021_Human,Prion disease,5/273,0.1174190985798078,0.6640795869213381,0,0,1.9815663530175207,4.244526433521899,PPP3CA;CAV2;ITPR2;CACNA1C;COX6B2
1446,KEGG_2021_Human,Osteoclast differentiation,3/127,0.1191570091705562,0.6640795869213381,0,0,2.560744016649324,5.44750467833456,PPP3CA;MAP3K7;IFNAR1
1447,KEGG_2021_Human,PI3K-Akt signaling pathway,6/354,0.1198324296199451,0.6640795869213381,0,0,1.8337101940832865,3.8905112792805294,NTRK2;MAGI2;BCL2;ITGB8;GNG12;IFNAR1
1448,KEGG_2021_Human,GnRH secretion,2/64,0.1226438163832368,0.6640795869213381,0,0,3.406762118337071,7.148991258211783,ITPR2;CACNA1C
1449,KEGG_2021_Human,Oocyte meiosis,3/129,0.123288402982508,0.6640795869213381,0,0,2.5198412698412698,5.274604641328511,PPP3CA;ITPR2;CPEB4
1450,KEGG_2021_Human,Cortisol synthesis and secretion,2/65,0.1257865596889854,0.6640795869213381,0,0,3.35251676428147,6.950333087264424,ITPR2;CACNA1C
1451,KEGG_2021_Human,Amphetamine addiction,2/69,0.1385428514202368,0.6640795869213381,0,0,3.151727991060739,6.229628659692471,PPP3CA;CACNA1C
1452,KEGG_2021_Human,Measles,3/139,0.1446932809963262,0.6640795869213381,0,0,2.3333728652751424,4.51073427512395,BCL2;MAP3K7;IFNAR1
1453,KEGG_2021_Human,Lipid and atherosclerosis,4/215,0.1468313292660306,0.6640795869213381,0,0,2.008453951581913,3.85316020091424,PPP3CA;BCL2;MAP3K7;NFE2L2
1454,KEGG_2021_Human,Selenocompound metabolism,1/17,0.1491150502899167,0.6640795869213381,0,0,6.580784574468085,12.52347733311014,MTR
1455,KEGG_2021_Human,Regulation of actin cytoskeleton,4/218,0.1520771984101253,0.6640795869213381,0,0,1.9799949482192476,3.7290571511636337,CHRM3;RDX;ITGB8;GNG12
1456,KEGG_2021_Human,Gastric acid secretion,2/76,0.1614862669771164,0.6640795869213381,0,0,2.8525798525798525,5.201209182230431,CHRM3;ITPR2
1457,KEGG_2021_Human,Pathways of neurodegeneration,7/475,0.1642409575833096,0.6640795869213381,0,0,1.5896614069690993,2.871597233226268,CHRM3;PPP3CA;ATXN1;BCL2;ITPR2;CACNA1C;COX6B2
1458,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,2/77,0.1648190846691282,0.6640795869213381,0,0,2.814402852049911,5.0741062177156495,ITGB8;CACNA1C
1459,KEGG_2021_Human,Retrograde endocannabinoid signaling,3/148,0.1649186669642718,0.6640795869213381,0,0,2.1875417130144603,3.9426126728276953,ITPR2;CACNA1C;GNG12
1460,KEGG_2021_Human,Oxytocin signaling pathway,3/154,0.1788426595769581,0.6640795869213381,0,0,2.099978637043366,3.614585827606258,PPP3CA;ITPR2;CACNA1C
1461,KEGG_2021_Human,Cellular senescence,3/156,0.1835544679362861,0.6640795869213381,0,0,2.072317098882564,3.5130827705895085,PPP3CA;ITPR2;HIPK3
1462,KEGG_2021_Human,Arginine biosynthesis,1/22,0.188603398542744,0.6640795869213381,0,0,5.012664640324215,8.361670444603366,GLS
1463,KEGG_2021_Human,Taste transduction,2/86,0.1953005837306723,0.6640795869213381,0,0,2.5117137764196587,4.102169751181436,CHRM3;CACNA1C
1464,KEGG_2021_Human,Insulin secretion,2/86,0.1953005837306723,0.6640795869213381,0,0,2.5117137764196587,4.102169751181436,CHRM3;CACNA1C
1465,KEGG_2021_Human,Mannose type O-glycan biosynthesis,1/23,0.1962795291870694,0.6640795869213381,0,0,4.784574468085107,7.790318149286441,POMK
1466,KEGG_2021_Human,Proximal tubule bicarbonate reclamation,1/23,0.1962795291870694,0.6640795869213381,0,0,4.784574468085107,7.790318149286441,GLS
1467,KEGG_2021_Human,Hepatitis B,3/162,0.197882316702814,0.6640795869213381,0,0,1.9935078109149929,3.229647686378671,BCL2;MAP3K7;IFNAR1
1468,KEGG_2021_Human,JAK-STAT signaling pathway,3/162,0.197882316702814,0.6640795869213381,0,0,1.9935078109149929,3.229647686378671,BCL2;PIAS2;IFNAR1
1469,KEGG_2021_Human,Cardiac muscle contraction,2/87,0.1987324566199866,0.6640795869213381,0,0,2.4820383768480654,4.01046717959294,CACNA1C;COX6B2
1470,KEGG_2021_Human,Wnt signaling pathway,3/166,0.207581204902502,0.6640795869213381,0,0,1.9441915693647336,3.0567214961459057,PPP3CA;MAP3K7;CXXC4
1471,KEGG_2021_Human,Hypertrophic cardiomyopathy,2/90,0.2090701326333077,0.6640795869213381,0,0,2.397058823529412,3.751602056413905,ITGB8;CACNA1C
1472,KEGG_2021_Human,cGMP-PKG signaling pathway,3/167,0.2100227892507753,0.6640795869213381,0,0,1.9322383949645947,3.0153338246110373,PPP3CA;ITPR2;CACNA1C
1473,KEGG_2021_Human,Tight junction,3/169,0.2149250550633125,0.6640795869213381,0,0,1.9087640886125143,2.9346596834978858,PARD6B;RDX;RAPGEF6
1474,KEGG_2021_Human,Endocytosis,4/252,0.2159470821101395,0.6640795869213381,0,0,1.7055797733217088,2.614179456344523,PARD6B;GRK5;CAV2;WWP1
1475,KEGG_2021_Human,Salivary secretion,2/93,0.2194618617493781,0.6640795869213381,0,0,2.317682317682318,3.514943260893697,CHRM3;ITPR2
1476,KEGG_2021_Human,GnRH signaling pathway,2/93,0.2194618617493781,0.6640795869213381,0,0,2.317682317682318,3.514943260893697,ITPR2;CACNA1C
1477,KEGG_2021_Human,IL-17 signaling pathway,2/94,0.2229358450352153,0.6640795869213381,0,0,2.2923738665426643,3.4405580061036805,USP25;MAP3K7
1478,KEGG_2021_Human,Collecting duct acid secretion,1/27,0.2262683966074298,0.6640795869213381,0,0,4.047667757774141,6.01496943456091,ATP6V1A
1479,KEGG_2021_Human,Dilated cardiomyopathy,2/96,0.2298965272128094,0.6640795869213381,0,0,2.2433723973148254,3.29803998346794,ITGB8;CACNA1C
1480,KEGG_2021_Human,Circadian entrainment,2/97,0.2333824524117058,0.6640795869213381,0,0,2.2196453701097663,3.22975435891768,CACNA1C;GNG12
1481,KEGG_2021_Human,Aldosterone synthesis and secretion,2/98,0.236871595914967,0.6640795869213381,0,0,2.1964126559714794,3.163354937056446,ITPR2;CACNA1C
1482,KEGG_2021_Human,Axon guidance,3/182,0.2473280279411025,0.6640795869213381,0,0,1.768967381510182,2.471317792799153,PPP3CA;PARD6B;SEMA6D
1483,KEGG_2021_Human,Pancreatic secretion,2/102,0.2508530547945053,0.6640795869213381,0,0,2.108128342245989,2.915305282288427,CHRM3;ITPR2
1484,KEGG_2021_Human,T cell receptor signaling pathway,2/104,0.2578537884033945,0.6640795869213381,0,0,2.066582782845759,2.8009689440643366,PPP3CA;MAP3K7
1485,KEGG_2021_Human,Toll-like receptor signaling pathway,2/104,0.2578537884033945,0.6640795869213381,0,0,2.066582782845759,2.8009689440643366,MAP3K7;IFNAR1
1486,KEGG_2021_Human,C-type lectin receptor signaling pathway,2/104,0.2578537884033945,0.6640795869213381,0,0,2.066582782845759,2.8009689440643366,PPP3CA;ITPR2
1487,KEGG_2021_Human,NF-kappa B signaling pathway,2/104,0.2578537884033945,0.6640795869213381,0,0,2.066582782845759,2.8009689440643366,BCL2;MAP3K7
1488,KEGG_2021_Human,Glucagon signaling pathway,2/107,0.2683598308997783,0.6640795869213381,0,0,2.007231983702572,2.640366236169961,PPP3CA;ITPR2
1489,KEGG_2021_Human,Alzheimer disease,5/369,0.2707192550933099,0.6640795869213381,0,0,1.4517887004300047,1.8970130299840355,CHRM3;PPP3CA;ITPR2;CACNA1C;COX6B2
1490,KEGG_2021_Human,Chemokine signaling pathway,3/192,0.2727418698853883,0.6640795869213381,0,0,1.6745178358081585,2.1755829080139875,GRK5;GNG12;CXCL16
1491,KEGG_2021_Human,Nicotinate and nicotinamide metabolism,1/35,0.2829474603528049,0.6640795869213381,0,0,3.094023779724656,3.906186615672604,NAMPT
1492,KEGG_2021_Human,Toxoplasmosis,2/112,0.2858620834012417,0.6640795869213381,0,0,1.9155080213903743,2.3986868944594413,BCL2;MAP3K7
1493,KEGG_2021_Human,Mucin type O-glycan biosynthesis,1/36,0.2897354754914663,0.6640795869213381,0,0,3.005471124620061,3.723138334881813,GALNT13
1494,KEGG_2021_Human,Focal adhesion,3/201,0.2958456031485871,0.6640795869213381,0,0,1.5976702508960574,1.9458306723948509,CAV2;BCL2;ITGB8
1495,KEGG_2021_Human,"Alanine, aspartate and glutamate metabolism",1/37,0.2964595682571994,0.6640795869213381,0,0,2.921838061465721,3.5525005418174813,GLS
1496,KEGG_2021_Human,Epstein-Barr virus infection,3/202,0.2984216663649698,0.6640795869213381,0,0,1.5895607067596045,1.922172795287834,BCL2;MAP3K7;IFNAR1
1497,KEGG_2021_Human,Proteoglycans in cancer,3/205,0.3061572475025996,0.6640795869213381,0,0,1.5657138294474608,1.8532672390939755,CAV2;RDX;ITPR2
1498,KEGG_2021_Human,Various types of N-glycan biosynthesis,1/39,0.3097183761096093,0.6640795869213381,0,0,2.767777155655095,3.244089070477027,MGAT4A
1499,KEGG_2021_Human,Sphingolipid signaling pathway,2/119,0.3102877703355498,0.6640795869213381,0,0,1.8002650943827414,2.1067694453079877,ASAH1;BCL2
1500,KEGG_2021_Human,"Growth hormone synthesis, secretion and action",2/119,0.3102877703355498,0.6640795869213381,0,0,1.8002650943827414,2.1067694453079877,ITPR2;CACNA1C
1501,KEGG_2021_Human,Neurotrophin signaling pathway,2/119,0.3102877703355498,0.6640795869213381,0,0,1.8002650943827414,2.1067694453079877,NTRK2;BCL2
1502,KEGG_2021_Human,Rap1 signaling pathway,3/210,0.319066995172007,0.6640795869213381,0,0,1.527505064671965,1.7449517987067795,PARD6B;MAGI2;RAPGEF6
1503,KEGG_2021_Human,cAMP signaling pathway,3/216,0.3345682362958077,0.6640795869213381,0,0,1.4840224140542178,1.6248775486353848,PDE4D;PDE4B;CACNA1C
1504,KEGG_2021_Human,Lysosome,2/128,0.3414289530957894,0.6640795869213381,0,0,1.6709107885578474,1.7955869086341008,ASAH1;AP4B1
1505,KEGG_2021_Human,Vasopressin-regulated water reabsorption,1/44,0.3417879913863361,0.6640795869213381,0,0,2.4453240969816923,2.625213489652861,DYNC2LI1
1506,KEGG_2021_Human,Purine metabolism,2/129,0.3448642368667688,0.6640795869213381,0,0,1.6576697966230156,1.7647626516086876,PDE4D;PDE4B
1507,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,2/131,0.3517173781531811,0.6640795869213381,0,0,1.6318036728433445,1.70511625308354,PPP3CA;IFNAR1
1508,KEGG_2021_Human,Type II diabetes mellitus,1/46,0.3541968763481647,0.6640795869213381,0,0,2.3364066193853428,2.424961973536866,CACNA1C
1509,KEGG_2021_Human,Human cytomegalovirus infection,3/225,0.3577878124757045,0.6640795869213381,0,0,1.4232054635280442,1.4627921666946766,PPP3CA;ITPR2;GNG12
1510,KEGG_2021_Human,Vascular smooth muscle contraction,2/133,0.3585459868415123,0.6640795869213381,0,0,1.6067273543699228,1.6480175986237933,ITPR2;CACNA1C
1511,KEGG_2021_Human,Oxidative phosphorylation,2/133,0.3585459868415123,0.6640795869213381,0,0,1.6067273543699228,1.6480175986237933,ATP6V1A;COX6B2
1512,KEGG_2021_Human,Other types of O-glycan biosynthesis,1/47,0.3603137742640697,0.6640795869213381,0,0,2.2854995374653098,2.33299229092702,GALNT13
1513,KEGG_2021_Human,Apelin signaling pathway,2/137,0.3721236741947494,0.6640795869213381,0,0,1.558803723509606,1.5409227209892165,ITPR2;GNG12
1514,KEGG_2021_Human,Autophagy,2/137,0.3721236741947494,0.6640795869213381,0,0,1.558803723509606,1.5409227209892165,BCL2;MAP3K7
1515,KEGG_2021_Human,Estrogen signaling pathway,2/137,0.3721236741947494,0.6640795869213381,0,0,1.558803723509606,1.5409227209892165,BCL2;ITPR2
1516,KEGG_2021_Human,Sphingolipid metabolism,1/49,0.3723752074302826,0.6640795869213381,0,0,2.1900487588652484,2.1634469174820667,ASAH1
1517,KEGG_2021_Human,Thermogenesis,3/232,0.3757764297531913,0.6640795869213381,0,0,1.3792083392027046,1.3499152148926334,COX6B2;SMARCA2;COX20
1518,KEGG_2021_Human,Vibrio cholerae infection,1/50,0.3783208179838206,0.6640795869213381,0,0,2.1452453321754232,2.085205747179162,ATP6V1A
1519,KEGG_2021_Human,Cysteine and methionine metabolism,1/50,0.3783208179838206,0.6640795869213381,0,0,2.1452453321754232,2.085205747179162,MTR
1520,KEGG_2021_Human,N-Glycan biosynthesis,1/50,0.3783208179838206,0.6640795869213381,0,0,2.1452453321754232,2.085205747179162,MGAT4A
1521,KEGG_2021_Human,Human papillomavirus infection,4/331,0.3817601557295081,0.6640795869213381,0,0,1.288304818580048,1.240589527938647,ATP6V1A;PARD6B;ITGB8;IFNAR1
1522,KEGG_2021_Human,Ubiquitin mediated proteolysis,2/140,0.3822318552628632,0.6640795869213381,0,0,1.5246841819731844,1.466331321898649,WWP1;PIAS2
1523,KEGG_2021_Human,Apoptosis,2/142,0.3889324287598575,0.6680254987974689,0,0,1.502750190985485,1.4191216250690293,BCL2;ITPR2
1524,KEGG_2021_Human,Spinocerebellar ataxia,2/143,0.3922707870845602,0.6680254987974689,0,0,1.4920165358212918,1.3962333925556445,ATXN1;ITPR2
1525,KEGG_2021_Human,Shigellosis,3/246,0.411422916798079,0.6798384462935919,0,0,1.2988185317934422,1.1535243769538337,BCL2;ITPR2;MAP3K7
1526,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,2/150,0.4154032521299532,0.6798384462935919,0,0,1.4209423327070383,1.2483057093981609,BCL2;CACNA1C
1527,KEGG_2021_Human,Salmonella infection,3/249,0.4189858375083237,0.6798384462935919,0,0,1.282782585890375,1.115915867217755,DYNC2LI1;BCL2;MAP3K7
1528,KEGG_2021_Human,Parkinson disease,3/249,0.4189858375083237,0.6798384462935919,0,0,1.282782585890375,1.115915867217755,ITPR2;COX6B2;NFE2L2
1529,KEGG_2021_Human,VEGF signaling pathway,1/59,0.4293720233296841,0.6798384462935919,0,0,1.8115370506236244,1.5315305740460652,PPP3CA
1530,KEGG_2021_Human,Notch signaling pathway,1/59,0.4293720233296841,0.6798384462935919,0,0,1.8115370506236244,1.5315305740460652,ATXN1
1531,KEGG_2021_Human,Cushing syndrome,2/155,0.4316565199063786,0.6798384462935919,0,0,1.374156792841914,1.154463612728904,ITPR2;CACNA1C
1532,KEGG_2021_Human,Viral myocarditis,1/60,0.4347804016993901,0.6798384462935919,0,0,1.7807428777497296,1.4832060277160146,EIF4G3
1533,KEGG_2021_Human,Long-term depression,1/60,0.4347804016993901,0.6798384462935919,0,0,1.7807428777497296,1.4832060277160146,ITPR2
1534,KEGG_2021_Human,Necroptosis,2/159,0.4444858928824486,0.6887529150971275,0,0,1.3388739398480876,1.0856084773239534,BCL2;IFNAR1
1535,KEGG_2021_Human,Hippo signaling pathway,2/163,0.4571541398503365,0.7020581433415883,0,0,1.3053442720961903,1.021738203215913,MOB1B;PARD6B
1536,KEGG_2021_Human,Hepatocellular carcinoma,2/168,0.4727540264157597,0.7086066104901709,0,0,1.265704529347336,0.9482405882410816,SMARCA2;NFE2L2
1537,KEGG_2021_Human,Mitophagy,1/68,0.4762513396174245,0.7086066104901709,0,0,1.5674817402349952,1.162772908212185,TAX1BP1
1538,KEGG_2021_Human,Influenza A,2/172,0.4850393683741372,0.7086066104901709,0,0,1.235671594841145,0.8940395618051542,DNAJC3;IFNAR1
1539,KEGG_2021_Human,Central carbon metabolism in cancer,1/70,0.4861370932432568,0.7086066104901709,0,0,1.5218933086648163,1.0976877837318262,GLS
1540,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,1/70,0.4861370932432568,0.7086066104901709,0,0,1.5218933086648163,1.0976877837318262,ATP6V1A
1541,KEGG_2021_Human,RIG-I-like receptor signaling pathway,1/70,0.4861370932432568,0.7086066104901709,0,0,1.5218933086648163,1.0976877837318262,MAP3K7
1542,KEGG_2021_Human,Adherens junction,1/71,0.4910101422937567,0.7096953317187071,0,0,1.5000759878419452,1.0669897919270015,MAP3K7
1543,KEGG_2021_Human,p53 signaling pathway,1/73,0.5006187620991769,0.710004378331421,0,0,1.4582594562647757,1.0089849149873038,BCL2
1544,KEGG_2021_Human,Tuberculosis,2/180,0.5090728305160297,0.710004378331421,0,0,1.1796551102565642,0.7964608836622468,PPP3CA;BCL2
1545,KEGG_2021_Human,Thyroid hormone synthesis,1/75,0.510046933272438,0.710004378331421,0,0,1.4187032777458308,0.95514557315215,ITPR2
1546,KEGG_2021_Human,Bacterial invasion of epithelial cells,1/77,0.5192980268305403,0.710004378331421,0,0,1.3812290033594623,0.9050880504159952,CAV2
1547,KEGG_2021_Human,Leishmaniasis,1/77,0.5192980268305403,0.710004378331421,0,0,1.3812290033594623,0.9050880504159952,MAP3K7
1548,KEGG_2021_Human,Synaptic vesicle cycle,1/78,0.5238582058577641,0.710004378331421,0,0,1.3632218844984805,0.8813696124873632,ATP6V1A
1549,KEGG_2021_Human,Alcoholism,2/186,0.5266139491359411,0.710004378331421,0,0,1.1408393396884446,0.7316060573536031,NTRK2;GNG12
1550,KEGG_2021_Human,RNA transport,2/186,0.5266139491359411,0.710004378331421,0,0,1.1408393396884446,0.7316060573536031,TRNT1;EIF4G3
1551,KEGG_2021_Human,RNA degradation,1/79,0.5283753513164063,0.710004378331421,0,0,1.3456764866339337,0.8584721012735822,DIS3L
1552,KEGG_2021_Human,B cell receptor signaling pathway,1/81,0.537282153678791,0.7163762049050546,0,0,1.311901595744681,0.8149951164980914,PPP3CA
1553,KEGG_2021_Human,Peroxisome,1/82,0.5416726071913932,0.7166745264378434,0,0,1.2956396112424482,0.794348231541045,PECR
1554,KEGG_2021_Human,Colorectal cancer,1/86,0.5588238918519959,0.7278364639562899,0,0,1.2344180225281602,0.7183336427853815,BCL2
1555,KEGG_2021_Human,MicroRNAs in cancer,3/310,0.5634976580277229,0.7278364639562899,0,0,1.0246926552485027,0.5877556136473379,RDX;BCL2;GLS
1556,KEGG_2021_Human,ECM-receptor interaction,1/88,0.5671585753182062,0.7278364639562899,0,0,1.2059183174370265,0.6838959826123543,ITGB8
1557,KEGG_2021_Human,Gap junction,1/88,0.5671585753182062,0.7278364639562899,0,0,1.2059183174370265,0.6838959826123543,ITPR2
1558,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,1/89,0.5712669920587159,0.7278364639562899,0,0,1.1921542553191489,0.6674854887829307,PPP3CA
1559,KEGG_2021_Human,Small cell lung cancer,1/92,0.583360945693056,0.732017501876569,0,0,1.1526771101239186,0.6212343676056309,BCL2
1560,KEGG_2021_Human,Th1 and Th2 cell differentiation,1/92,0.583360945693056,0.732017501876569,0,0,1.1526771101239186,0.6212343676056309,PPP3CA
1561,KEGG_2021_Human,Rheumatoid arthritis,1/93,0.5873163677846891,0.732017501876569,0,0,1.1400901942645698,0.606746478551064,ATP6V1A
1562,KEGG_2021_Human,Phosphatidylinositol signaling system,1/97,0.6027680021033904,0.7333623894179548,0,0,1.092364804964539,0.5529800747843862,ITPR2
1563,KEGG_2021_Human,Prostate cancer,1/97,0.6027680021033904,0.7333623894179548,0,0,1.092364804964539,0.5529800747843862,BCL2
1564,KEGG_2021_Human,mRNA surveillance pathway,1/98,0.6065401271846599,0.7333623894179548,0,0,1.0810484755428822,0.5405073635769386,CPSF2
1565,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,1/98,0.6065401271846599,0.7333623894179548,0,0,1.0810484755428822,0.5405073635769386,ITPR2
1566,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.6139778143964273,0.7333623894179548,0,0,1.0591016548463357,0.5166260638484753,BCL2
1567,KEGG_2021_Human,Progesterone-mediated oocyte maturation,1/100,0.6139778143964273,0.7333623894179548,0,0,1.0591016548463357,0.5166260638484753,CPEB4
1568,KEGG_2021_Human,Th17 cell differentiation,1/107,0.6389253142273043,0.7515164327825264,0,0,0.988809714973906,0.4429548242151346,PPP3CA
1569,KEGG_2021_Human,HIF-1 signaling pathway,1/109,0.6457538853778853,0.7515164327825264,0,0,0.9703999211977936,0.4243916255425338,BCL2
1570,KEGG_2021_Human,Coronavirus disease,2/232,0.6466536747198484,0.7515164327825264,0,0,0.9105324343176006,0.3969415216175845,MAP3K7;IFNAR1
1571,KEGG_2021_Human,Ras signaling pathway,2/232,0.6466536747198484,0.7515164327825264,0,0,0.9105324343176006,0.3969415216175845,NTRK2;GNG12
1572,KEGG_2021_Human,TNF signaling pathway,1/112,0.655756612516465,0.7569807876028992,0,0,0.9440291355184972,0.3983477982956184,MAP3K7
1573,KEGG_2021_Human,Chemical carcinogenesis,2/239,0.6626626361211028,0.7598531560855312,0,0,0.8833231796746317,0.3634780039870586,BCL2;CACNA1C
1574,KEGG_2021_Human,Amyotrophic lateral sclerosis,3/364,0.6716719236285603,0.7650832507557112,0,0,0.8690018765079082,0.3458499434612445,PPP3CA;BCL2;COX6B2
1575,KEGG_2021_Human,AMPK signaling pathway,1/120,0.6810780389255715,0.7690648707963769,0,0,0.8802074021097801,0.3380686372858019,MAP3K7
1576,KEGG_2021_Human,Thyroid hormone signaling pathway,1/121,0.6841100304177073,0.7690648707963769,0,0,0.8728280141843971,0.331357382106564,THRB
1577,KEGG_2021_Human,Platelet activation,1/124,0.693035035804481,0.7740391308985112,0,0,0.8514097906936516,0.3121904503146862,ITPR2
1578,KEGG_2021_Human,Relaxin signaling pathway,1/129,0.7073560334170956,0.7849370177273577,0,0,0.8179438164893617,0.2831894541028257,GNG12
1579,KEGG_2021_Human,Yersinia infection,1/137,0.7288997621664047,0.8036587121321899,0,0,0.7695165832290363,0.2433358082061613,MAP3K7
1580,KEGG_2021_Human,Pathways in cancer,4/531,0.742590682581871,0.8063652450785687,0,0,0.7911790348222986,0.2354630175167747,BCL2;GNG12;IFNAR1;NFE2L2
1581,KEGG_2021_Human,Cell adhesion molecules,1/148,0.7559691835213245,0.8063652450785687,0,0,0.7115356781010277,0.1990554260961577,ITGB8
1582,KEGG_2021_Human,Gastric cancer,1/149,0.7582924527504591,0.8063652450785687,0,0,0.7066920644048303,0.1955319038356254,BCL2
1583,KEGG_2021_Human,Spliceosome,1/150,0.7605937192718881,0.8063652450785687,0,0,0.7019134656575753,0.1920827900285196,PRPF3
1584,KEGG_2021_Human,Phagosome,1/152,0.7651310714551991,0.8063652450785687,0,0,0.6925461462589827,0.1854002300113539,ATP6V1A
1585,KEGG_2021_Human,mTOR signaling pathway,1/154,0.769582875087977,0.8063652450785687,0,0,0.6834237240995689,0.1789932055228445,ATP6V1A
1586,KEGG_2021_Human,Cytokine-cytokine receptor interaction,2/295,0.7705497286059522,0.8063652450785687,0,0,0.7124527750907996,0.1857015892725884,CXCL16;IFNAR1
1587,KEGG_2021_Human,Non-alcoholic fatty liver disease,1/155,0.7717771987998114,0.8063652450785687,0,0,0.6789513677811551,0.1758887157720408,COX6B2
1588,KEGG_2021_Human,Hepatitis C,1/157,0.7761036787202905,0.8063652450785687,0,0,0.6701786688488817,0.1698696249971107,IFNAR1
1589,KEGG_2021_Human,Ribosome,1/158,0.7782362249014093,0.8063652450785687,0,0,0.6658761349776392,0.1669519070823661,MRPS6
1590,KEGG_2021_Human,Neutrophil extracellular trap formation,1/189,0.835206759175329,0.8553847917706107,0,0,0.5552003168854686,0.0999782350545738,MAP3K7
1591,KEGG_2021_Human,Neuroactive ligand-receptor interaction,2/341,0.83549212219455,0.8553847917706107,0,0,0.6143265029261906,0.1104155807378228,CHRM3;THRB
1592,KEGG_2021_Human,Pathogenic Escherichia coli infection,1/197,0.8473738939295655,0.8624160340584928,0,0,0.5323219713417282,0.0881595709336651,MAP3K7
1593,KEGG_2021_Human,Diabetic cardiomyopathy,1/203,0.8559089369108723,0.865978453815706,0,0,0.516352433115652,0.0803399414795445,COX6B2
1594,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,1/219,0.8764180092125162,0.8815432607283789,0,0,0.4780646105797384,0.063062517422709,PPP3CA
1595,KEGG_2021_Human,Huntington disease,1/306,0.9464911352820512,0.9464911352820512,0,0,0.3401813742588071,0.0187078236527197,COX6B2
